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ABSTRACT
Pointing the Zinc Finger on Protein Folding: Energetic Investigation into The Role of The Metal-Ion in
The Metal-Induced Protein Folding of Zinc Finger Motifs
by
Inna Bakman-Sanchez
Advisor: Dr. Brian R. Gibney
Interactions between inorganic metal-ion cofactors and organic protein scaffolds are important for
the proper structure and function of metalloproteins. Zinc finger proteins (ZFPs) are an example of proteins
with such crucial metal-protein interactions. Incorporation of the Zn(II)-ion into ZFPs allows for their correct
folding into structures that can carry out vital biological functions which include gene expression and tumor
suppression. In addition, engineered ZFPs have shown to be promising genetic therapeutics in the clinic.
And yet, there is still a gap in a quantitative understanding of the energetic contribution of the metal-protein
interactions towards the structure and function of these important metalloproteins. Detailed knowledge of
the principles that governs such interactions in natural metalloproteins will provide the much-needed insight
for the rational construction of novel engineered zinc proteins for promising corrective therapeutics for
genetic disorders. In this thesis, the investigation of the role that a specific metal-ion has on the energetics
of metal-induced protein folding events is presented. To compare with Zn(II) related studies, an
unstructured peptide scaffold, GGG, with Cys4-xHisx (x=0,1,2) metal-binding coordination motifs is utilized
to determine the thermodynamics of Co(II) and Pb(II) binding to the three motifs. Furthermore, the
difference between Co(II) and Pb(II) affinities to GGG and their affinities to natural ZFPs that undergo metalinduced protein folding events, provides the energetic cost of folding for these natural ZFPs – values that
were hithertofore unknown. The data demonstrate that the Co(II)-ion has no binding preference for cysteine
thiolate over histidine imidazole, while Pb(II)-ion prefers cysteine thiolate. Each substitution of Cys by His
lower the contribution of Pb(II)-binding towards protein stabilization by approximately 2.0 kcal/mol - similarly
to previously observed results for Zn(II). Lastly, both metal-ion studies agreed with previous Zn(II) studies,
indicating that the cost for apo-ZFPs folding in natural ZFPs is minimal, less than 4.5 kcal/mol.
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CHAPTER ONE – Introduction
Life, which is presumably viewed as organic, is, as a matter of fact, inorganic too. More than 30%
of all proteins and almost 50% of all enzymes require incorporation of a metal cofactor for a proper structure
and function.[1,2,3] These metal cofactors aid in many important biological processes, such as respiration
and photosynthesis, water oxidation, nitrogen fixation, genetic transcription and translation, and drug
metabolism.[1,4] Thus, the diversity in a cellular proteome can be partially attributed to these metal cofactors,
their coordination geometries, and the protein folding around them. Scientific intrigue into metalloprotein
structure-function relationships can be traced back to the late 1950’s when the first protein X-ray crystal
structure, sperm whale myoglobin, showed the presence of an iron-ion.[5] After more than half a century of
research, we gained a vast understanding of the common metal-ion cofactors, how these inorganic
cofactors are trafficked and introduced into proteins, and how they interact with the protein scaffolding
around them. Despite these advances, there is still very little quantitative knowledge about the energetic
contribution of the metal-protein interactions towards the structure and function of these metalloproteins.
Understanding the fundamental thermodynamics of such interactions will provide integral insight into the
fundamental principles of protein folding of natural metalloproteins and will contribute greatly to improving
the rational design of engineered metalloproteins for therapeutics.

1.1 Structural and Functional Roles of Metal Cofactors
The role of metal-ion cofactors can be broadly categorized into two roles - structural and functional.
Structural metal-ions are essential for proper folding and stabilization of the native structure of
metalloproteins and are therefore integral to the protein’s biochemical function. It can simply be put as the structural metal cofactors ‘activate’ the protein by folding it into the required structure for its appropriate
function. Functional metal-ions, on the other hand, are cofactors that are present in the active site of
metalloproteins and carry out biological reactions, such as electron transfer, substrate binding, and a variety
of catalysis processes.[1,3,4]
In terms of structural metal cofactors - although the primary structure of a protein encodes for its
possible secondary and tertiary folded structures, many proteins require incorporation of a metal cofactor
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for additional structural information that ensures correct folding and stabilization.[3,4] For example, the
classical C2H2 zinc finger transcription factor, which has a primary amino acid sequence that encodes for
secondary ββα fold, is found unstructured until Zn(II)-ion is incorporated into its binding site. As a result,
the protein gains a tetrahedral coordination around the metal-ion which allows it to bind deoxyribonucleic
acid (DNA) (Figure 1.1).[6-9]

Figure 1.1: Zn(II)-ion as a structural metal cofactor in a classical C2H2 zinc finger domain. The primary
amino acid sequence of Finger 1 domain in Zif268 protein (PDB: 1ZAA)[10] encodes for secondary ββα fold
but remains unfolded and lacking the secondary structure. Pink, yellow, and green represent α-helix,
β-sheets, and loop regions, respectively. The incorporation of Zn(II)-ion into the binding site of the ZFP
leads to a ββα folded holo-structure, allowing for the exposed α-helix to bind to DNA.

In terms of functional metal cofactors, a variety of metal ions bring their intrinsic chemical reactivity
to biochemical processes. Iron and copper ions are examples of redox-active metals that can switch
between oxidized and reduced forms, and thus, facilitate electron-transfer reactions as observed in the
heme-binding cytochromes and blue-copper proteins involved in respiration and photosynthesis,
respectively. These two metal ions also aid in the storage and transport of dioxygen (O 2) when found in the
hemoproteins hemoglobin and myoglobin (for iron ion), or hemocyanin (for copper ion).[11,12] The fact that
the same metal cofactor can have different biochemical functions is attributed to the protein’s overall
structure, the variety of the coordinating ligands to the metal, the electrostatic forces, hydrogen bonding,
and other factors. In fact, there are some cases that show that the factors that govern how a protein affects
the function of the metal cofactor are much more subtle, for example, as with heme-metalloenzymes allene
oxide synthase (AOS) and catalase. AOS is an enzyme in the prostaglandin synthesis pathway that
catalyzes the epoxidation of fatty acid hydroperoxides into allene oxides[13,14], while the catalase is an
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enzyme that protects organisms from reactive oxygen species by disproportionating hydrogen peroxide into
water and dioxygen[15]. Both enzymes are five-coordinate hemoproteins bound by a proximal tyrosinate
ligand and with distal histidine (His) and asparagine (Asn) residues within hydrogen-bonding distance from
each other. In addition, both enzymes exhibit similar overall protein structure, i.e. a β-barrel (Figure 1.2).
Despite the structural similarities between the two and the microenvironment of the metal cofactor within
them, neither of these enzymes can catalyze the reaction of the other.[13] This example emphasizes the gap
in our understanding of these complex metal-protein interactions and how they regulate chemical properties
and reactivities of the metal cofactors.

Figure 1.2: Heme-metalloenzymes allene oxide synthase (AOS) and catalase. (A) Structure of AOS (PDB:
1U5U)[16] and a schematic representation of the proposed epoxidation mechanism of hydroperoxides.
(B) Structure of catalase (PDB: 1M7S)[17] and the proposed mechanism for its function - hydrogen peroxide
disproportionation.
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1.2 Zinc - an Essential Metal Cofactor
Zn(II) is one of the most prevalent and essential metal cofactors in living organisms. In 1869,
Raulin[18] was the first to show the nutritional importance of Zn(II) while studying the growth of Aspergillus
niger, a common bread mold. About a century later, in 1963, Prasad et al.[19] presented evidence of the
nutritional essentiality of Zn(II) to humans. Today, the importance of Zn(II)-ion is established on the
molecular level is essential to the development, growth, homeostasis and healing processes in biological
systems.[20-22] As a matter of fact, it has been determined that about 10% of all encoded proteins in
eukaryotes bind Zn(II)-ion as a metal cofactor.[23] The biochemical utility of Zn(II) can be attributed to it being
a moderate Lewis acid thus capable of binding soft, borderline, and hard ligands (e.g. cysteine thiolates,
histidine imidazoles, and carboxylate groups), soluble, readily bioavailable in the cell, redox inactivity, rapid
ligand exchange kinetics, and the fact that it is a non-toxic ion.[21,24]
Zn(II)-ion can be found both as a functional and structural cofactor in metalloproteins. Carbonic
anhydrase (CA) is an example of Zn(II) in the role of a functional (catalytic) cofactor. CA has a pre-folded
Zn(II) binding site with three His-residues. Zn(II) binds in a tetrahedral geometry with water or hydroxide ion
binding as a fourth ligand and catalyzing the reversible hydration of carbon dioxide (Figure 1.3A).[25,26]
Another example is the DNA repair protein Escherichia coli Ada (Figure 1.3B). Ada has a catalytic Cys4
binding site in which Zn(II) activates one of the thiolate ligands to act as a nucleophile and participate in the
repair process of methyl groups on the phosphotriesters in DNA.[27] Interestingly, even though Zn(II) itself
is redox inert, it plays a pivotal role as a functional cofactor in the redox-active zinc sites, or ‘redox switches’,
such as heat shock protein Hsp33 and protein kinase C. These switches regulate antioxidant response
within the cell and therefore are involved in the cellular defense against oxidative stress.[28,29]
Although Zn(II) can act as both functional and structural metal cofactor, it has been shown that in
66% of all unique Zn(II)-binding metalloproteins deposited to the Protein Data Bank (PDB), Zn(II)-ion is
exclusively a structural cofactor[32]. These metalloproteins can be further categorized by the organization of
their Zn(II)-binding site: (1) pre-organized site with structured apo- and holo-state proteins, (2) disorganized
site with structured apo- and holo-state proteins, and (3) disorganized site with structured holo-state protein
only.
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Figure 1.3: Zn(II)-ion as a functional metal cofactor. (A) Structure of carbonic anhydrase (PDB: 2ILI)[30] with
a Zn(II)-His3 active site and a schematic representation of CO2 capture and regeneration mechanism.
(B) Structure of E. coli Ada (PDB: 1ZGW)[31] with an active site where Zn(II)-ion is surrounded by four
coordinating Cys-residues, and the proposed mechanism pathway for DNA repair by Ada.

Human transcription factor IIB (TFIIB) is an example of the first group - a pre-organized site with
structured apo- and holo-state. It plays an essential role in initiation of RNA polymerase II (pol II)
transcription by recognizing the promoter, recruitment of pol II, and selection of the transcription start
site.[33,34] In other words, TFIIB acts as a bridge between promoter TFIID and pol II by docking its N-terminal
domain, containing the Zn(II)-Cys3His1 ribbon, into pol II. Interestingly, the apo- and the Zn(II)-TFIIB
structures of the N-terminal domain are nearly identical (Figure 1.4A), which leads to the conclusion that
metal-coordination doesn’t result in significant structural rearrangement of TFIIB, the presence of structural
Zn(II) metal cofactor is still necessary for activating this metalloprotein.
Virion infectivity factor (Vif), an accessory protein to the human immunodeficiency virus (HIV), is an
example for the second structural group - a disorganized active site with structured apo- and holo-state.
Vif is an essential protein for HIV replication in the host cells. It functions as a counter-defense to the CD4+
T cells defense mechanism by neutralizing the antiviral host protein APOBEC3 (apolipoprotein B mRNA
editing catalytic polypeptide). When HIV enters the host cell, the immune system activates APOBEC3 which
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mutates cytosines in single-strand DNA replication intermediates of the virus and by that blocks the reverse
transcription of HIV. The Zn(II)-ion cofactor binds to the HCCH domain in Vif, leading to a significant
confirmation change from mostly a random-coil conformation (apo-state) to a more stabilized holo-structure
with an increase in β-sheet content. The holo-state then can bind tightly cullin-5 (Cul5) based ubiquitin
ligase (Figure 1.4B,C), to induce ubiquitination and degradation of APOBEC3G in HIV-1.[35,36]
Zinc finger proteins (ZFPs) are an example for the third type of Zn(II)-ion structural cofactor binding
site - a disorganized site with structured holo-state only. ZFPs typically found unfolded in the apo-state and
metal binding to their Cys4-xHisx (x=0,1,2) coordination motifs leads to spontaneous folding into
a ββα structure (Figure 1.1). These holo-ZFPs then can bind DNA/RNA, mediate protein-protein or
protein-lipid interactions[37-42]. This wide array of ZFP binding targets and resulting biochemical functions
emphasize the importance of Zn(II)-ion as an essential structural metal cofactor to living organisms.
These metal-induced structural changes, whether they are between two well-defined structures
(e.g. TFIIB) or a transition between an unstructured to structured states (e.g. ZFPs), require that the
energetic contribution from metal-protein interactions overcome the thermodynamic barrier separating the
two states. To date, there is no direct method to measure the energetics of metal-protein interactions in
cases where metal-binding and protein folding are thermodynamically coupled. As long as protein
conformational changes are coupled to metal binding, there remains a gap in our understanding of the
complete metal-protein interactions and these metalloprotein’s structural changes.
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Figure 1.4: Zn(II)-ion as a structural metal cofactor. (A) Structure of apo-TFIIB (PDB: 1RO4)[43] and
Zn(II)-TFIIB (PDB: 2ILI)[44]. The overall backbone fold of both structures is not affected by the incorporation
of Zn(II) cofactor. (B) Model of apo-Vif binding Zn(II)-ion to form a Zn(II)-Vif structure with Cul5 recognition
surface.[36] (C) Structure of Zn(II)-Vif-Cul5 complex (PDB: 4NRF, chains 1 and x)[45]. The Zn(II)-HCCH core
in Vif (green) positioning Arg and Leu residues (cyan) for direct contact with Cul5 (magenta) through Asp
and Leu residues (orange).
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1.3 Zinc Finger Proteins
Zinc finger proteins (ZFPs) are one of the most abundant classes of metalloproteins in
eukaryotes[25] and are involved in a broad spectrum of biological functions, including cellular differentiation
and development, and tumor suppression.[46,47] Although more than a thousand different members of this
class have been discovered, the classical and most comprehensive group of ZFPs is still considered to be
the DNA-binding metalloproteins - zinc finger transcription factors (ZFP-TFs). These transcription factors
interact to bind a specific promoter sequence on DNA (or RNA) during gene regulation transcription
processes, and therefore are responsible in part for gene expression control.[38,48]
In 1985, Miller et al.[49] and Brown et al.[50] reported the first example of this metalloprotein group the transcription factor IIA (TFIIA) from Xenopus laevis, an African clawed frog. TFIIA was described as a
DNA-binding domain that is composed of twelve repeated sub-domains. Each sub-domain consisted of
30 amino acids, with seven of them conserved including the two cysteine (Cys) and two histidine (His)
residues that bind Zn(II)-ion and three other conserved amino acids (Tyr6 or Phe6, Phe17, and Leu23) that
create a hydrophobic core in the folded structure. Each 30 amino acid sequence forms an independent
finger like structure – hence the name “zinc finger”. Further studies[51-58] showed that each zinc finger
domain forms a folded left-handed ββα structure in which the tetrahedrally coordinated Zn(II)-ion is bound
to two Cys residues on the β-sheet fold and to two His residues on the α-helix. The individual finger domains
connect to the consecutive fingers by a short linker consisting of a conserved five amino acids sequence
Thr-Gly-X-Lys-Pro (where X is a variable residue). The region between the second Cys residue and the
first His residue was described as the sequence of amino acids that binds DNA (or RNA), but the precise
pattern of this interaction was still unknown.
In 1991 Pavletich and Pabo[59] presented the X-ray crystal structure of a mouse transcription factor
Zif268-DNA complex (Figure 1.5A), which clearly showed the amino acids that are responsible for
nucleobase recognition and binding. Each zinc finger motif in Zif268 had amino acids at positions -1, 3, and
6 on the α-helix interact, through hydrogen-bonds, with three contiguous base pairs (bp) on the DNA
operator region 5’-GCGTGGGCGT-3’. Later study by Fairall et al.[60] added that the amino acid at the helical
position 2 on the finger is also involved in the interaction with DNA, by binding to a fourth base on the
complementary DNA strand 5’-ACGCCCACGC-3’ (Figure 1.5B).
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Figure 1.5: Site-specific DNA recognition by classical C2H2 zinc finger proteins. (A) 3D NMR structure of
the three fingers (green) from Zif268 protein bound to a major DNA groove (PDB: 1ZAA)[10]. The colored
amino acids on each finger are involved in the binding to the DNA. (B) Schematic representation of the
interactions between α-helical amino acids in positions -1 (red), 3 (yellow), and 6 (purple) to three
contiguous base pairs (bp) on the DNA strand (blue), and from the α-helical position 2 (cyan) of the finger
to the fourth-bp on the complementary strand (tan).
Since the discovery of the first zinc finger motif in TFIIA, subsequent studies [61] have presented an
intriguing observation - the number of zinc finger motifs differ significantly in different proteins. They range
from two zinc motifs in the yeast Saccharomyces cerevisiae transcription factor ADR1 (which is required
for the expression of the gene for the zinc enzyme alcohol dehydrogenase) [62], to twelve motifs in TFIIA,
to thirteen in the human zinc finger gene on the Y chromosome (ZFY)[63], and up to 37 fingers in Xenopus
laevis zinc finger protein Xfin[64]. Yet, all of these zinc finger motifs contained this sequence of amino acids:
(Tyr/Phe)-X-Cys-X2-5-Cys-X3-(Tyr/Phe)-X5-ψ-X2-His-X3-4-His, where ψ is a hydrophobic residue, such as
Leucine (Leu), and X is a variable residue.
Albeit they have some conserved amino acids and a uniform globular ββα structures, ZFP-TFs
differ in their individual amino acid sequences. This sequence variability results in the ability of individual
group members to each bind a specific promoter in a sequence-specific manner. Given the diversity of the
ZFP family, ZFP-TFs are ubiquitous in the cellular environment and regulate targets with a broad spectrum
of biological functions. With this idea in mind and the knowledge of the specific interaction pattern between
well-defined residue positions on ZFP-TFs to DNA, it became possible to modulate the sequences of
ZFP-TFs and create tailor-made zinc fingers to bind any desired DNA sequence.
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1.4 Engineered Zinc Finger Proteins
The breakthrough determination of the interaction pattern between specific amino acids in positions
-1, 2, 3, and 6 on the α-helix of ZFP-TFs to specific nucleobases on the DNA sequences lead to the
establishment of a new technology - engineered ZFPs - which are a key to understanding fundamental
biochemical principles and applications, such as gene regulation, gene therapy, drug discovery, inhibition
of HIV, and even for improvement of agricultural crops.[65-72]
The pioneers of this field, Desjarlais and Berg[73], were the first to engineer variants of ZFP-TF Sp1
(specificity protein 1) to study specificity interactions to a preselected DNA site. Their observations paved
the way for consequent studies to establish the interaction pattern between ZFP-TFs and DNA, a.k.a. the
‘recognition code’ (Figure 1.6)[74]. In 1994, Choo et al.[75], reported the first engineered peptide containing
three zinc finger motifs that targeted a specific DNA sequence in the fusion gene BCR-ABL (which leads to
chronic myelogenous leukemia – a blood-cell cancer where the bone marrow produces too many blood
cells) and was able to repress the expression of this gene both in vitro and in vivo.

Figure 1.6: Interaction pattern between zinc finger transcription factors (ZFP-TFs) and DNA.
This ‘recognition code’ describes the residues at key positions on the α-helix of ZFP-TFs and the
nucleobases on DNA they bind to. In bold are the most frequent residues as indicated by phage assay,
whereas the residues with asterisk represent the findings from structural analysis. Residues with question
mark imply that their contact with the particular nucleobase is uncertain, and blank positions indicate
undefined interactions.[74]
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Today, many biotech companies are developing artificial ZFPs in order to control the cell’s fate,
both in humans and plants. Sangamo Therapeutics, Inc. is conducting Phase 2 clinical trials on engineered
ZFPs. Their designed zinc finger nucleases (ZFNs) are being evaluated as in vivo gene editing therapies
for lysosomal storage diseases - mucopolysaccharidosis (MPS) type I and II, a.k.a. Hurler syndrome and
Hunter syndrome, respectively.[76-79] These designed ZFNs allow for a targeted editing of the genome by
cleaving the double-strand in DNA at targeted locations via the highly specific pair of 'genomic scissors'
(Figure 1.7). Each ZFN is a chimeric protein of Flavobacterium okeanokoites (FokI) nuclease and an array
of ZFPs. To ensure enhanced DNA binding specificity, the ZFPs chain is built by the ‘mixing and matching’
of independent modules of two fingers. Furthermore, several modules are linked together to allow for
recognition of longer stretches of DNA, and to increase the probability for both ZFNs to bind the DNA in a
correct orientation so that the two FokI domains can interact with each other and cleave the DNA.[80-82]

Figure 1.7: Schematic representation of gene correction by engineered zinc finger nucleases (ZFNs). Each
chain of zinc finger proteins (ZFPs) is constructed from two-finger modules to ensure a specific binding to
the targeted DNA while the FokI nucleases cleave the double-strand. The shaded boxes represent three
base pair DNA subunits.
This double strand breakage by FokI domains triggers the cell’s natural DNA repair process and
harnessing this process will allow for genome editing as potential therapeutics. Depending on the targeted
mutation, gene editing can be done either by non-homologous end joining (NHEJ) or homology direct repair
(HDR) pathways (Figure 1.8).[80] The NHEJ-mediated DNA repair is a pathway that rejoins together the
created cleaved ends of the double-strand DNA resulting in a loss of genetic material at the breakage site.
Or in other words, the undesired gene is being “knocked-out”. This method could be effective in treating
HIV infection by targeting and disrupting the CCR5 gene, which encodes a crucial co-receptor protein that

11

allows HIV to get into the cell.[83] In contrast, the HDR-mediated genetic alteration is a template dependent
pathway in which a homologous stretch of DNA is introduced into the cell alongside the ZFNs. This donor
template is integrated into the breakage site and the lesions are repaired by the cell’s repair mechanism homologous recombination. The resulting new DNA sequence enables the correct gene to be expressed
in the cell. Currently, this method is being tested in vivo as a novel therapeutic approach for lysosomal
storage diseases MSP type I and type II. In patients suffering from MSP I and MSP II, due to defects in
α-L-Iduronidase (IDUA) and iduronate-2-sulfatase (IDS) genes, respectively, there is no expression of
sugar degrading enzymes. As a result, long linear sugar chains - glycosaminoglycans (GAGs) dermatan
and heparin sulfate - are accumulated in lysosomes throughput the body causing cell damage and
dysfunction, such as joint stiffness, skeletal deformations, cardiovascular disorders, enlarged internal
organs, and cognitive decline. The treatment that is being tested for MPS I and MPS II is based on delivering
engineered ZFNs into the liver cells alongside with IDUA or IDS templates, respectively. In the liver, these
ZFNs can cleave the albumin gene on the double-strand DNA, allowing for the introduced IDUA or IDS
transgenes to be integrated into the breaking site by the cell’s natural DNA repair process. The corrected
DNA will be able to express the IDUA or IDS enzymes that are missing in MSP I and MSP II patients,
respectively.[77,78]

Figure 1.8: Schematic representation of genome editing by non-homologous end joining (NHEJ) and
homology direct repair (HDR) pathways.
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Sangamo Therapeutics, Inc., have also shown progress in designing zinc finger transcription
factors (ZFP-TFs) for treatments of tauopathies neurodegenerative diseases, such as Alzheimer's disease,
through gene regulation.[84] In contrast to the engineered ZFNs, these ZFP-TFs do not cleave nor modify
the targeted DNA, but instead of the cleaving FokI domain they have an activation or repression domain.
Thus, when theses ZFP-TFs bind to the targeted DNA, they can simply regulate gene expression through
gene repression or gene activation. Tauopathies, as the name indicates, are caused by the accumulation
of toxic tau protein in the brain resulting in a widespread neuronal dysfunction. Thus, if we can repress tau
genes using engineered targeted ZFP-TFs, perhaps we could treat such intractable diseases in the near
future.[85]
Although the perspectives of engineered zinc finger therapeutics look more promising than ever,
there are still many challenges in designing them, and in particular designing them to have the maximal
targeted gene therapeutic activity with minimal off-target effects. Current ZFPs development platforms are
focused on identifying potential DNA target sites and designing amino acid sequences for ZFPs that could
possibly bind them.[86,87] Yet, these platforms have been treating the Zn(II) metal cofactor as a rivet to be fit
into ZFPs sterically without considering metal-protein interaction energies and how they contribute towards
ZFPs structures. This is to great extent a result of the limited understanding of the free energy contributions
of metal-protein interactions due to the difficulty in separating the energetics of metal-ligand interactions
from the observed protein-protein interactions - specifically when structural changes are coupled to metal
binding. Thus, as long as there is a gap in understanding of the metal-protein binding energetics, there will
remain a gap in realizing the full potential of ZFPs-gene targeted therapeutics.
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1.5 Metal-Induced Protein Folding
Proteins that require incorporation of structural metal cofactors for correct protein folding,
stabilization, and biological function are said to undergo a ‘metal-induced protein folding event’, just as
described earlier in the examples of zinc finger proteins (ZFPs). The crucial Zn(II)-ligand interactions that
allow for unfolded apo-ZFPs to gain a holo-folded structure (such as the common ββα structure) and
biochemical function have been studied for over several decades. As yet, our understanding of the
energetics of metal-based structural changes remains incomplete. Experimentally, it has been difficult to
quantitate the free energy contribution of metal-ligand interactions towards the protein folding and the
energetic barrier between the apo- and holo-confirmations, as the metal binding is coupled to these
conformational changes.
When the binding of the Zn(II)-ion to an apo-folded metalloprotein occurs, the free energy
contribution by the metal-ligand binding (ΔGML) is the same as observed experimentally (ΔGML-obs), thus it
can be derived from the experimentally measured dissociation constant, Kd value, as shown in eqn. 1.1.
ΔGML = ΔGML-obs = - RT ln(Kd)

(Eqn. 1.1)

In contrast, introduction of the metal-ion into an apo-unfolded metalloprotein (such as ZFPs), which
leads to a holo-folded confirmation (Figure 1.9), results in a smaller experimentally observed free energy
of metal-ligand binding (ΔGML-obs) than the actual free energy contribution of the metal-ligand binding
(ΔGML). This energetic difference is the change in free energy that is required to overcome the
thermodynamic barrier between the apo-unfolded and apo-folded confirmations, or in other words, it is the
free energy cost for protein folding (ΔGapofolding).
ΔGapofolding = ΔGML - ΔGML-obs

(Eqn. 1.2)

The coupled thermodynamics of the metal-ion binding (ΔGML) and the protein folding (ΔGapofolding), makes
the free energy contribution of each of them individually to be indistinguishable (eqn. 1.2). While the ΔGML-obs
can be calculated using eqn. 1.1, there is no direct method to measure and determine the ΔGapofolding.
Therefore, literature estimates for the cost of protein folding range from 0 to +16 kcal/mol and presume that
the protein folding process is driven thermodynamically by the binding of the Zn(II)-ion.[88-90]
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Figure 1.9: Metal induced protein folding and free energy diagram for ZFPs vs. GGG peptide. The binding
of Zn(II)-ion to the Cys4-xHisx (x=0,1,2) coordination motif in an unfolded apo-ZFP leads to a spontaneous
folding into a ββα structure, resulting in a coupled protein folding (ΔGapoZFP-folding) and metal-ion binding
(ΔGML-ZFP) thermodynamics. On the other hand, the GGG peptide has no secondary structure in both
apo-and holo-states, thus has no energetic folding cost (ΔGapoGGG-folding = 0.0 kcal/mol), allowing for an easy
determination of the metal-ion binding thermodynamics from the experimentally observed data
(ΔGML-GGG = ΔGML-GGG-obs).
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In an effort to elucidate the individual thermodynamics of metal-ion binding and protein folding, the
Gibney lab has designed a simple 16-amino acid glycine rich peptide scaffold, GGG, that binds Zn(II) and
lacks folding events.[91,92] This de novo peptide was designed as a maquette of a more complex natural zinc
protein – metallothionein (MT), which undergoes metal-induced folding but has no defined secondary
holo-structure.[93] Since GGG exhibits no secondary structure in both apo- and holo-states, it is assumed
that GGG has minimal free energy cost for protein folding, i.e. ΔGapoGGG-folding = 0.0 kcal/mol (Figure 1.9),
and as so it presumably has the maximal binding affinity for each specific coordination motif to the Zn(II)-ion.
Therefore, the experimentally observed metal binding contribution and the actual free energy contribution
by the binding are isoenergetic, i.e. ΔGML-GGG-obs = ΔGML-GGG.[91,92] Natural ZFPs with the same metal binding
motif as the GGG peptide are expected to have weaker observed Zn(II)-binding constants than the
designed peptide, which will equal to the cost of ZFPs folding, allowing for a quantitative determination of
their folding cost (eqn. 1.3):
ΔGapoZFP-folding = ΔGML-ZFP-obs - ΔGML-GGG-obs

(Eqn. 1.3)

Metal-ion binding to a protein with protonated ligands result in conditional dissociation constants,
Kd values, that are highly pH dependent due to the proton release upon metal complexation, as shown in
eqn. 1.4 with the term [H+].
M(II)(H2O)62+ + Protein-(LH)4 ⇌ M(II)-Protein + 6H2O + 4H+

𝐾𝑑 =

[M(II)−Protein][H+ ]4
[M(II)(H2 O)6

2+

][Protein−(LH)4 ]

(Eqn. 1.4)

The Gibney research group has developed a minimal equilibria model for their designed GGG peptide, as
shown in Scheme 1.1, to describe the pH dependence through protonation patterns of metal-peptide
complexation.[91,92] This model is based on the intrinsic acid dissociation constants, pKa values, of the
binding ligands in the apo-GGG, and the metal-ligand effective acid dissociation constants, pKaeff values,
of these ligands in the holo-GGG complex. The equilibria model provides a mathematical fit (eqn. 1.5) for
the conditional binding constants, Kd, vs. pH, thus allowing for the determination of the pH-independent
formation constant, KfML value, for the metal-peptide complexation by the plateau of the graph in the basic
pH values, where the four metal-binding ligands in the GGG peptide are deprotonated.
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Scheme 1.1: Minimal equilibria used to model the pH dependence of the conditional Kd values for
metal-protein complexation.
(Eqn. 1.5)
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Utilizing this equilibria model for the three zinc-binding motifs Cys4, Cys3His1, and Cys2His2, Gibney
and coworkers reported[92] that in the absence of proton competition (i.e. at pH 9.0) GGG-Cys4 had the
highest affinity for Zn(II), while substitution of Cys residue for His residue lowered the strength of the peptide
for Zn(II) by about 2.0 kcal/mol (GGG-Cys4 > GGG-Cys3His1 > GGG-Cys2His2), concluding that Cys is a
better ligand for Zn(II) than His. However, at physiological pH (i.e. at pH 7.4) all three binding motifs had
similar Kd values, leading to the conclusion that altering the binding motif from Cys 4 to Cys2His2 results in
little change for Zn(II)-GGG complexation, just as previously observed in natural ZFPs.[94] A comparison of
the conditional dissociation constants from Zn(II)-GGG complexes to the reported Zn(II)-binding constants
for natural ZFPs with the same coordination motifs, using eqn. 1.3, allowed for the determination of the
energetic cost of natural ZFPs folding. The Gibney lab revealed that ΔGapoZFP-folding is minimal,
≤ +4.2 kcal/mol, regardless of the coordination motif.[92] In addition, isothermal titration calorimetry (ITC)
measurements showed that entropy-enthalpy ratio, which drives the metal binding, increased with the
increase of Cys residues in the GGG peptide. This observation was explained by the fact that deprotonation
of the thiols is enthalpically unfavorable, but the release of protons leads to gain in entropy.
Several groups supported these conclusions in the literature. For instance, Krizek et al.[95,96]
reported that in their designed synthetic 26 amino acid Consensus Peptide (CP-1), which is based upon
the consensus sequence from 131 ZFPs, substitution of Cys residue by His gave a strength order for Zn(II)
to be CP-1 (CCCC) > CP-1 (CCHC) > CP-1 (CCHH). Another example are the thermodynamic studies of
Zn(II) to three natural zinc finger proteins Sp1-3 (Cys2His2), MyT1-2 (Cys2His1Cys), and GR-2 (Cys4) by
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Rich et al.[97]. The group showed that all three ZFPs had similar affinity to Zn(II) at pH 7.4, regardless of the
different coordination motifs. Furthermore, as seen by Gibney et al., Rich et al.[97] noted that the binding of
the natural ZFPs to Zn(II) is enthalpically disfavored and entropically favored with the increase of Cys
residues, so while for Sp1-3 the entropy and enthalpy were equal, for GR-2 the binding to Zn(II) was
entropically driven. Lastly, Ghimire-Rijal and Maynard[36] also saw similar enthalpy-entropy compensation
(EEC) pattern in their studies of Zn(II)-binding to the Vif-HCCH motif from HIV-1, HIV-2, SIVAgm (African
green monkey), and SIVMac (rhesus macaque). The group observed that all four Vif proteins were able to
reach similar affinity to bind Zn(II) by varying their EEC pattern based on the increase in Cys residues in
the overall protein sequence. Interestingly, the HCCH binding motif in Vif showed to have higher cost of
protein folding using Gibeny’s GGG comparison, +6.4 kcal/mol at pH 7.4. As discussed earlier
(Section 1.2), unlike most ZFPs, apo-Vif has a secondary structure (apo-Vif from HIV-1 for example is
12% α-helix, 33% β-sheet, and 55% random coil)[35], thus it requires the disruption of the apo-structure and
refolding. This additional step adds to the energetic penalty for folding the protein upon the metal-ion
binding.
Despite these examples that support Gibney and coworkers in the literature, one paper called these
conclusions into questionl[91,92] as well as the data reported by Krizek et al.[96]. Séneque and Latour[98]
reevaluated the data for CP-1 and reported that a substitution of Cys residue by His gave a strength order
of CP1(CCCH) > CP1(CCCC) > CP1(CCHH) for Zn(II). Furthermore, they have determined that
CP1(CCHH) binds Zn(II) 13,900-fold (5.6 kcal/mol) tighter than GGG-Cys2His2. In other words, their
analysis suggests that it should cost +5.6 kcal/mol to fold the GGG-Cys2His2 peptide, and not 0.0 kcal/mol
as was assumed by Gibney et al., and thus this value needs to be added to the ΔGapoGGG-folding value
calculated for GGG-Cys2His2 and all the subsequent ΔΔGapoGGG-folding values. In addition to the
thermodynamic differences, Séneque and Latour also observed kinetic differences between the data. While
Buchsbaum and Berg[99] observed rapid metal-exchange kinetics during competition titration when
determining the conditional binding constants, Kd values, for Zn(II)-CP-1, Séneque and Latour measured
slow kinetics with an equilibrium time greater than 24 hours at pH 6.65.
Due to the raised questions by Séneque and Latour[98], Gibney and corworkers has reevaluated
their methodology for separating the coupled energetics of metal-induced protein folding by studying the
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thermodynamics of Zn(II)-binding to a natural Cys2His2 zinc finger protein with metal-induced protein folding
events[100] - the C-terminal finger of the Wilms’ tumor suppressor protein (WT1-4)[101]. Gibney and coworkers
reported that the pH-independent dissociation constant, KfML value, and the corresponding free energy
contribution by the metal-ligand binding, ΔGML value, for Zn(II)-WT1-4 are identical, within an experimental
error of 10-fold or 1.4 kcal/mol, to the corresponding values for Zn(II)-GGG-Cys2His2. In addition, both
WT1-4 and GGG-Cys2His2 showed to have equivalent binding affinities for Zn(II) over a broad range of pH
values. These observations lead to the conclusion that the cost of protein folding for WT1-4 must be similar
within error to the cost of GGG-Cys2His2 folding, i.e. ΔGapoWT1-4-folding = ΔGapoGGG-folding. Since the cost of GGG
folding is assumed to be minimal, the free energy contribution of metal-binding to fold the natural WT1-4 is
also minimal, i.e. 0.0 kcal/mol.[100] In toto, the Zn(II)-WT1-4 thermodynamic studies showed that Gibney’s
method for separating the free energy contribution of metal-ligand interactions towards the protein folding
can be utilized in studies of natural proteins as well as in synthetic peptides, such as the GGG and CP-1
peptides.
To further validate their approach of using GGG to determine the cost of natural ZFPs folding and
to test their assumption that the free energy to fold the designed GGG peptide is indeed 0.0 kcal/mol,
Gibney et al. evaluated the thermodynamics of Zn(II)-binding to human Transcription Factor IIB (TFIIB).[102]
As described earlier (Section 1.2), the zinc binding domain in TFIIB has identical folded apo- and
holo-structures

(Figure

1.4A)

-

indicating

that

the

cost

for

protein

folding

is

minimal

(i.e. ΔGapoTFIIB-folding = 0.0 kcal/mol), and therefore TFIIB should possess the maximal Zn(II)-binding affinity
for the Cys3His1 coordination motif. The KfML and ΔGML values reported for Zn(II)-TFIIB were identical to the
corresponding values for Zn(II)-GGG-Cys3His1. Furthermore, TFIIB and GGG-Cys3His1 showed similar pH
dependent conditional dissociation constants, Kd values, for Zn(II). Thus, the group concluded that
GGG-Cys3His1, just like TFIIB, does not use its free energy of metal-binding to drive protein folding confirming the assumption that the cost of GGG folding is indeed 0.0 kcal/mol.[102]
With a better understanding of the metal-protein coordination thermodynamics and a clear method
of simplifying the complete metal-protein interactions through chemical equilibria analysis, a question
remains as to the role of a specific metal-ion cofactor on these thermodynamics. Many studies use Co(II)
as a probe for studying Zn(II)-binding to metalloproteins since both metal-ions can occupy the same binding
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site and easily displace one another without disturbing the holo-protein structure.[103-105] Yet, very limited
information has been provided regarding Co(II)-ZFPs binding thermodynamics, nor do the reported binding
constants for Co(II)-ZFPs take in consideration the important metal-induced protein folding events.
In addition, some studies identified Zn(II)-binding sites as a target for Pb(II), leading to the hypothesis that
lead’s toxicity is due to the substitution of Zn(II) by Pb(II) in metalloproteins.[106-108] Nevertheless, in these
studies Zn(II) and Pb(II) are being compared through their conditional competition constants, which are
highly pH dependent, and do not factor in the differences in metal-induced protein folding events upon each
metal-ion binding, as will be discussed later in Chapter Three of this thesis. Thus, as long as there is a gap
in understanding the effects of specific metal-ion binding energetics on metal-protein interactions and thus
protein-protein interactions, there will remain a gap in realizing the full scope of ZFPs related diseases and
potential de novo metalloprotein designed therapeutics.

1.6 Scope of Thesis
The work of this thesis endeavors to understand the principles that governs the thermodynamics
for metalloprotein structure and function. And by doing so, gain a comprehensive knowledge on the rules
that determine these protein-interactions with DNA or other proteins and lipids. On this account, the goal of
the research described herein is to study metal-induced protein folding phenomena in metalloproteins.
For this purpose, UV-vis spectroscopy, fluorimetry, and potentiometry over a broad pH range was used to
measure the thermodynamics of Co(II) and Pb(II) binding to an unstructured minimally designed peptide,
GGG, with incorporated Cys4-xHisx (x=0,1,2) metal-binding coordination motifs. Utilizing this suite of
equilibrium measurements, the pH-independent formation constant for each metal-peptide complexation
was determined. In addition, these equilibria models elucidate the individual thermodynamics of metal-ion
binding and protein folding. Lastly, a comparison between the Co(II) and Pb(II) binding constants to the
GGG peptide, and between their observed binding constants in natural ZFPs with the same metal binding
motif, reveals the folding cost of these ZFPs. The thermodynamic data derived from these studies will shed
a light on the effect metal-ion cofactors have on metal-protein energetics. This supports our understanding
of ZFP-related diseases, such as lead poisoning, and may improve the rational design of engineered zinc
proteins for promising corrective therapeutics for genetic disorders.
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CHAPTER TWO The Intrinsic Affinities of Zinc Finger Motifs for Co(II)

2.1 Introduction
Metal-induced protein folding is an essential process which allows proteins to fold into a specific
three-dimensional structure for their proper biological activity. [3,4] The most studied class of proteins that
exhibit this behavior are the zinc finger transcription factors (ZFP-TFs), which require the incorporation of
Zn(II)-ion for proper folding, stability, and function.[6-9] The roles and importance of ZFP-TFs have been
discussed in Chapter One of this thesis, which illustrate the scientific intrigue with ZFP-TFs and why they
have been studied for over several decades. The major challenge evaluating Zn(II)-ion affinities to ZFP-TFs
is due to the fact that Zn(II) has filled d-shell orbitals (with d10 electrons), thus it is lacking electronic
transitions in the visible region of the electromagnetic spectrum, making it a spectroscopically silent metal
ion. Therefore, many studies use the Co(II)-ion, with its unfilled d-shell orbitals (d7 electrons), to evaluate
Zn(II)-affinities by measuring the displacement of Co(II) by Zn(II), or vice-versa, via UV-vis
spectroscopy.[8,98,104,105,109-114] This application was first reported in 1959 by Coleman and Vallee [103], for the
substitution of Zn(II) by various metal-ions in carboxypeptidase. Coleman and Vallee showed that both
Zn(II) and Co(II) occupy the same binding site in this metalloprotein, and that the two metal-ions can
displace one another with minor differences between the Zn(II)- and Co(II)-carboxypeptidase structures.
These observations can be partially attributed to the similar size of Zn(II) and Co(II), i.e. ionic radii of 0.60 Å
and 0.58 Å, respectively, as well as their lack of strong geometric preferences. [96]
Upon the coordination of the Co(II)-ion to the ligands, the negatively charged electrons in the d-shell
orbitals of the Co(II)-ion are repelled by the negative point of charge on the ligands, leading to a split in the
energy levels of the d orbitals.[115] The created energy gap between the two sets of the d orbitals has the
same magnitude as the energy of a photon of visible light. Thus, for complexes of metal-ions with unfilled
d-shell orbitals, such as Co(II) with d7 electrons, absorbance of light in the visible region may lead to the
excitation of an electron from a lower-energy d orbital into a higher-energy d orbital, resulting in

21

spectroscopically visible bands, a.k.a. the ligand field d→d electronic transition bands (Figure 2.1).
The nature of the ligands and the metal-ion coordination geometry in the complex dictates the wavelengths
and the intensity of these d→d bands, making the Co(II)-ion an excellent spectroscopic probe with easily
distinguishable coordination motifs in its complexes. For example, octahedral complexes for Co(II), such
as formed by free Co(II)-ion in aqueous solution, have very low d→d band extinction coefficient values
(5-10 M-1cm-1). On the other hand, complexes such as Co(II)-ZFPs, exhibit tetrahedral coordination, and
have d→d band extinction coefficients about 100-fold higher. Furthermore, the visible absorbance spectrum
for tetrahedral complexes shifts to higher wavelengths as the number of bound Cys ligands
increases.[95,96,104,105,116,117]
Interestingly, Co(II)-ion can also be spectroscopically seen in the UV region. When Co(II) binds to
thiolates, such as the Cys ligands, an electron is transferred from the ligand to the metal-ion. Thus, S→Co(II)
ligand-metal charge-transfer (LMCT) transition bands are observable (Figure 2.1).[95,96,116-118]

Figure 2.1: Co(II) as a good spectroscopic probe for studying metal-binding affinities to ZFPs. The
Co(II)-ion with d7 electrons can be spectroscopically seen both in the visible region and in the UV region.
The absorbance of visible waves leads to the excitation of an electron in the metal’s lower-energy d orbital
into a higher-energy d orbital, resulting in ligand field d→d electronic transition bands. While the absorbance
of UV waves leads to the excitation of an electron from the thiolate ligand to the metal’s unfilled d orbital,
resulting in S→Co(II) ligand-metal charge-transfer (LMCT) transition bands.

Since the Co(II)-ion is generally used for binding geometry comparisons, previous studies provide
limited information regarding the intrinsic affinities of Co(II) to each of the zinc finger protein binding motifs:
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Cys4, Cys3His1, and Cys2His2. In addition, the preference of Co(II) to bind cysteine thiolate over histidine
imidazole is poorly understood in comparison to Zn(II) whose preference for the cysteine thiolate ligands
over histidine imidazole. Furthermore, the binding constants for Co(II)-ZFPs that are reported do not take
into consideration the important metal-induced protein folding events, as discussed in Section 1.5.
In this chapter, a minimal peptide model of a zinc finger protein, GGG, with incorporated Cys4,
Cys3His1, or Cys2His2 binding motifs, is utilized to determine the intrinsic affinities of Co(II) to each of these
three ZFPs coordination motifs. This glycine rich 16-amino acid GGG peptide has been chosen as it is
unstructured in both apo- and holo-states and therefore has minimal protein folding effects. Thus may
provide the maximal Co(II) affinities for these three coordination motifs as evaluated using the metal-ligand
pH-independent formation constant, KfML.[91,92] In other words, the Co(II)-binding free energy is not used to
drive GGG folding, i.e. ΔGapoGGG-folding = 0.0 kcal/mol. UV-vis absorption and fluorescence emission
spectroscopies as well as potentiometry measurements are employed to characterize the pH dependence
of the thermodynamics of Co(II)-binding to the GGG peptide variants. From the fluorescence data the
protonation mechanism upon metal binding is determined, while the UV-vis data provides the metal-ligand
coordination structures at each protonation step. The metal’s preference to bind cysteine thiolate or histidine
imidazole is determined independently of pH by a comparison of Co(II)-GGG pH-independent formation
constants, KfML values, to each coordination motif in the GGG variants. Furthermore, a comparison of the
Co(II) affinities of each coordination motif between the GGG peptide and natural ZFPs reveals the folding
events and the cost for ZFPs folding, ΔGapoZFP-folding, in the latter.

2.2 Experimental Procedures
Materials.

Cobalt(II)

chloride,

hydrochloric

acid

(HCl),

trifluoroacetic

acid

(TFA),

dimethylformamide (DMF), ethanedithiol (EDT), 1-hydroxybenzotriazole (HOBt), diethyl ether, acetic
anhydride (Ac2O), diisopropylethylamine (DIPEA), piperidine, ethylene glycol tetraacetic acid (EGTA),
2-(N-morpholino)ethanesulfonic

acid

(MES),

4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic

piperazine-N,N′-bis(2-ethanesulfonic
acid

(HEPES),

and

acid)

(PIPES),

2-Bis(2-hydroxyethyl)amino-2-

(hydroxymethyl)-1,3-propanediol (BisTris), all were obtained from the Sigma-Aldrich Chemical Company.
The Fmoc-protected amino acids are from Bachem.
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Peptide Synthesis and Purification. The GGG-series with incorporated ZFPs binding motifs
(Cys4, Cys3His1, and Cys2His2) were assembled on a solid-phase peptide synthesizer (SPPS) using a
standard Fmoc/tBu protocol with HBTU/HOBt coupling[96] (Figure 2.2). The sequences of the three GGG
peptides are as follows:

GGG-Cys4

NH2-KLCEGGCGGCGGCGGW-CONH2

GGG-Cys3His1

NH2-KLHEGGCGGCGGCGGW-CONH2

GGG-Cys2His2

NH2-KLHEGGHGGCGGCGGW-CONH2

The amino acids of the ZFPs binding motifs in each peptide are shown in bold. Each peptide assembly
started by coupling the C-terminal amino acid to the linker on an insoluble solid Wang Resin (0.2 mmol/g
of resin loaded). The elongation of the peptide chain was carried out by repeating the synthesis cycle:
removal of Fmoc protecting group from the N-terminal on the chained amino acid using 20% piperidine in
DMF, activation of the carboxyl group on the added amino acid using 0.4 M DIPEA in DMF, and coupling
the two amino acids. At the end of the synthesis, the peptide was cleaved from the solid phase resin using
a 90:8:2 (v/v/v) mixture of TFA: ethanedithiol: water for 3 hours, which simultaneously removed all side
chain protecting groups (SPG). The SPG used are as follows: Lys (tBoc), Glu (OtBu), Cys (Trt), His (tBoc),
and Trp (tBoc). The synthesized crude peptides were purified on a C18 column using 0.1%
TFA/water/acetonitrile gradients, via the prep Beckman-Coulter Gold System reverse-phase high
performance liquid chromatography (RP-HPLC). The gradients slightly shifted to a lower percentage of
acetonitrile in water and 0.1% (v/v) TFA, with every substitution of Cys residue with His residue in the GGG
sequence, resulting in the following linear gradients: 20-26% in 60 minutes for GGG-Cys4, 16-22% in
60 minutes for GGG-Cys3His1, and 15-21% in 60 minutes for GGG-Cys2His2. The purified-collected
fractions were lyophilized and then tested for their purity on an analytical RP-HPLC, followed by liquid
chromatography–mass spectrometry (LC/MS) test to identify their molecular mass (Figures 2.2 and 2.3).
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Figure 2.2: GGG-Cys4 peptide synthesis, purification, and identification. Solid phase synthesis was
employed to synthesize the GGG-Cys4 peptide, followed by HPLC purification (bottom right) and LC/MS
identification (bottom left). AA = Amino Acid; SPG = Side chain Protecting Group. The expected mass for
this peptide was 1,442.6 g/mol. The calculated mass of the purified peptide was 1,442.5 g/mol, confirming
that it is a pure GGG-Cys4 peptide.
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Figure 2.3: Verification of purity and identification of synthesized GGG-Cys3His1 and GGG-Cys2His2
peptides. (A) The calculated mass from LC/MS experiment (1,475.6 g/mol) is similar to the expected mass
of 1,476.6 g/mol, confirming this is the GGG-Cys3His1 peptide. (B) The purity and identity of GGG-Cys2His2
were confirmed by identical experimental and theoretical mass (1,510.6 g/mol).

Ultraviolet-Visible Spectroscopy. Varian Cary 100 / 300 spectrophotometers were used to record
Ultraviolet-visible (UV-vis) spectra (at 200-850 nm wavelengths) of samples in a 1.0 cm pathlength screw
cap rectangular quartz cell under strict anaerobic conditions. These recorded absorbance spectra for
Co(II)-GGG complexes were corrected by subtracting the spectrum of the free unbound apo-GGG peptide.
The concentration of a 6.8 mM CoCl2 stock solution was determined spectrophotometrically using ε 510nm
of 4.8 M-1cm-1.[119] All peptide stock concentrations were determined spectrophotometrically using ε 280nm
of 5,600 M-1cm-1. The measured extinction coefficients for Co(II) at the d→d bands and at the S→Co(II)
LMCT bands were used to confirm the 1:1 Co(II)-peptide binding stiochiometry.
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Fluorescence Spectroscopy. Cary Eclipse fluorimeter was used to record the emission spectra
for peptide samples resulting from excitation at wavelength of 280 nm (of the C-terminal tryptophan), with
excitation and emission slit widths of 5 nm. These samples were prepared under strict anaerobic conditions
and maintained in a 1.0 cm path length screw cap quartz cells.

Kinetics of Metal-Ion Binding / Exchange. The equilibration times for the metal-ion binding to
apo-GGG and metal-ion substitution in the holo-GGG competition titration reactions, as well as the
exchange of the metal-ion between peptide and competitor EGTA, were determined via the change in
UV-vis and fluorescence spectra over time. The peptide samples were prepared in a 1.0 cm path length
screw cap quartz cells under strict anaerobic conditions. 1.0 eq of aqueous CoCl2 was added and the
measurements of absorption and fluorescence spectra were taken every minute. After 2 minutes the
spectra were identical, leading to the conclusion that the equilibration times less than 2 minutes. To ensure
that indeed the reaction are given enough time to reach equilibrium, all titration measurements in this work
were given 5 minutes to reach equilibrium after addition of the metal-ion solution and prior to recording of
their spectra.

Co(II) Binding Titrations. Direct and competitive isothermal titrations allowed to determine the
conditional metal-ligand dissociation constants, Kd values, of Co(II)-GGG complexes. All additions of CoCl2
were done in an anaerobic glovebox. Every three additions, the septum in the screw cap on the cuvette
was replaced to ensure no oxygen leaked into the sample when exposed to the room environment for
spectroscopic measurements. The anaerobic conditions of the solutions were easily monitored via UV-vis
absorbance, making sure there is no observed peak at 400 nm due to metal ion oxidation.

Direct Co(II) titration: Titrations were carried out into 1.0 mL samples of peptide solutions in buffer
(20 mM MES / BisTris in 100 mM KCl) with pH range 5.0 - 7.0. Microliter aliquots of aqueous CoCl2 were
added and samples were allowed to equilibrate for 5 minutes before the measurements of their individual
absorption and fluorescence spectra were taken. The KdCo(II)-GGG values, at pH below 7.0, were determined
from fitting a plot of increase in the ligand field d→d electronic transitions and the S→Co(II) LMCT
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absorbances, as well as the decrease in Trp fluorescence emission at 355 nm (λ maxem), against the
[Co(II)]/[peptide] ratio to the 1:1 equilibrium binding model as described in eqns. 2.1 and 2.2 ,respectively
(full derivation is shown in the Appendix).

Abs = Abs0 + εBound × (

F = F0 + (Flim − F0 ) × (

𝐾d +[MT ]+[LT ]±√(−𝐾d −[MT ]−[LT ])2 −4[MT ][LT ]

)

(Eqn. 2.1)

𝐾d +[MT ]+[LT ]±√(−𝐾d −[MT ]−[LT ])2 −4[MT ][LT ]
)
2[LT ]

(Eqn. 2.2)

2

Where Abs and F are the measured absorbance and fluorescence emission intensities, respectively; Abs0
and F0 are the absorbance and fluorescence intensities of the apo-GGG, respectively; 𝜀𝐵𝑜𝑢𝑛𝑑 is the
molar-extinction coefficient of the Co(II)-GGG complex while Flim is the limiting emission intensity of this
holo-GGG complex; MT is the total concentration of the Co(II) added; LT is the total concentration of the
GGG peptide; Kd is the conditional dissociation constant for Co(II)-GGG complex.

EGTA Competition titration: For pH values above 7.0, to accurately determine the Kd values for
Co(II)-GGG complexes, competition titrations with EGTA were required. These titrations were carried out
using 1.0 mL samples of peptide solutions in a buffer (20 mM PIPES / HEPES in 100 mM KCl, pH range
7.0 - 8.8) with a presence of the competitor EGTA. Microliter aliquots of CoCl2 were titrated under strictly
anaerobic conditions. UV-vis and fluorescence spectra were recorded after 5 minutes from each titration.
Eqns. 2.3-2.8 are the competition equilibrium-binding model which was used to fit plots of the spectral data
against [Co(II)]/[peptide] to determine the competition constant, Kcomp values. Full derivation of these eqns.
is shown in the Appendix.

EGTA + [Co(II)(H2 O)6 ]2+ ⇌ [Co(II) − EGTA] + 6H2 O

(Eqn. 2.3)

𝐆𝐆𝐆 + [Co(II)(H2 O)6 ]2+ ⇌ [Co(II) − 𝐆𝐆𝐆] + 6H2 O

(Eqn. 2.4)

𝐾comp =

[Co(II)−EGTA][𝐆𝐆𝐆]

=
[EGTA][Co(II)−𝐆𝐆𝐆]
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Co(II)−𝐆𝐆𝐆

𝐾d

Co(II)−EGTA

𝐾d

(Eqn. 2.5)

−b±√(b)2 +4(1−𝐾comp )([MT ][LT ]𝐾comp )

Abs = Abs0 + εBound × (

2(1−𝐾comp )

−b±√(𝑏)2 +4(1−𝐾comp )([MT ][LT ]𝐾comp )

F = F0 + (Flim − F0 ) × (

2(1−𝐾comp )[LT ]

)

(Eqn. 2.6)

)

(Eqn. 2.7)

b = (−[MT ] − [LT ])𝐾comp − [MT ] − [BT ]

(Eqn. 2.8)

Where Abs and F are the measured absorbance and fluorescence emission, respectively; Abs 0 and F0 are
the absorbance and fluorescence measured for the GGG prior to the addition of the metal-ion, respectively;
𝜀𝐵𝑜𝑢𝑛𝑑 is the molar-extinction coefficient of the holo-GGG while Flim is the limiting fluorescence of this
Co(II)-GGG complex; MT is the total concentration of the Co(II) added; LT is the total concentration of the
GGG peptide in the solution; BT is the total concentration of the competitor, EGTA, present in the solution;
Kcomp is the conditional competition binding constant.
Each measured Kcomp value, when coupled with metal-competitor conditional equilibrium dissociation
constant, KdCo(II)-EGTA value, gives the conditional metal-ligand dissociation constants for Co(II) to the GGG
peptides, KdCo(II)-GGG (rearrangement of eqn. 2.5). The KdCo(II)-EGTA value can be easily determined over a
broad pH range using the Co(II)-EGTA formation constant (i.e. KfCo(II)-EGTA = 2.24×1012 M-1)[120] and the mole
fraction (αY4− ) of fully deprotonated EGTA complexes at the experimental pH values, as shown in eqns. 2.9
and 2.10 and derived in the Appendix.

𝐾dCo(II)−EGTA =

αY4− =

1
𝐾f Co(II)−EGTA ×αY4−

𝐾1 𝐾2 𝐾3 𝐾4
[H+ ]4 +[H+ ]3 𝐾1 +[H+ ]2 𝐾1 𝐾2 +[H+ ]𝐾1 𝐾2 𝐾3 +𝐾1 𝐾2 𝐾3 𝐾4

(Eqn. 2.9)

(Eqn. 2.10)

Where K(1-4) are the EGTA stepwise acid dissociation constant values of K1=1.00×10-2, K2=2.19×10-3,
K3=1.41×10-9, K4=3.39×10-10.[120]
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Potentiometric pH Titration. Potentiometric pH titrations of the holo-GGG complexes allowed for
the determination of the metal-ligand effective acid dissociation constants, pKaeff values. Each Co(II)-GGG
complex in unbuffered water at pH 9.0 was placed in a 1.0 cm path length cuvette with a magnetic stir bar
and fitted with a pH electrode (Figure 2.4). Throughout the titration, strictly anaerobic conditions were
maintained using a constant flow of hydrated nitrogen gas. Addition of microliter aliquots of 0.1 M HCl was
followed by measurement of the UV-vis absorbance and fluorescence emission spectra. After each addition
of acid, the solution was stirred and allowed to equilibrate for 5 minutes prior to recording the change in the
pH of the solution and measurement of the solution’s spectra. The pH dependence of the UV-vis and
fluorescence spectra for each Co(II)-GGG complex were fit to the simplest chemically reasonable
protonation model, as shown in eqns. 2.11-2.16 (and formally derived in the Appendix), which yielded the
pKaeff values of the ligands bound to the metal-ion. The non-linear least square fitting of the data, using
eqns. 2.11 and 2.12, indicated that Co(II)-GGG-Cys4 complex undergoes a cooperative three-protonation
transition involving three Cys residues (pKa1,2,3eff) and a separate one-proton transition of the forth Cys
residue (pKa4eff). Eqns. 2.13 and 2.14 for Co(II)-GGG-Cys3His1 complex showed a cooperative three-proton
transition involving three Cys residues (pKa2,3,4eff). And eqns. 2.15 and 2.16 for Co(II)-GGG-Cys2His2
complex exhibited a cooperative two-proton transition involving two Cys residues (pKa3,4eff).
For the Co(II)-GGG-Cys4 complex:
(Eqn. 2.11)

Abs = Abs0 +

εMLH
(−3pH+3p𝐾𝑎1,2,3 𝑒𝑓𝑓 )
(pH−p𝐾𝑎4 𝑒𝑓𝑓 )
10
+10
+1

+

εMLH4
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 +3pH)
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +4pH)
10
+10
+1

(Eqn. 2.12)

F = F0 +

∆FMLH
(−3pH+3p𝐾𝑎1,2,3 𝑒𝑓𝑓 )
(pH−p𝐾𝑎4 𝑒𝑓𝑓 )
10
+10
+1

+

∆FMLH4
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 +3pH)
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +4pH)
10
+10
+1

For the Co(II)-GGG-Cys3His1 complex:
Abs = Abs0 +

F = F0 +

εMLH3
(3pH−3p𝐾𝑎2,3,4 𝑒𝑓𝑓 )
10
+1

∆FMLH3
(3pH−3p𝐾𝑎2,3,4 𝑒𝑓𝑓 )
10
+1
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(Eqn. 2.13)

(Eqn. 2.14)

For the Co(II)-GGG-Cys2His2 complex:
Abs = Abs0 +

F = F0 +

ε

MLH2
(2pH−2p𝐾𝑎3,4 𝑒𝑓𝑓 )
10
+1

∆FMLH2
10

(2pH−2p𝐾𝑎3,4 𝑒𝑓𝑓 )

(Eqn. 2.15)

(Eqn. 2.16)
+1

Where Abs and F are the measured absorbance and fluorescence intensities, respectively; Abs0 and F0
are the initial absorbance of the Co(II)-GGG complexes; εMLH , εMLH2 , εMLH3 , and εMLH4 are the molarextinction coefficient of the MLH, MLH2, MLH3, and MLH4 species, respectively; ΔFMLH, ΔFMLH2, ΔFMLH3, and
ΔFMLH4 are the change in fluorescence emission due to the formation of the various protonation species of
the metal complexes; and pKaeff terms are the effective acid dissociation constants of these metal-ligand
complexes.

Figure 2.4: Potentiometric pH titration setup. A 1.0 cm path length cuvette with a magnetic stir, fitted with
a pH electrode, and maintained under a constant stream of hydrated nitrogen gas. Addition of microliter
aliquots of 0.1 M HCl was followed by measurement of the UV-vis absorbance (not shown in the figure) and
fluorescence emission spectra. The change in pH upon addition of the acid was monitored using a pH
meter.
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pH Dependence of Conditional Dissociation Constants. As described in Section 1.5 of this
thesis, the conditional dissociation constants, Kd values, of Co(II)-GGG complexes are expected to be pH
dependent. Therefore, they were measured at various pH value solutions and determined as described
above. The resulting Kd values were plotted as -log Kd vs. pH and fitted to the general equilibrium model
shown in eqn. 2.17 and derived in the Appendix.

− 𝑙𝑜𝑔 𝐾𝑑 = 𝑙𝑜𝑔 [𝐾𝑓 𝑀𝐿 ×

𝛼𝐿
]
𝛼𝑀𝐿

(Eqn. 2.17)

Where Kd is the observed conditional dissociation constant at any given pH value; KfML is the
pH-independent formation constant for the Co(II)-GGG complexes; αL and αML are the molar fractions of
the fully deprotonated apo- and holo-GGG in the solution, respectively.
The dissociation of the Co(II)-GGG complexes is governed by the intrinsic pKa values of the binding ligands
in the apo-GGG peptides, and the pKaeff values of these ligands in the holo-GGG complexes, as shown in
Scheme 1.1 (Section 1.5) and given by eqns. 2.18-2.20.
For the Co(II)-GGG-Cys4 complex:
(Eqn. 2.18)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−pH+p𝐾𝑎4 ) + 10(−4pH+3p𝐾𝑎1,2,3 +p𝐾𝑎4 )
)
(−pH+p𝐾
)
(−2pH+p𝐾
𝑎4
𝑎4 +p𝐾𝑎3 ) + 10(−3pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 ) + 10(−4pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 +p𝐾𝑎1 )
1 + 10
+ 10

For the Co(II)-GGG-Cys3His1 complex:
(Eqn. 2.19)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−3pH+3p𝐾𝑎2,3,4 ) + 10(−4pH+p𝐾𝑎1 +3p𝐾𝑎2,3,4 )
)
(−pH+p𝐾
)
𝑎4 + 10(−2pH+p𝐾𝑎4 +p𝐾𝑎3 ) + 10(−3pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 ) + 10(−4pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 +p𝐾𝑎1 )
1 + 10

For the Co(II)-GGG-Cys2His2 complex:
(Eqn. 2.20)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−2pH+p𝐾𝑎3,4 ) + 10(−4pH+2p𝐾𝑎1,2 +2p𝐾𝑎3,4 )
)
1 + 10(−pH+p𝐾𝑎4) + 10(−2pH+p𝐾𝑎4+p𝐾𝑎3) + 10(−3pH+p𝐾𝑎4+p𝐾𝑎3 +p𝐾𝑎2 ) + 10(−4pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2+p𝐾𝑎1)

Figure 2.5 shows an example of -log Kd vs. pH plot that is used to describe the pH dependence of the
conditional dissociation constants and allowed for the determination of the metal(II)-peptide formation
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constants. The individual measured Kd values are represented by black circles. The intrinsic pKa values
and the pKaeff values are noted in the plot. The plateau of the acid region, i.e. below both the intrinsic pKa
and the pKaeff, yields the pH-independent formation constant for fully protonated metal(II)-peptide complex,
KfMLH4 value. The slope of the plot, i.e. between the values of the intrinsic pKa and the pKaeff, represents the
pH-dependence of the Kd values as a result of a proton release upon metal complexation (as previously
shown in Section 1.5, eqn. 1.4). Whereas the plateau of this fit at the basic region, i.e. above the intrinsic
pKa, gives the pH-independent formation constant for fully deprotonated metal(II)-peptide complex,
KfML value. This KfML value reveals the free energy contribution from metal-ion binding applied toward protein
stabilization, as shown in eqn. 2.21:
ΔGCo(II)-GGG-Obs = - RT ln(KfML)

(Eqn. 2.21)

Figure 2.5: Plot of -log Kd vs pH used to show the pH dependence of conditional dissociation constants,
Kd values, and determination of the metal(II)-peptide formation constant, KfML value.

It is important to note that Kd values are profoundly affected by protein’s intrinsic pKa and pKaeff values,
as well as the metal(II)-peptide formation constants, KfML and KfMLH4 values. Figure 2.6 shows a plot
of -log Kd vs. pH for Zn(II)-GGG-Cys4 complexation (black solid line) and the changes in Kd values (blue
dotted line) as a function of pKa and pKaeff values or a function of KfML and KfMLH4 values. Figure 2.6A
illustrates how the observed Kd changes when the pKa and pKaeff values have been changed by 1.0 unit to
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more acidic values without changing the KfML and KfMLH4 values. This results in shifting the fit for
the -log Kd vs. pH plot to the left, and tighter binding affinities at physiological pH, e.g. the Kd value at
pH 7.4 changed from 2.6 × 10-13 M to 2.5 × 10-16 M or in other words, a 4.1 kcal/mol tighter affinity for Zn(II).
Figure 2.6B illustrates the impact of increasing the KfML (and KfMLH4) values by 3.0 kcal/mol without changing
the pKa and pKaeff values. This resulting in shifting the fit up, and tighter binding affinities as well,
e.g. Kd value at pH 7.4 changed from 2.6 × 10-13 M to 1.6 × 10-15 M or a 3.0 kcal/mol tighter affinity for the
metal-ion. It should be noted that all four curves in Figure 2.6A/B maintain the same energetic difference
between the KfML and KfMLH4 values. Simultaneous changes to both the pKa and pKaeff values as well as the
KfML and KfMLH4 values will result in a change in the energetic difference between the KfML and KfMLH4 values
and is not shown here.

Figure 2.6: Changes in conditional dissociation constants, Kd values, as a function of (A) pKa and pKaeff
values and (B) KfML and KfMLH4 values. Black solid line represents a -log Kd vs pH plot for Zn(II)-GGG-Cys4.
Blue dotted line represents the -log Kd vs pH fit for the same complexation upon applied changes.
(A) The pKa and pKaeff values have been changed by 1.0 unit to more acidic values, shifting the fit to the
left (blue dotted line), and resulting in tighter binding affinities, e.g. Kd value at pH 7.4 changed from
2.6 × 10-13 M to 2.5 × 10-16 M. (B) The KfML and KfMLH4 values have been added a 3.0 kcal/mol, shifting the
fit up (blue dotted line), and resulting in tighter binding affinities, e.g. Kd value at pH 7.4 changed from
2.6 × 10-13 M to 1.6 × 10-15 M.

Experimental Error. Based on multiple titration trials, the experimental error for individual Kd
values was estimated to be less than factor of 5.5, or 1.0 kcal/mol. The error of the KfML values determined
using the pH, pHeff and Kd values was estimated to be less than factor of 5.5, or 1.0 kcal/mol.
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2.3 Results
Experimental Design. When a metal-ion binds to an unfolded apo-ZFPs via its Cys4, Cys3His1, or
Cys2His2 coordination motif, the protein spontaneously folds into its biologically active structure,
e.g. the ββα structure.[3,4,6-9] Therefore, the thermodynamics of metal-ion affinity and protein folding are
coupled which obscure both values, as described in Section 1.5 and shown in Figure 1.9. The Gibney lab
has developed a method to separate these thermodynamics using the designed GGG peptide which
possess a minimized free energy cost for the protein folding, i.e. ΔGapoGGG-folding = 0 kcal/mol, and the
maximal metal-ion affinities for the ZFP coordination motifs.[91,92] The GGG peptide scaffold was derived
from a 16-amino acid [4Fe-4S] ferredoxin model compound, IGA, where the isoleucine (I) and alanine (A)
residues were substituted by glycine (G) residue.[121,122] The rational design for this substitution was to
emulate structural Zn(II) sites as closely as possible and to limit the formation of any secondary structures
in either apo- or holo-GGG. The three common Zn(II) coordination motifs in natural ZFPs, Cys4, Cys3His1,
and Cys2His2 were incorporated into the designed GGG by varying the two X amino acid residues in the
sequence to either Cys or His residues.

IGA

NH2-KLCEGGCIGCGACGGW-CONH2

GGG

NH2-KLXEGGXGGCGGCGGW-CONH2 ;

XX = CC, HC, or HH

These GGG variants were utilized to determine the intrinsic affinities of Co(II) to each of these three
ZFPs coordination motifs from minimal equilibria models for Co(II)-GGG complexations. Each proton
competition equilibrium was modeled based on measured pH dependent conditional dissociation constants,
the Kd values, for the Co(II)-binding to the GGG variants, as well as the intrinsic and effective acid
dissociation constants, the pKa and pKaeff values for the apo- and holo-GGG, respectively.
These intrinsic affinities will be used to investigate the preference of Co(II)-ion for binding cysteine
thiolate versus histidine imidazole. Previously, GGG has been used to show that Zn(II) prefers cysteinate
to histidine imidazole coordination. A further comparison of the Co(II) affinities of each coordination motif
between the GGG peptide and natural ZFPs is expected to elucidate the cost of protein folding in natural
ZFPs, ΔGapoZFP-folding, is minimal (less than +4.5 kcal/mol) for all three coordination motifs (Cys4, Cys3His1,
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and Cys2His2), based on the previously reported results for Zn(II)[92,101,102] This is because the methodology
used to separate these thermodyanically coupled values is expected not to rely on the identity of the
metal-ion cofactor if both metals yield similar holo-ZFP structures.

Co(II) Binding Titrations. A comparison of apo vs. Co(II)-bound spectra of the three coordination
motifs for GGG are shown in Figure 2.7. Incorporation of Co(II) into each of the three GGG variants showed
distinctive UV-vis spectra, which are sensitive to both the metal-ion coordination geometry and the
coordination motif. Figure 2.7A shows that addition of 1.0 equivalent (eq) of CoCl 2 into buffered (20 mM
HEPES 100 mM KCl, pH 8.2) solutions of GGG-Cys4, GGG-Cys3His1, and GGG-Cys2His2 result in
characteristic ligand field d→d electronic transitions, which are observed (insert in Figure 2.7A) at 685 nm,
645 nm, and 625 nm, respectively. The extinction coefficients of these electronic transitions indicate that
all three GGG variants bind Co(II) in a tetrahedral coordination geometry. The observed shift in wavelength
of the d→d bands is due to the sensitivity of the Co(II)-ion to the ligand type. In addition, the incorporation
of Co(II) into the GGG variants at these conditions results in characteristic S→Co(II) LMCT transitions,
which are observed by increased intensity of absorption bands in the near-UV spectrum at 306 nm for
Co(II)-GGG-Cys4 and Co(II)-GGG-Cys3His1, and at 292 nm for GGG-Cys2His2.
The Trp fluorescence emissions maximum (λ maxem) at 355 nm for both apo- and holo-GGG in all
three peptide variants (Figure 2.7B) indicates that Trp is exposed to the solvent[123] and doesn’t shift with
Co(II) incorporation. This observation is consistent with Trp position at the C-terminal of the designed GGG
peptides and the lack of hydrophobic burial in these peptides’ scaffold. Addition of 1.0 equivalent of CoCl2
into apo-peptide solutions at pH 8.2, results in decreased Trp fluorescence emission intensity of the
holo-GGG complexes by ~ 90%, which is expected as the paramagnetic Co(II)-ion is a strong fluorescence
quencher.
Figure 2.7 affirms that both absorbance and fluorescence spectroscopy measurements can be
used to determine the conditional metal-ligand dissociation constants, Kd values, of Co(II)-GGG complexes.
When combined together these spectroscopies give a more complete picture of the binding kinetics and
thermodynamics of the complexation process.
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Figure 2.7: Non-bonding vs. bonding Co(II)-GGG spectra. UV-vis absorbance and fluorescence emission
spectra for apo-GGG (dashed purple line) and Co(II)-GGG complexes (solid lines) in 20mM HEPES 100
mM KCl pH 8.2. (A) Upon metal ion binding, an increase in the ligand field d→d electronic transition bands
at 625-685 nm is observed, which indicates the formation of tetrahedral Co(II)-GGG complexes. As well,
an increase in the absorbance is observed for Co(II)-thiolate charge transfer bands at 292-306 nm region.
(B) A decrease in Trp fluorescence emission intensity at 355 nm results from the incorporation of Co(II) into
the GGG variants.
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Figure 2.8 shows UV-vis absorbance and fluorescence emission spectra upon direct 6.8 mM CoCl2
titration into buffered 30 μM apo-GGG solutions at pH 8.2 (20 mM HEPES 100 mM KCl). The inserts show
plots of the change in spectra intensity as a function of the molar ratio of Co(II) to peptide and are fit to a
1:1 metal−peptide binding model.

Figure 2.8: Determination of Co(II)-GGG equilibrium via UV-vis absorbance (A,C,E) and Trp fluorescence
emission (B,D,F) spectra at pH 8.2 (20mM HEPES 100 mM KCl). Arrows indicate progress of titration. The
inserts are equilibrium binding plots that fit to a 1:1 metal−peptide binding model upon titration of 6.8 mM
CoCl2 into 30 μM apo-GGG variants. (A,B) Into GGG-Cys4 solution, 0.3 eq of Co(II) were titrated at a time.
(C,D) 0.2 eq of Co(II) were titrated at a time into GGG-Cys3His1 solution. (E,F) Titration of 0.2 eq, at a time,
of Co(II) into GGG-Cys2His2 solution.
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Analysis of the Conditional Dissociation Constant pH Dependence via Direct Co(II) Titration.
The conditional metal-ligand dissociation constants, Kd values, for Co(II)-GGG variants between
pH 5.0 - 7.0 were determined by direct 6.8 mM CoCl2 titration as described in the experimental section.
Figure 2.9 shows direct binding titration in 20 mM BisTris 100 mM KCl buffered peptide solutions at pH 6.7
for both GGG-Cys4 and GGG-Cys3His1, and pH 7.0 for GGG-Cys2His2. All three peptide variants fit to an
equilibrium binding model of 1:1 metal-peptide, giving Kd value of 4.9 μM for Co(II)-GGG-Cys4 (Figure
2.9A,B), Kd value of 9.0 μM for Co(II)-GGG-Cys3His1 (Figure 2.9C,D), and Kd value of 14.3 μM for
Co(II)-GGG-Cys2His2 (Figure 2.9E,F), from UV-vis and fluorescence titration data.

Figure 2.9: Determination of the Kd values for Co(II)-GGG complexes via direct titration of CoCl2 into
20 mM BisTris 100 mM KCl buffered solutions of (A,B) 23 μM GGG-Cys4 at pH 6.7 titrated with 0.3 eq of
6.8 mM CoCl2 at a time to give Kd value 4.9 μM. (C,D) 0.2 eq of 6.8 mM CoCl2 titrated at a time into 28 μM
GGG-Cys3His1 solution (pH 6.7) to give Kd of 9.0 μM. (E,F) 52 μM GGG-Cys2His2 solution is titrated by
0.5 eq of 13.5 mM CoCl2 at pH 7.0 to give Kd value of 14.3 μM. For samples (B) and (D), excitation and
emission slit widths of 5 nm were employed. For sample (F), due to a higher concentration of the peptide
in the solution, these slits were adjusted to 2.5 nm and 5 nm, excitation and emission, respectively.
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Analysis of the Conditional Dissociation Constant pH Dependence via Competition Titration.
Figure 2.10 shows competition titration curves at pH 8.8 (20 mM HEPES 100 mM KCl), where 6.8 mM
CoCl2 was titrated into peptide solutions containing 150 μM EGTA, a competitive chelator. EGTA is
competing with the peptide for metal-ion binding with a dissociation constant, KdCo(II)-EGTA, value of
4.88 × 10-12 M (for pH 8.8) - calculated as described in eqn. 2.9, with KfCo(II)-EGTA value of 2.24 × 1012 M-1
and αY4− is 9.15 × 10-2.[120] The competition equilibrium binding isotherms fit to competition constant value
of 18.3 for Co(II)-GGG-Cys4 (Figure 2.10A,B), Kcomp value of 8.0 for Co(II)-GGG-Cys3His1 (Figure 2.10C,D),
and Kcomp value of 12.1 for Co(II)-GGG-Cys2His2 (Figure 2.10E,F). These competition constants were fitted
into eqn. 2.5 to determine the dissociation constants, KdCo(II)-GGG, for Co(II)-GGG-series and resulted in
values of 89.6 pM for Co(II)-GGG-Cys4, Kd value of 38.9 pM for Co(II)-GGG-Cys3His1, and dissociation
constant value of 59.1 pM for Co(II)-GGG-Cys2His2.

Figure 2.10: Determination of the Kd values for Co(II)-GGG complexes via competition titration with EGTA
at pH 8.8 (20 mM HEPES 100 mM KCl). (A,B) Titration of 6.8 mM CoCl2 into 23 μM GGG-Cys4 solution,
with 7.0 eq EGTA presence, fit a competition constant value of 18.3 between GGG-Cys4 and EGTA. Since
the Kd of Co(II)-EGTA is 4.88 pM at pH 8.8, the resulting Co(II)-GGG-Cys4 dissociation constant is 89.6 pM.
(C,D) A solution of 28 μM GGG-Cys3His1 and 5.0 eq EGTA was titrated with 6.8 mM CoCl2 to fit Kcomp value
8.0, resulting in Co(II)-GGG-Cys3His1 Kd value of 38.9 pM. (E,F) Into 32 μM GGG-Cys2His2 and 5.0 eq
EGTA, 6.8 mM CoCl2 were titrated to fit Kcomp value 12.1, resulting in Co(II)-GGG-Cys2His2 dissociation
constant value of 59.1 pM.
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Potentiometric pH Titration. The Co(II)-GGG effective acid dissociation constants, pKaeff values,
were measured via potentiometric pH titrations in the range of pH 9.0 to pH 4.0 followed by both UV-vis
and fluorescence spectroscopies. As the pH of the solution is lowered by addition of microliter aliquots of
0.1 M HCl, an increase in tryptophan fluorescence emission intensity at 355 nm is observed. This is a result
of thiolate and imidazole ligand protonation and dissociation from the bound Co(II). When Co(II) is bound
to the peptide, at higher pH values, it has higher quenching effect on Trp fluorescence, but as the pH is
lowered and the peptide is protonated and loses its bounded structure, the Trp position become farther
from Co(II) and feels less the quenching effect. Lowering the pH of the solution on the other hand leads to
a decrease in both the absorbance spectra at S→Co(II) LMCT (due to Co(II)-ligand bond dissociation) and
d→d bands (Co(II) loses its tetrahedral structure).
Figure 2.11A-left, shows that the fluorescence emission for the pH change in 200 μM
Co(II)-GGG-Cys4 solution is best fit to an equilibrium model involving two separate protonation events,
a cooperative three-proton event with a pKa1,2,3eff value of 6.4 and a one-proton event with pKa4eff value of
6.6. Figure 2.11A-center, shows the UV-vis absorbance at S→Co(II) LMCT bands for pH change in 200 μM
Co(II)-GGG-Cys4 solution, and best fit to an equilibrium model with a cooperative three-proton event
pKa1,2,3eff value of 6.2 and a one-proton event with a pKa4eff value of 6.7. Figure 2.11A-right, shows the
UV-vis absorbance for pH change at Co(II) d→d bands in 86 μM Co(II)-GGG-Cys4 solution, and best fitted
to an equilibrium model with a cooperative three-proton event pKa1,2,3eff value of 6.3 and by a one-proton
event with a pKa4eff value of 6.7.
Figure 2.11B shows the pH change in 86 μM Co(II)-GGG-Cys3His1 solution. The three spectral
probes (Trp fluorescence emission and the UV-vis for both S→Co(II) LMCT transition and Co(II) d→d bands)
fit to a model involving a cooperative three-proton event with pKa2,3,4eff value of 6.5. The protonation of the
histidine imidazole, i.e. pKa1eff is not observed spectroscopically. In Figure 2.11C the pH change, upon
addition of acid into 86 μM Co(II)-GGG-Cys2His2 solution, provided a cooperative two-proton event with
a metal-ligand effective acid dissociation constant for Cys, pKa3,4eff value of 6.9. Again, the pKa values
attributed to histidine imidazole, pKa1eff and pKa2eff, are not spectroscopically observable.
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Figure 2.11: Potentiometric pH titration of Co(II)-GGG complexes. The effective acid dissociation constants
for Co(II)-GGG complexes were determined from Trp fluorescence at 355nm, absorbance spectra at
S→Co(II) LMCT bands, and absorbance at Co(II)-peptide d→d bands. (A) Co(II)-GGG-Cys4; Fluorescence:
pKa1,2,3eff = 6.4, pKa4eff = 6.6; UV-vis at 306 nm: pKa1,2,3eff = 6.2, pKa4eff = 6.7; UV-vis at 685 nm:
pKa1,2,3eff = 6.3, pKa4eff = 6.7 (B) Co(II)-GGG-Cys3His1; Fluorescence: pKa2,3,4eff = 6.5; UV-vis at 306 nm:
pKa2,3,4eff = 6.5; UV-vis at 645 nm: pKa2,3,4eff = 6.5 (C) Co(II)-GGG-Cys2His2; Fluorescence: pKa3,4eff = 6.9;
UV-vis at 292 nm: pKa3,4eff of 6.9; UV-vis at 625 nm: pKa3,4eff of 6.9.
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pH Dependence of Conditional Dissociation Constants. The conditional dissociation constants
for the Co(II)-GGG complexes are highly pH dependent due to the competition between metal-ion and
proton binding. The binding affinity at any given pH is conditioned by the speciation of the apo- and
holo-peptide. Apo-peptide speciation is defined by the intrinsic acid dissociation constants, pKa values,
determined from previous work[92]. Holo-peptide speciation is defined by the effective acid dissociation
constants, pKaeff values, determined from the Co(II)-GGG potentiometric pH titration, as described above.
This pH dependence and speciation of Co(II)-GGG complexes can be modeled by minimal equilibria sets
as shown is Scheme 2.1. The measured Kd values over a broad pH range are fitted to these equilibria
models and presented in Figure 2.12. From Scheme 2.1 and Figure 2.12, the Co(II)-GGG complexation
reaction and the conditional Kd values can be described by a combination of equilibria steps, which depend
on the pH conditions of the solution.

Scheme 2.1: Minimal equilibria used to model the pH dependence of Co(II)-GGG complexation.
(A) Co(II)-GGG-Cys4. (B) Co(II)-GGG-Cys3His1. (C) Co(II)-GGG-Cys2His2.
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Figure 2.12: pH dependence of conditional dissociation constants, Kd values. (A) Co(II)-GGG-Cys4,
(B) Co(II)-GGG-Cys3His1, (C) Co(II)-GGG-Cys2His2. The formation constants, KfML values, for Co(II)-GGG
with Cys4, Cys3His1, and Cys2His2 binding motifs are 3.4 × 1011, 2.2 × 1011, and 1.0 × 1011 M-1, respectively.
Resulting in free energy contribution of -15.7, -15.5, and -15.0 kcal/mol to the stabilization of
Co(II)-GGG-Cys4, Co(II)-GGG-Cys3His1, and Co(II)-GGG-Cys2His2, respectively.

In the case of Co(II)-GGG-Cys4 (Scheme 2.1A and Figure 2.12A), the binding reaction can be
described by the following four equilibria steps, and the Kd value measured at any pH value is given by any
one or mixture of these equilibria:
𝐩𝐇 > p𝐾𝑎1−4 𝐶𝑦𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠
Co(II) + [𝐆𝐆𝐆 − (Cys − )4 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )4 ]

(Eqn. 2.22)

p𝐾𝑎1−4 𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)4 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )4 ] + 4H +

(Eqn. 2.23)

p𝐾𝑎1−4 𝐶𝑦𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)4 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )3 − (CysH)] + 3H +

(Eqn. 2.24)

p𝐾𝑎1−4 𝐶𝑦𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇
Co(II) + [𝐆𝐆𝐆 − (CysH)4 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (CysH)4 ]

(Eqn. 2.25)

At high pH values (eqn. 2.22), above the intrinsic pKa of the free Cys ligands (i.e. p𝐾𝑎1−4 𝐶𝑦𝑠 ), the fit levels
out and corresponds to the value of the pH-independent formation constant, KfML value, for deprotonated
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Co(II)-GGG-Cys4 complex. The fit to the data in eqn. 2.18, gives KfML value of 3.2 × 1011 M-1 for this complex.
This value corresponds to -15.7 kcal/mol free energy contribution to the protein’s stabilization by Co(II)
binding based on the relation ΔGCo(II)-GGG-Obs = - RT ln(KfML), as was previously shown in eqn. 2.21. As the
pH is lowered below the intrinsic pKa values of the Cys ligands (eqn. 2.23) the conditional dissociation
constants, Kd values, become pH dependent due to proton competition, with a [H+]4 dependence. When the
pH values approach the effective pKa4eff-Cys and pKa1,2,3eff-Cys values of the Co(II)-GGG-Cys4 complex
(eqn. 2.24), the measured solutions will contain a mixture of protonated cysteine thiol complexes with all
four Cys ligands protonated (i.e. Co(II)-GGG-(CysH)4 or Co(II)-tetrathiol) and only one Cys ligand
protonated (i.e. Co(II)-GGG-(CysH) or Co(II)-trithiolate monothiol). At these conditions the Kd values are
pH dependent as well, however the dependency is weaker than [H+]4 as fewer protons are released upon
Co(II) binding. At low pH values (eqn. 2.25), below both the intrinsic pKa values of the Cys ligands and
the pKaeff of the Co(II)-GGG complex, the fit levels out again and corresponds to the value of
the pH-independent formation constant, KfMLH4, for fully protonated Co(II)-GGG-Cys4 complex. Fitting the
data to eqn. 2.18 gives a KfMLH4 value of 3.2 × 10-4 M-1 for Co(II)-GGG-(CysH)4 complex, indicating a limited
affinity for Co(II) at these pH conditions.
In the case of Co(II)-GGG-Cys3His1 (Scheme 2.1B and Figure 2.12B), the binding reaction can be
described by the following five equilibria steps, and the Kd value measured at any pH value is given by any
one or mixture of these equilibria:
𝐩𝐇 > p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎2,3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (Cys − )3 − (His)] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )3 − (His)]

(Eqn. 2.26)

p𝐾𝑎2−4 𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎2,3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)3 − (His)] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )3 − (His)] + 3H +

(Eqn. 2.27)

p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > 𝐩𝐇 > p𝐾𝑎2,3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)3 − (HisH + )] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )3 − (His)] + 4H +

(Eqn. 2.28)

p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎2,3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)3 − (HisH + )] ⇌ [Co(II) − 𝐆𝐆𝐆 − (CysH)3 − (His)] + 1H +

(Eqn. 2.29)

p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎2,3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠 > 𝐩𝐇
Co(II) + [𝐆𝐆𝐆 − (CysH)3 − (HisH + )] ⇌ [Co(II) − 𝐆𝐆𝐆 − (CysH)3 − (HisH + )]

45

(Eqn. 2.30)

At high pH values (eqn. 2.26), above the intrinsic pKa of the free Cys and His ligands (i.e. p𝐾𝑎2−4 𝐶𝑦𝑠 and
p𝐾𝑎1 𝐻𝑖𝑠 ), the fit levels out and corresponds to the value of the pH-independent formation constant, KfML, for
deprotonated Co(II)-GGG-Cys3His1 complex. The fit to the data, as shown in eqn. 2.19, gives KfML value
of 2.2 × 1011 M-1 for this complex, which corresponds to -15.5 kcal/mol free energy contribution to the
stabilization of GGG by the binding of Co(II)-ion, based on eqn. 2.21. As the pH is lowered below the
intrinsic pKa values of the unbound Cys ligands (eqn. 2.27), proton competition leads the Kd values to
express [H+]3 dependence as a result of the release of three protons from the cysteine thiol ligands in the
complexation of Co(II) and GGG-(CysH)3-(His). Further lowering the pH of the solutions, below the intrinsic
pKa value of the unbound His ligand (eqn. 2.28), leads to a release of four protons by the binding of Co(II)
to GGG-(CysH)3-(HisH+). Therefore, the Kd values under these conditions exhibit [H+]4 dependence.
When the pH values drop below the effective pKa2,3,4eff-Cys value of the Co(II)-bound thiolates (eqn. 2.29),
the metal complexation produces triprotonated trithiols deprotonated imidazole complex. At these
conditions the Kd values are pH dependent as well, however the dependency is only [H+]1. At low pH values
(eqn. 2.30), below the effective pKa1eff-His value of the Co(II)-bound imidazolium, both the reactants and the
products are tetraprotonated, thus the reaction is expected to be pH-independent. However, experimentally
the formation of the Co(II)-GGG-(CysH)3-(HisH+) species is not observed, leading to the prediction of its
formation below pH 4.8. Fitting the data to eqn. 2.19 results in the leveling of the fit at low pH values, which
corresponds to the value of the pH-independent formation constant, KfMLH4 of 3.6 × 10-4 M-1 for fully
protonated Co(II)-GGG-Cys3His1 complex.
In the case of Co(II)-GGG-Cys2His2 (Scheme 2.1C and Figure 2.12C), the binding reaction can be
described by the following five equilibria steps, and the Kd value measured at any pH value is given by any
one or mixture of these equilibria:
𝐩𝐇 > p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (Cys − )2 − (His)2 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )2 − (His)2 ]

(Eqn. 2.31)

p𝐾𝑎3−4 𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)2 − (His)2 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )2 − (His)2 ] + 2H +

(Eqn. 2.32)

p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > 𝐩𝐇 > p𝐾𝑎3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (Cys − )2 − (His)2 ] + 4H +
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(Eqn. 2.33)

p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1,2 𝑒𝑓𝑓−𝐻𝑖𝑠
Co(II) + [𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (CysH)2 − (His)2 ] + 2H +

(Eqn. 2.34)

p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎3,4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2 𝑒𝑓𝑓−𝐻𝑖𝑠 > 𝐩𝐇
Co(II) + [𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ] ⇌ [Co(II) − 𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ]

(Eqn. 2.35)

At high pH values (eqn. 2.31), above the intrinsic pKa of the free Cys and His ligands (i.e. p𝐾𝑎3−4 𝐶𝑦𝑠 and
p𝐾𝑎1−2 𝐻𝑖𝑠 ), the fit levels out and corresponds to the value of the pH-independent formation constant,
KfML value, for deprotonated Co(II)-GGG-Cys2His2 complex. The fit to the data, as shown in eqn. 2.20, gives
KfML value of 1.0 × 1011 M-1 for this complex, which corresponds to -15.0 kcal/mol free energy contribution
to the stabilization of Co(II)-GGG-Cys2His2 complex, based on eqn. 2.21. As the pH is lowered below the
intrinsic pKa values of the Cys ligands in the apo-peptide (eqn. 2.32), proton competition leads to the
Kd values to express [H+]2 dependence as a result of the release of two protons from the cysteine thiol
ligands to produce Co(II)-GGG-(Cys-)2-(His)2. Further lowering the pH of the solutions, below the intrinsic
pKa value of the His ligands in the apo-peptide (eqn. 2.33), leads to a release of four protons to produce
the Co(II)-GGG-(Cys-)2 -(His)2 from the complexation of free Co(II) and dithiol diimidazolium GGG peptide.
Therefore, the Kd values under these conditions exhibit [H+]4 dependence. When the pH values drop below
the effective pKa3,4eff-Cys value of the Co(II)-bound thiolates (eqn. 2.34), the metal complexation produces
diprotonated dithiol dideprotonated diimidazole complex (i.e. the Co(II)-GGG-(CysH)2-(His)2). At these
conditions the Kd values are pH dependent as well, with the dependency of [H +]2. At low pH values
(eqn. 2.35), below the effective pKa1,2eff-His value of the Co(II)-bound imidazolium, both the reactants and
the products are tetraprotonated, thus the reaction is expected to be pH-independent. However,
experimentally the formation of the Co(II)-GGG-(CysH)2-(HisH+)2 species is not observed leading for the
prediction of its formation below pH 5.0. Fitting the data to eqn. 2.19 results in the leveling of the fit at low
pH values, which corresponds to the value of the pH-independent formation constant, KfMLH4 of
3.2 × 10-4 M-1 for fully protonated Co(II)-GGG-Cys2His2 complex.
The evaluation of proton competition in Co(II)-GGG complexes, as modeled by the minimal
equilibria in Scheme 2.1, is based on a combination of results from several experimental determinations,
thus it is critical to check and validate these models. Eqns. 2.36, which is derived from eqn. 2.37, allows for
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a thermodynamic comparison of the free energy difference between the conditional binding constants, the
𝑒𝑓𝑓

intrinsic pKa values and the effective pKaeff values (i.e. ∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎 ), to the free energy
difference between the formation constants of fully protonated bound complex, MLH42+, and fully
𝑀𝐿2−

deprotonated bound complex, ML2-, (i.e. ∆∆𝐺 = ∆𝐺 𝐾𝑓

− ∆𝐺

𝑀𝐿𝐻4 2+

𝐾𝑓

). By definition, the two must be

equivalent.
𝑒𝑓𝑓

∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎

𝑒𝑓𝑓

𝑀𝐿2−

?

⇔ ∆𝐺 𝐾𝑓
?

− ∆𝐺

𝑀𝐿𝐻4 2+

𝐾𝑓

2−

∆∆𝐺 = −2.303𝑅𝑇(Σ𝑝𝐾𝑎 − Σ𝑝𝐾𝑎 ) ⇔ −2.303𝑅𝑇(𝑙𝑜𝑔𝐾𝑓𝑀𝐿

(Eqn. 2.36)
𝑀𝐿𝐻4 2+

− 𝑙𝑜𝑔𝐾𝑓

)

(Eqn. 2.37)

Calculations of the ΔΔG values for the Co(II)-GGG complexes are given in the Appendix (eqns. A.89-A.95).
Notably, each of the three Co(II)-GGG complexes have identical thermodynamic differences, validating the
proposed complete minimal equilibria models described in Scheme 2.1.

2.4 Discussion
In this study, the thermodynamic contribution of Co(II)-ion binding to the three ZFPs coordination
motifs - Cys4, Cys3Hi1, and Cys2His2, in a designed minimalistic unstructured GGG peptide has been
evaluated as a function of pH. Equilibrium measurements were utilized to elucidate the solution speciation
of each Co(II)-GGG complex over a broad pH range (i.e. between pH 4.0 – 9.0) and to determine the
intrinsic affinities of Co(II) to these three ZFPs motifs. The data indicates pH-independent formation
constants, KfML values, of 3.4 × 1011 M-1, 2.2 × 1011 M-1, and 1.0 × 1011 M-1, which correspond to free energy
contribution of -15.7, -15.5, and - 15.0 kcal/mol by the metal-ion binding to the protein stabilization, for
Co(II)-GGG-Cys4, Co(II)-GGG-Cys3His1, and Co(II)-GGG-Cys2His2, respectively. These values are
identical, within an experimental error of 5.5-fold or 1.0 kcal/mol, therefore leading to the conclusion that at
high pH values (i.e. above pH 9.0) the Co(II)-ion has no preference binding cysteine thiolate over histidine
imidazole. As the pH is lowered below the intrinsic cysteine pKa values, the dissociation constants, KdML
values, become pH dependent due to proton competition. All three Co(II)-GGG complexes continue to
possess similar Kd values within experimental error (i.e. less than 1.0 kcal/mol) at the pH approaches
physiological values. Figure 2.13 shows that the substantial difference between the pH dependence for the
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Co(II) complexes of each coordination motif is observed in the slope of the -logKd vs. pH plots. These slopes
represent the protonation pattern of each complex and are unique to the coordination motif based on its
intrinsic pKa and effective pKaeff values. In the case of Co(II)-GGG-Cys4 a one-proton protonation event is
observed followed by a cooperative three-proton event, while for Co(II)-GGG-Cys3His1 it’s the other way
around, a cooperative three-proton event (protonation of the three Cys residues) is followed by one-proton
event (protonation of His residue). And in the case of Co(II)-GGG-Cys2His2 a cooperative protonation of the
two Cys ligands is followed by another presumed cooperative protonation of the two His ligands.

Figure 2.13: Comparison of the Kd values as a function of pH for the three Co(II)-GGG complexes. All three
complexes, GGG-Cys4 (full circles ●, black line), GGG-Cys3His1 (empty circles 〇, red line), and
GGG-Cys2His2 (diamonds ◆, blue line), show to possess the same conditional dissociation constants,
Kd values, within experimental error (i.e. 1.0 kcal/mol). The three differ in their fit’s slope, which corresponds
to the unique protonation pattern for each complex.

The lack of energetic penalty for protein folding in the GGG scaffold allows for evaluation of the
energetic cost for natural ZFPs folding by a comparison of the Kd values for Co(II)-GGG complexes at pH
range 6.4 – 8.0 with literature constants for natural ZFPs that undergo metal-induced protein folding events,
as shown in eqn. 2.38. These thermodynamic values are reported in Table 2.1.
ΔGapoZFP-folding = ΔGML-Co(II)-ZFP-obs - ΔGML-Co(II)-GGG-obs
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(Eqn. 2.38)

Table 2.1: The cost of protein folding upon Co(II)-ion binding in zinc finger proteins.

Protein

pH

Protein
Kd

Protein
ΔGML-Obs
(kcal/mol)

GGG
Kd

GGG

Protein

ΔGML-Obs

ΔGapoZFP-folding

(kcal/mol)

(kcal/mol)

Ref

Co(II)-Cys4 Sites
hERR-DBD

7.4

610 nM

-8.82

40 nM

-10.09

+ 1.27

(w/ two Cys 4 sites)

7.4

220 nM

-9.44

40 nM

-10.09

+ 0.65

GR-DBD

7.4

410 nM

-9.06

40 nM

-10.09

+ 1.03

(w/ two Cys 4 sites)

7.4

170 nM

-9.60

40 nM

-10.09

+ 0.49

XPAzf

7.4

16 nM

-10.63

40 nM

-10.09

- 0.53

124

CP-1 (CCCC)

7.0

350 nM

-8.80

987 nM

-8.19

- 0.61

96

BRCA1 RING-1

7.0

30 nM

-10.26

987 nM

-8.19

- 2.07

125

CP1 (CCCC)

7.0

360 pM

-12.88

987 nM

-8.19

- 4.69

98

94

94

Co(II)-Cys3His1 Sites
Drosophila Fw

8.0

400 nM

-8.72

465 pM

-12.73

+ 4.00

126

MyT1-2

7.4

2.6 μM

-7.62

19 nM

-10.52

+ 2.91

97

MPVM F1_CS

7.5

670 nM

-8.42

9.85 nM

-10.92

+ 2.50

127

MPVM F1_WT

7.5

630 nM

-8.45

9.85 nM

-10.92

+ 2.46

127

BRCA1 RING-2

7.0

8.0 μM

-6.95

308 nM

-8.88

+ 1.93

125

MyT1-2

7.0

5.0 μM

-7.23

308 nM

-8.88

+ 1.65

97

90 nM

-9.99

154 nM

-9.29

+ 0.71

119

7.0

1.0 μM

-8.18

308 nM

-8.88

+ 0.70

128

7.0

500 nM

-8.59

308 nM

-8.88

+ 0.29

125

NZF-1

6.9

400 nM

-8.72

623 nM

-8.46

- 0.26

129

CP-1-H24C

7.0

100 nM

-9.54

308 nM

-8.88

- 0.67

95

CP-1 (CCHC)

7.0

63 nM

-9.82

308 nM

-8.88

- 0.94

96

RMLV NC

7.0

20 nM

-10.50

308 nM

-8.88

- 1.62

130

CP1 (CCHC)

7.0

39 pM

-14.19

308 nM

-8.88

- 5.31

98

18-peptide

HIV-CCHC
RMLV NC
CCHC box
BRCA1 RING-2
(anticooperative binding)

7.08.0
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Protein

pH

Protein
Kd

Protein
ΔGML-Obs
(kcal/mol)

GGG
Kd

GGG

Protein

ΔGML-Obs

ΔGapoZFP-folding

(kcal/mol)

(kcal/mol)

Ref

Co(II)-Cys2His2 Sites
Trx[ZS].B

7.5

158 μM

-5.18

9.9 nM

-10.91

+ 5.73

131

Trx[ZS].A

7.5

154 μM

-5.20

9.9 nM

-10.91

+ 5.72

131

Ant-F

7.5

45 μM

-5.93

9.9 nM

-10.91

+ 4.99

132

Sp1f3

8.0

2.1 μM

-7.74

987 pM

-12.28

+ 4.54

133

Sp1f2

8.0

1.2 μM

-8.07

987 pM

-12.28

+ 4.21

133

Trx[ZS].F

7.5

4.0 μM

-7.36

9.9 nM

-10.91

+ 3.55

131

Trx[ZS].C

7.5

2.0 μM

-7.77

9.9 nM

-10.91

+ 3.14

131

MZF-Coreless

7.0

6.3 μM

-7.09

100 nM

-9.54

+ 2.45

138

apoROS87

6.8

8.3 μM

-6.85

223 nM

-9.07

+ 2.21

134

TFIIIA

7.0

3.8 μM

-7.39

100 nM

-9.54

+ 2.15

135

FS01DMB

7.0

2.8 μM

-7.57

100 nM

-9.54

+ 1.97

136

MZF-Coreless-Δ8

7.0

2.5 μM

-7.64

100 nM

-9.54

+ 1.90

138

mMTF1-5

7.0

1.7 μM

-7.87

100 nM

-9.54

+ 1.68

137

mMTF1-6

7.0

1.7 μM

-7.87

100 nM

-9.54

+ 1.68

137

mMTF1-1

7.0

1.6 μM

-7.90

100 nM

-9.54

+ 1.64

137

Sp1-3

7.0

1.0 μM

-8.18

100 nM

-9.54

+ 1.36

97

MTF1

7.0

500 nM

-8.59

100 nM

-9.54

+ 0.95

137

mMTF1-3

7.0

500 nM

-8.59

100 nM

-9.54

+ 0.95

137

MZF

7.0

400 nM

-8.72

100 nM

-9.54

+ 0.82

138

MZF-Δ8

7.0

400 nM

-8.72

100 nM

-9.54

+ 0.82

138

mMTF1-4

7.0

400 nM

-8.72

100 nM

-9.54

+ 0.82

137

mMTF1-ZF(H28C)

7.0

400 nM

-8.72

100 nM

-9.54

+ 0.82

137

mMTF1-ZF(H88C)

7.0

400 nM

-8.72

100 nM

-9.54

+ 0.82

137

mMTF1-ZF(H177C)

7.0

400 nM

-8.72

100 nM

-9.54

+ 0.82

137

mMTF1-2

7.0

300 nM

-8.89

100 nM

-9.54

+ 0.65

137

mMTF1-ZF(H147C)

7.0

110 nM

-9.49

100 nM

-9.54

+ 0.06

137

mMTF1-ZF(H58C)

7.0

70 nM

-9.76

100 nM

-9.54

- 0.21

137

CP-1

7.0

63 nM

-9.82

100 nM

-9.54

- 0.28

96

SUP37

6.4

559 nM

-8.53

930 nM

-8.22

- 0.30

139

CP-1

7.0

50 nM

-9.96

100 nM

-9.54

- 0.41

95

WT-1

6.5

270 nM

-8.96

654 nM

-8.43

- 0.52

140

Sp1-3

7.4

4.6 μM

-7.28

16 nM

-10.63

- 0.66

97

CP1-Δ8 (CCHH)

7.0

23 nM

-10.42

100 nM

-9.54

- 0.87

98

mMTF1-ZF(H117C)

7.0

20 nM

-10.50

100 nM

-9.54

- 0.95

137

CP1

7.0

< 10 nM

-10.91

100 nM

-9.54

- 1.36

88

CP1 (CCHH)

7.0

56 pM

-13.98

100 nM

-9.54

- 4.44

98
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In cases where the Co(II) data comparison shows that ΔGapoZFP-folding values are positive, metal-ion
binding contributes free energy to the protein folding process. In other words, the protein folding process is
being thermodynamically driven by the metal-ion binding. These data indicate that the free energy cost of
protein folding in most ZFPs is minimal, less than +4.5 kcal/mol. This value is similar to that derived from
the corresponding Zn(II) binding analysis, as expected, since the thermodynamic model doesn’t depend on
the metal-ion, as long as it generates a metal-bound structure similar to that of the Zn(II)-bound structure.
This +4.5 kcal/mol value is significantly lower than previously estimated in the literature
(i.e. +16 kcal/mol)[88-90].
Some cases show the value of ΔGapoZFP-folding close to zero kcal/mol. This finding indicates that the
energetic cost for folding these natural ZFPs is equivalent to the cost of folding the GGG peptides.
This value is presumed to be zero kcal/mol because GGG lacks secondary structure in both apo- and
holo-states and the Zn(II)-GGG-Cys3His1 data are identical to Zn(II)-TFIIB which is prefolded prior to Zn(II)
binding. These data support the conclusion that the free energy cost of protein folding in most ZFPs is
minimal, less than +4.5 kcal/mol
Three cases show a cost for protein folding greater than +4.5 kcal/mol which are regarded as
outliers. These three are the Cys2His2 sites of Trx[ZS].A, Trx[ZS].B, and Ant-F. The Escherichia coli
thioredoxin mutants, Trx[ZS].A and B[131] are found unfolded in the apo-state and metal-binding drives their
folding. Yet, the observed Kd values of 154 μM and 158 μM for Co(II)-binding to Trx[ZS].A and Trx[ZS].B,
respectively, are +5.7 kcal/mol weaker than the Kd value of 9.9 nM observed for the Co(II)-GGG-Cys2His2
complexation at pH 7.4. This highly unfavorable energetic cost is attributed to the significantly unfavorable
steric interactions in these mutants’ holo-structures that are not present in the unstructured apo-state.
These steric clashes represent an additional energetic penalty to protein folding between the apo- and
holo-states. AntF, the artificial “antennafinger” protein,[132] is structured in both the apo- and holo-states but
possesses different protein folds in the apo- and holo-states. The observed Kd value of 45 μM for Co(II)
binding to the at pH 7.5, that is +4.99 kcal/mol weaker than the Kd value of 9.9 nM for the
Co(II)-GGG-Cys2His2 complexation can be attributed to a siginifcant structural changes. Unlike most ZFPs,
apo-Ant-F has a well-defined and stable α-helical secondary structure in the apo-state. The conformational
change into a less helical, ββα holo-Ant-F requires the disruption of the apo-structure and refolding.
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This additional step adds to the energetic cost for folding the protein upon the metal-ion binding.
Figure 2.14 illustrates the assumption that structural changes are responsible for the difference in the
energetic cost for protein folding in Ant-F. The solid blue line represents the -log Kd vs. pH fit for
Co(II)-GGG-Cys2His2 complexation, with a Kd value at pH 7.5 marked as a full circle. As discussed earlier
and shown in Figure 2.6B, conformational changes will either lift up (i.e. negative energetic cost, tighter
affinity for the metal-ion) or lower down (i.e. positive energetic cost, weaker affinity for the metal-ion) the fit
of the -log Kd vs. pH plot. In the case of Co(II)-Ant-F, the +4.99 kcal/mol difference will lower the Kd value
as shown by the black arrow, resulting in the dotted purple line which represents the pH dependence of the
conditional binding constants for Co(II)-Ant-F complexation (Figure 2.14).

Figure 2.14: pH dependence of conditional dissociation constants, Kd values, for Co(II)-GGG-Cys2His2 as
compared to Co(II)-Ant-F. The +4.99 kcal/mol free energy difference between the two complexations at pH
7.5 is shown by the black arrow.

The plateau of the acid region gives the pH-independent formation constant for fully protonated
Co(II)-Ant-F complex, KfMLH4 value of -0.22. As negative Kd values are physically impossible, this minor
difference (i.e. 0.3 kcal/mol) can be ascribed to experiment error. One may argue that this difference is a
result of changes in the Ant-F intrinsic pKa and pKaeff values, in addition to the structural changes. Indeed,
the presence of negatively charged neighboring groups next to the metal-binding ligands, i.e. Cys and His,
in the α-helical structure of the apo-Ant-F increases the intrinsic pKa values of these ligands. Furthermore,
this helical structure lacks the possible interactions between Cys-SH group with carbonyl oxygen of the
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peptide bond, which can be found in a β-turn, thus increasing the intrinsic pKa values of the Cys ligands as
compared to a ββα apo-structure.[41] Simultaneous changes to both the pKa and pKaeff values as well as the
KfML and KfMLH4 values will result in a change in the energetic difference between the KfML and KfMLH4 values
and is not shown here.
In few cases, Co(II)-binding affinities that are tighter than GGG are observed - the Cys4 site of
BRCA1 RING-1[125] shows a -2.07 kcal/mol cost for protein folding, the Cys3His1 site of RMLV NC[130] has a
-1.62 kcal/mol energetic cost for folding, and the Cys2His2 binding motif in Berg’s designed zing finger
Consensus Peptide 1 (CP-1)[88] has a folding cost of -1.36 kcal/mol. If our data and analysis is correct, the
accuracy of these published binding affinities for these peptides may be called into question. This may be
due to poor experimental design in some cases and over-interpretation of data in others. For example, the
BRCA1 RING (breast cancer suppressor protein 1 really interesting new gene) [125] is a zinc finger domain
with two distinct metal-ion binding sites - Cys4 and Cys3His1 (Figure 2.15A). The binding of the metal-ions
is reported to occur sequentially and not cooperatively, leading to a complicated analysis of the binding
constants for each site separately and resulted in a tighter observed Kd value for the Cys4 site. In their
study, Roehm and Berg[125] used a mutant peptide, BRCA1-∆site1, in which two Cys residues from site I
were substituted by alanine (Ala) residues (Figure 2.15B), thus disrupting the Co(II)-binding capacity of
site I. A direct titration of this mutant with Co(II) yield an observed increase in the vis-absorption spectrum
which correlated to Cys3His1 coordination motif. Therefore, the group assumed that the resulting Kd value
for the BRCA1-∆site1 peptide must reflect the Co(II) affinity of site II when site I is unbound. Deducing the
Kd value for BRCA1-∆site1 from the observed Kd value for BRCA1 RING peptide, allowed the group to
determine the conditional metal-ligand dissociation constant, Kd value, of Co(II)-BRCA1 RING-1
complexation. As the structure of Co(II)-BRCA1-∆site1 complex was not reported, one is left to wonder
whether the assumed Co(II)-binding in site II indeed represents the original Cys 3His1 site II coordination.
Figure 2.15B shows a proposed alternative “site II” which is created by the two Cys residues from site I and
the Cys and His residues from the native site II. As the alternative “site II” possesses a Cys 3His1
coordination, the vis-absorption spectrum is expected to show characteristic Co(II) d→d bands at the same
wavelengths as reported by the group for their assumption[125]. This is a feasible reason for the tighter
observed Kd value for the Cys4 site (site I).
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Figure 2.15: Structure of the RING finger domain in the breast and ovarian cancer tumor suppressor
BRCA1. (A) 3D NMR structure of BRCA1 RING domain (PDB: 1JM7) [141] and a schematic representation
of the RING’s (a.k.a. C3HC4) two tetrahedral metal-ion binding sites – site I with Cys4 coordination motif
(orange) and site II with Cys3His1 coordination motif (blue). (B) Schematic representation of BRCA1-∆site1
peptide[125], in which two Ala residues substitute two Cys residues in site I. The assumed metal-binding
composition in site II and the proposed possible alternative site II are shown as well.

In Table 2.1, one particular case stands out – the three binding motifs in CP1[98] with significantly
tighter Co(II)-binding affinities compared to Co(II)-GGG complexes, resulting in ΔGapoZFP-folding values that
are large and negative, i.e. > -4.4 kcal/mol. These binding affinities were published by Sénèque and
Latour[98], in their work reevaluating the Zn(II) and Co(II)-binding affinities and kinetics for CP-1 peptides.
As discussed in Section 1.5, Sénèque and Latour reported notably different findings than those previously
observed for CP-1 by Krizek et al.[96] and Buchsbaum and Berg[99]. This discrepancy was addressed by the
Gibney lab in two studies of Zn(II)-binding to a natural zinc proteins, the human Wilm’s tumor suppressor
protein (WT1-4)[100], and the transcription factor IIB (TFIIB) [102]. The reported Kd values for Zn(II)-WT1-4,
a ZFP with a metal-induced protein folding event, are comparable to the Kd values reported by Krizek et al.
(at the same pH values). In addition, a study of Zn(II)-TFIIB, which is folded in the apo- and holo-states and
has no cost of protein folding, demonstrated Kd values similar to those reported by Krizek et al. Lastly,
the Kd values GGG, which possess no protein fold, exhibits comparable Kd values to those reported by
Krizek et al. These studies support the Kd values reported by the Berg group and are inconsistent with the
findings of Sénèque and Latour.
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Similarly, the reported Co(II)-GGG data (Table 2.1) agrees with other thermodynamic studies on
natural ZFPs over the data presented by Sénèque and Latour. The accuracy of Sénèque and Latour’s
published binding affinities are questioned due to a poor interpretation of pKa data and the use of
incomplete equilibria descriptions for metal-protein complexation. Sénèque and Latour presented a
protonation and metal-ion complexation equilibria model (Scheme 2.2) based on five different protonation
states for both the apo- and holo-CP1 peptides. This is in agreement with the general minimal equilibria
model developed by Gibney and coworkers [91,92] for the speciation of the Zn(II)-GGG complexation
(Section 1.5, Scheme 1.1), and used for the analysis of the pH dependence and speciation of Co(II)-GGG
complexes in this thesis.

Scheme 2.2: Protonation and metal-ion complexation equilibria. Based on Scheme 2 as published by
Sénèque and Latour[98]. The minimal set of species used for the fit of measured apparent binding constants,
Kapp values, as a function of pH are highlighted with a dashed box. Where Ka1-4 and K’a1-4 are the proton
dissociation constants of the apo- and holo-peptide, respectively; and β110 is the metal binding equilibrium
constant between the fully deprotonated metal complex, ML, and the fully deprotonated apo-peptide, L.

However, in contrast to our work, Sénèque and Latour used only one effective acid dissociation constant,
pK’a4 value, to characterize the pH dependence of the conditional apparent metal-ligand constants, Kapp
values, for Zn(II)-CP1 complexations - as highlighted with a dashed box in Scheme 2.2. For clarity, their
Kapp values are equivalent to 1/Kd values in the Gibney model. Sénèque and Latour claimed that eliminating
the pK’a1, pK’a2, and pK’a3 values avoided “overparameterization” of the equilibria model and was justified
because the resulting fit of the conditional binding constants as a function of pH was “satisfactory”.
Therefore, they claimed that the full speciation equilibria of the holo-CP1 is not necessary. Figure 2.16A
presents the pH dependence of Kapp for Zn(II)-CP1 variants as reported by Sénèque and Latour. Simple
extension of the axes (Figure 2.16B) reveals that all three fits possess negative Kapp values at pH below
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3.0 for Zn(II)-CP1(CCCC) and at pH below 2.0 for the Zn(II)-CP1(CCHC) and Zn(II)-CP1(CCHH)
complexes. Negative Kapp (or 1/ Kd) values are physically impossible as by definition they are equal to the
ratio between the concentration of the metal-peptide complex, ML, to the concentrations of the free metalion, M, and the free peptide, L, as shown in eqn. 2.39. Concentrations describe the amounts of the species
(in moles) per volume of the solution. Thus, their minimal value is zero molar. This observation emphasizes
the importance of full speciation equilibria descriptions for the study of metal-protein complexation as
presented by Gibney and coworkers.

𝐾𝑎𝑝𝑝 =

[ML]total
[M]×[L]total

(Eqn. 2.39)

Figure 2.16: Apparent binding constants, Kapp values, as a function of pH for Zn(II)-CP1(CCCC) (squares
∎, blue line), Zn(II)-CP1(CCHC) (diamonds ◆, red line), and Zn(II)-CP1(CCHH) (circles ●, black line).
(A) Plot is based on data reported in Figure 5 by Sénèque and Latour[98]. (B) Extension of the axes to show
the Kapp values as a function of pH at pH values below 3.0.

Furthermore, the reported pH titration curves of the Zn(II)-CP1 complexes (Figure 2.17) raise questions to
the validity of the obtained pK’a4 values. The red Xs in Figure 2.17 represent the reported pK’a4 values of
5.6, 5.3, and 4.5 for Zn(II)-CP1(CCCC), Zn(II)-CP1(CCHC), and Zn(II)-CP1(CCHH), respectively. To obtain
these values, circular dichroism (CD) spectroscopy was used to monitor the change as a function of pH.
The CD bands are assigned to S→Zn(II) LMCT bands and the change as a function of pH was analyzed

57

via the SPECFIT/32 program[142]. It is evident from Figure 2.17B/C that the reported pK’a4 values represent
minor contributors to the CD signal with the major components, representing the pK’a1-3 values, being
ignored.

Figure 2.17: Potentiometric pH titration of Zn(II)-CP1 complexes, based on the data reported in Figure 6
by Sénèque and Latour[98]. (A) Zn(II)-CP1(CCCC). (B) Zn(II)-CP1(CCHC). (C) Zn(II)-CP1(CCHH). The red
‘X’ represents the obtained pK’a4 values by the group: 5.6, 5.3, and 4.5 for Zn(II)-CP1(CCCC),
Zn(II)-CP1(CCHC), and Zn(II)-CP1(CCHH), respectively.

For the purpose of determining the actual pK’a values, the three pH titration curves of the Zn(II)-CP1
complexes were reanalyzed using the Gibney equilibrium model with KaleidaGraph [143], as was used for
the analysis of the GGG data in this thesis. Detailed analysis is given in the Appendix. The resulted refits
of the data indicated the following: a) the Zn(II)-CP1(CCCC) complex undergoes a cooperative
three-protonation transition involving three Cys residues (pK’a1,2,3) value of 4.8 and a separate one-proton
transition of the forth Cys residue (pK’a4) value of 5.8 (reported as 5.6), b) the Zn(II)-CP1(CCHC) complex
undergoes a cooperative three-proton transition involving two Cys residues (pK’a2,3) value of 3.9 and a
separate one-proton event of the third Cys residue (pK’a4) value of 5.3 (as reported), and c) the
Zn(II)-CP1(CCHH) complex undergoes a cooperative two-proton transition involving two Cys residues
(pK’a3,4) value of 3.9 (reported at a single proton event at pH 4.5). The pH dependence and speciation of
Zn(II)-CP1 complexes can be modeled by minimal equilibria sets as shown is Scheme 2.3. The pKa values
and Kapp values, as reported by Sénèque and Latour, for each CP1 variant were refitted to these complete
minimal equilibria models and are shown in Figure 2.18. At low pH values, below both the intrinsic pKa
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values of the Cys and His ligands and the effective pK’a values of the Zn(II)-CP1 complexes, the three
revised fits level out and no longer possess negative Kapp values. This observation stresses the importance
of using complete equilibria descriptions to study the binding of metal-protein complexes.
The validity of the proposed complete minimal equilibria models for Zn(II)-CP1 complexation as described
in Scheme 2.31 was confirmed by identical thermodynamic differences between the conditional binding
constants, pKa and pK’a values, and between the formation constants of fully protonated bound complex,
MLH4, to fully deprotonated bound complex, ML, as given in the Appendix (eqns. A.100-A.105).

Scheme 2.3: Minimal equilibria used to remodel the pH dependence of Zn(II)-CP1 complexation for the
three binding motifs. (A) Zn(II)-CP1(CCCC). (B) Zn(II)-CP1(CCHC). (C) Zn(II)-CP1(CCHH).
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Figure 2.18: Revised pH dependence of conditional apparent binding constants, Kapp values, for Zn(II)-CP1
complexes. Based on pKa and Kd values reported by Sénèque and Latour[98] and the revised effective pK’a
values determined in this thesis. (A) Zn(II)-CP1(CCCC), (B) Zn(II)-CP1(CCHC), (C) Zn(II)-CP1(CCHH).

A question still remains regarding the significantly tighter metal-ion binding affinities observed by
Sénèque and Latour[98] compared to the GGG-complexes at pH 7.0. In their study, competitive titrations
were employed to determine the conditional apparent metal-ligand constants, Kapp values, of Zn(II)- and
Co(II)-CP1 complexes at pH 7.0. These titrations were carried out into buffered peptide solutions under an
argon atmosphere, with tris(2-carboxyethyl)phosphine (TCEP) added to reduce any disulfide bonds
formation. For the Co(II)-CP1(CCCC) study, the group used competition titration with Zn(II), where a peptide
solution in a buffer (100 mM BisTris in 100 mM KCl, pH 7.0) with a presence of ~25 eq Co(II) was titrated
with Zn(II) solution. The decrease in Co(II) characteristic d→d bands as the Zn(II)-ion displaces Co(II) from
its complexation with CP1(CCCC) peptide were monitored to determine the competition constant,
Kcomp value. On the other hand, for Co(II)-CP1(CCHC) and Co(II)-CP1(CCHH) studies, competition titrations
with 1.0 eq HEDTA chelator were performed monitoring the increase in the ligand field d→d electronic
transitions bands as the Co(II)-CP1 complexes were formed with each titration of microliter aliquots of
Co(II). Figure 2.19 shows the three competition titration fits as adopted from the data reported in Figures
S1 and S5 by Sénèque and Latour[98]. All three binding curves exhibit linearity up to 1.0 eq metal-ion
saturation, demonstrating a very tight binding affinity of the peptides for the metal-ion titrated. Therefore,
they are not reliable to accurately determine the Kcomp values that later are used to obtain the Kapp values
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for Co(II)-CP1 complexes. Furthermore, the Kapp value for Zn(II)-CP1(CCCC) that Sénèque and Latour used
in order to convert the measured KcompCo(II)/Zn(II) value into the corresponding Kapp value for
Co(II)-CP1(CCCC), was determined from a competition titration with a chelator as well, and the data once
again exhibited tight binding affinity of the CP1 peptide for the Zn(II)-ion. In addition, the Kapp value for
Zn(II)-CP1(CCCC) and the KcompCo(II)/Zn(II) value are questionable due to substantial interactions of Zn(II) with
TCEP with KfML value of 813[144]. These missteps, as well as the reliance on an equilibrium model with
assumptions fit via the SPECFIT/32 program are possible reasoning for the significantly tighter metal-ion
binding affinities reported by this group.

Figure 2.19: Determination of Co(II)-CP1 complexation conditional apparent metal-ligand constants,
Kapp values, at pH 7.0 (100 mM BisTris 100 mM KCl) by competition titration with (A) Zn(II)-ion or (B,C)
HEDTA. Data points were adopted from the reported Figures S1 and S5 by Sénèque and Latour[98].
(A) Co(II)-CP1(CCCC). (B) Co(II)-CP1(CCHC). (C) Co(II)-CP1(CCHH).

As the main objective of this thesis is to understand the role of a specific metal-ion cofactor on the
metal-protein thermodynamics, a comparison of the observed behavior for Co(II) to the previously reported
behavior for Zn(II) is important. While Co(II)-ion shows no preference for binding Cys ligand compared to
His ligand (with pH-independent formation constants, KfML values, of 3.4 × 1011 M-1, 2.2 × 1011 M-1, and
1.0 × 1011 M-1, for Co(II)-GGG-Cys4, Co(II)-GGG-Cys3His1, and Co(II)-GGG-Cys2His2, respectively), the
Zn(II)-ion does prefer to bind cysteine thiolate over histidine imidazole. The KfML values reported for
Zn(II)-GGG complexes are 5.6 × 1016 M-1, 1.5 × 1015 M-1, and 2.5 × 1013 M-1 for Zn(II)-GGG-Cys4,
Zn(II)-GGG-Cys3His1, and Zn(II)-GGG-Cys2His2, respectively, indicating a loss of approximately
2.0 kcal/mol for each Cys to His substitution.[92] The important insight reported here is that the difference in
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the preference of Co(II) and Zn(II) binding to the three ZFPs motifs is largely dependent on the Zn(II) binding
thermodynamics when protein folding effects are similar. This is because Co(II) binding is similar across
the three coordination motifs while Zn(II) binding affinity varies substantially.
The formation constants of the Co(II)-GGG complexes are weaker than the Zn(II)-GGG formation
constants by ~ 103 to ~ 105 fold. The preference of ZFPs to bind Zn(II) relative to Co(II) has been reported
in the literature before and was attributed to the difference in ligand-field stabilization energies
(LFSEs).[96,123,145] LFSE is a fundamental concept in crystal-field theory for transition metal ions with unfilled
d-shell orbitals, such as the d7 shell of Co(II), that upon binding to a protein undergo a transition from
octahedral structure to a tetrahedral structure. The two structures possess a different energetic split of the
d-orbitals, leading to energetic compensation for stabilizing the tetrahedral Co(II) complexes. On the other
hand, Zn(II) has a complete d10 shell and thus has no LFSE, making it more preferable for binding over
Co(II). In addition, the small difference in the effective ionic radii and polarizability of the two metal ions
could also contribute, but in a very small degree, to Zn(II) being more preferred over Co(II).[96]
The evaluation of the free energy cost for apo-ZFPs folding based on data in Table 2.1 indicates
that in most zinc fingers, less than +4.5 kcal/mol are required to fold the protein. This evaluation is
comparable with previously reported data in the Zn(II)-GGG complexes study where ΔGapoZFP-folding for most
ZFPs is less than +4.2 kcal/mol[92].
A comparison of the energetic cost for ZFPs folding upon Co(II) vs. Zn(II)-binding is shown in
Table 2.2. The data for both metal ions was evaluated by comparison of the literature metal(II)-ZFPs binding
affinities to the metal(II)-GGG constants. The Co(II)-GGG values were determined in this research and
presented earlier in Table 2.1, while the Zn(II)-GGG values were obtained from previously published Zn(II)
studies by Gibney et al. [92]. The ΔGapoZFP-folding values for most ZFPs compared are within an experimental
error of 1.0 kcal/mol between Co(II) and Zn(II), confirming that the proposed GGG model works for studying
the energetic cost for ZFPs folding regardless of the metal-ion cofactor.
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Table 2.2: The cost of protein folding upon Co(II) and Zn(II) binding in zinc finger proteins.

Protein ΔGapoZFP-folding (kcal/mol)
Protein
Co(II)

ΔΔGapoZFP-folding
(kcal/mol)

Zn(II)

Protein Fold

Ref

Cys4 Sites
XPAzf

- 0.53

+ 4.00

3.47

mixed αβ

92, 124

CP-1 (CCCC)

- 0.61

- 1.00

0.39

ββα

92, 96

Cys3His1 Sites
NZF-1

- 0.26

+ 1.20

1.46

CCHHC domain

92, 129

CP-1 (CCHC)

- 0.94

- 0.70

0.24

ββα

92, 96

RMLV NC

- 1.62

- 1.40

0.22

β turns

92, 130

Cys2His2 Sites
TFIIIA

+ 2.15

+ 3.10

0.95

ββα

92, 135

Ant-F

+ 4.99

+ 5.70

0.71

ββα

92, 132

CP-1 (CCHH)

- 1.36

- 1.10

0.26

ββα

88, 92

WT-1

- 0.52

- 0.70

0.18

ββα

92, 140

Sp1-3

+ 1.36

+ 1.50

0.14

ββα

92, 97

In Table 2.2 one example stands out: the Cys 4 binding motif in XPAzf peptide, with a large
difference between the cost for protein folding upon Co(II) vs. Zn(II) binding, ΔΔGapoZFP-folding value of
3.47 kcal/mol. The initial assumption for the large ΔΔGapoZFP-folding value was the less-common zinc finger
protein fold, a mixed αβ structure. A closer look at the experimental studies on the zinc finger domain in
Xeroderma pigmentosum group A complementing protein (XPAzf), a DNA repair protein, revealed that both
Co(II)- and Zn(II)-XPAzf complexes exhibit very similar CD spectra, leading to the conclusion they are
isostructural in the holo-state. This conclusion was further strengthened by nuclear magnetic resonance
(NMR) and extended x-ray absorption fine structure (EXAFS) structural studies that demonstrated identical
bond lengths and local geometries around the metal-ions in the holo-structures.[124] An alternative
assumption was to the level of accuracy of the published binding affinities for this peptide to each metal-ion.
Bal et al.[146] determined the observed conditional dissociation constant for Zn(II)-XPAzf complex, Kd value
of 153 pM at pH 7.4, by employing a competition titration with Ni(II). In addition, the group reported that
Ni(II)-XPAzf complexation leads to a much less structured protein folding with a square planar geometry
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around the metal-ion, as compared to a tetrahedral coordination and mixed αβ folding in the Zn(II)-XPAzf
complex. Thus, a question rises to the impact of changes in protein folding due to square planar
vs. tetrahedral ion incorporation. Kopera et al.[124], in their study of the Co(II)-XPAzf complexation, employed
both direct Co(II) titration and competitive titration with Zn(II). The Kd value for Zn(II)-XPAzf that was used
in order to convert the measured KcompCo(II)/Zn(II) value into the corresponding Kd value for Co(II)-XPAzf, was
determined from competition with Ni(II), as described earlier[146]. Interestingly, both experimental methods
showed similar (within experimental error of 2.5-fold) binding constants for Co(II)-XPAzf, Kd values of 16 nM
and 40 nM from direct and competitive titrations, respectively. Due to these observations, it is uncertain to
the reason for a 3.47 kcal/mol difference between the cost for protein folding upon Co(II) vs. Zn(II) binding
to XPAzf.

2.5 Conclusions
In this chapter, the thermodynamic contribution of Co(II)-binding to each of the three naturally
occurring ZFPs binding motifs in a designed unstructured simple peptide, GGG, was elucidated. The lack
of energetic penalty for protein folding in the GGG scaffold allowed for evaluation of the intrinsic affinity of
each site for Co(II). These data allowed for an anlysis of the energetic cost for natural ZFPs folding when
Co(II) binds proteins that undergo metal-induced protein folding events as well as those that do not. The
data demonstrated that Co(II)-ion has no preference for binding cysteine thiolate as compared to histidine
imidazole. The free energy cost for apo-ZFPs folding in most ZFPs appears to be minimal (less than
+4.5 kcal/mol) compared to the contribution of Co(II) binding (-10 kcal/mol). This evaluation is comparable
with the minimal energetic cost of folding, less than +4.2 kcal/mol, as was previously reported in the
Zn(II)-GGG complexes study[92]. Therefore, we confirm that the proposed GGG model is an effective asset
in the study of the energetic cost for ZFPs folding regardless of the metal-ion cofactor.
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CHAPTER THREE – ZFPs and Lead Toxicity

3.1 Introduction
Zinc finger proteins (ZFPs) have prominent roles in versatile cellular functions such as
differentiation and development, tumor suppression, and gene expression. Although ZFPs are diverse in
their binding motifs, structures, and functions, they all require a tertiary tetrahedral Zn(II)-protein
coordination geometry. Disruption of this geometry leads to the loss of protein activity and to many
diseases, including neurological disorders and cancer.[3,4,6-9] Oxidation of the Zn(II)-binding Cys and His
residues in the zinc finger is one example of this disruption, as the oxidized amino acid will no longer bind
the metal-ion. Replacement of the Zn(II)-ion by a xenobiotic metal is another example for possible
Zn(II)-ZFPs structure disruption.[147,148] Lead poisoning is a prime example.
Lead poisoning, a completely preventable sickness, is to this day considered to be a devastating
environmental disease and accounts for about 0.6% of the world’s burden of disease.[149,150] Young children
are the primary victims of lead poisoning, particularly in the lower social economic demographic as seen in
the 2014 water lead crisis at Flint, MI[151,152] and the 2016 crisis at Newark, NJ[153]. Lead targets the
circulatory, digestive, skeletal, and nervous systems, resulting in health problems such as anemia, kidney
damage, hyperirritability, poor memory, mental retardation, epileptic convulsions and even death.[154]
Furthermore, lead can damage child brain development, causing hyperactivity as well as difficulties in
learning, hearing, and reading, even at blood lead levels (BLLs) below the formerly recognized definition of
elevated BLL, i.e. 5 g/dL (Figure 3.1).[155-161] And unlike other toxins, elimination of lead doesn’t abolish its
effects on children – the damage is permanent. Therefore, it has been established by the US Environmental
Protection Agency that a safe BLL doesn’t exist.[162]
Evidence of the toxicity of lead and the awareness to its dangerous character can be traced back
to the ancient world.[163] The origin of human interaction with the naturally occurring lead ores, dating back
as early as 4000 BC, was through lead smelting for the recovery of silver. The low melting point, the
malleable nature, the competence to form alloys by rapidly binding with other metals, as well as the ability
to resist rust, corrosion, or dissolve in water, made lead an attractive metal for a widespread use: pottery
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glaze, paints, cosmetics, medicine, sling bullets, and water pipes (hence the name ‘plumbing’, a derivative
of the Latin name for lead – plumbum).[164,165] The Romans and Greeks even went to the extent of using
lead to sweeten their wine – a practice that was criticized for causing paralytic hands and being hurtful to
the nerves – yet persisted until the 18th century.[166] With the industrial revolution, lead poisoning became
an epidemic. In the 19th and early 20th centuries, workers in the smelting, painting, plumbing, and printing
industries, among others, suffered severe neurological damages, hallucinations, and death. [150,167,168]
By the 1920s, lead was found nearly in every item in an American home – from the residential lead-base
paints containing up to 70% lead pigment, to painted toys and furniture, to the canned foods and beverages
with lead-soldered seams, and to the lead solder and lead pipes delivering tap water to the home
(Figure 3.2). In 1923, a more pervasive and ominous source of environmental lead contamination appeared,
to which every American was exposed when breathing. The heavy metal, in the form of tetraethyl lead,
became a gasoline additive that gave cars more power and eliminated engine knock (a result of pockets of
air and fuel prematurely exploding in the combustion engine and therefore damaging the car).[169] By the
1950s, millions of children suffered symptoms related to chronic or acute exposure to lead. Today, a century
later, with restrictions and regulations to limit lead pollution, such as the phasing-out of leaded gasoline
(between 1976 – 1995) or the ban of lead-based house paints as well as lead paints used on consumer
products (1977), there is still an ongoing threat in lead exposure which costs the US alone approximately
$50.9 billion a year to contain.[170] The main global consumption of lead is for energy storage (i.e. lead-acid)
batteries for vehicles, which results in a secondary exposure to lead from recycling of these batteries
affecting many developing countries which have inherited US industrial practices sans the necessary
regulation to protect the foreign workforce.[154,162]
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Figure 3.1: Health effects of lead exposure on children and adults. Information source: ref [154,155].

Figure 3.2: National advertisements (1918-1923) for the benefits of using lead-based products.[168,171]
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3.2 Hypothesis for Lead’s Toxicity
The varieties of symptoms that are associated with lead toxicity (Figure 3.1) suggest that lead
affects different targets in vivo, yet no specific targets are known. Some studies identified that the target
proteins for Pb(II) contain Zn(II) or Ca(II) binding sites,[106,107] leading to the hypothesis that lead’s toxicity
is due to the binding of Pb(II)-ion to these sites.[108] Several groups supported this hypothesis in the
literature. For instance, Erskine et al.[172] reported an X-ray structure (Figure 3.3A) of Pb(II) bound to the
Cys3 active site in the zinc enzyme δ-aminolevulinic acid dehydratase (ALAD), which catalyzes the second
step in the heme biosynthetic pathway. When bound to Pb(II), the enzyme no longer synthesizes heme,
leading to cessation of hemoglobin production which leads to anemia - one of the symptoms of lead
poisoning.[173] Another example is the X-ray structure (Figure 3.3B) of Pb(II) bound to the calcium protein
calmodulin (CaM), as was reported by Wilson and Brunger[174]. Exposure to Pb(II) shown to affect the
function of CaM, a ubiquitous secondary messenger protein that interacts and regulates the activity of
hundreds of proteins, thus directly responsible to many cellular processes including growth and
movement.[175,176] However, these findings didn’t explain the variety of other developmental and behavioral
problems that are seen in children exposed to lead.

Figure 3.3: Pb(II)-ion in the active sites of the zinc enzyme δ-aminolevulinic acid dehydratase (ALAD) and
the calcium protein calmodulin (CaM). (A) Structures of Pb(II)-ALAD (PDB: 1QNV)[177]. (B) Structure of
Pb(II)-CaM (PDB: 1N0Y)[178].

Godwin and colleagues[179,180] attempted to address the question of the other developmental
damages that children suffer from when exposed to lead. The group suggested that substitution of Zn(II)
by Pb(II) in zinc finger transcription factors (ZFP-TFs) with cysteine rich Zn(II)-binding sites, i.e. Cys3His1
or Cys4, is the cause for these health effects. To evaluate this hypothesis, the group studied Zn(II) and
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Pb(II) binding affinities to a synthetic Consensus Peptide 1 (CP-1) with three binding motifs incorporated
(Cys4 Cys3His1, and Cys2His2). They have determined that CP-1(CCCC) binds Pb(II) 30-fold tighter than
Zn(II) and substitution of Cys residue for His residue changes the peptide’s preference from Pb(II) to Zn(II),
thus Pb(II) is not an effective competitor to Zn(II) for the Cys2His2 binding sites.[180] Further studies focused
on the natural GATA transcription factors with Cys4 Zn(II)-binding sites. This family of ZFP-TFs performs
an important role in the development of blood cells, nervous system, and genitourinary systems – all
consisting of tissues that may be affected by lead poisoning.[181] The group reported an order of magnitude
difference for the affinity of GATA for Pb(II) compared to Zn(II), with Zn(II) being preferable by the protein.
The group added that while the Zn(II)-GATA complex has a tetrahedral four-coordination binding geometry,
the lone electron pair on the Pb(II)-ion pushes for a hemidirected three-coordination geometry for Pb(II)GATA complexation (Figure 3.4), thus changing the fold of the protein and its function of binding DNA.
Consequently, it was proposed that lead’s toxicity is a result of the metal’s preference to form a
three-coordination structure in sulfur-rich binding sites. An intriguing suggestion by Jarzęcki’s density
functional theory (DFT) studies[182] noted that the strong preference of the protein for Pb(II) is due to the
CβH•••S interactions which stabilize the Pb(II)-Cys3 sites in proteins. This was also seen by others in the
literature.[183-185]

Figure 3.4: Coordination geometries of Zn(II)-Cys4 and Pb(II)-Cys4.

Godwin’s proposed hypothesis that lead’s toxicity is ascribed to the ability of the Pb(II)-ion to mimic
Zn(II) and replace it in sulfur-rich binding sites is based on highly pH dependent conditional binding affinity
constants of these two metal-ions to ZFPs. While the acid dissociation constants for the apo-peptide,
pKa values, are identical for both complexations, the effective acid dissociation constants of the
holo-peptide, pKaeff values, are different. Therefore, an accurate comparison requires pH-independent
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formation constants, Kf values, for Zn(II)- and Pb(II)-ZFPs complexations. Furthermore, the published
studies have yet to explore the important metal-induced protein folding events, as discussed previously in
Section 1.5 of this thesis.
In this chapter, a minimal peptide model of a zinc finger protein, GGG, is utilized to determine the
intrinsic affinities of Pb(II) to each of the three ZFPs binding motifs - Cys4, Cys3His1, and Cys2His2. This
glycine rich 16-amino acid GGG peptide has been chosen as it is unstructured in the apo- and holo-states
and therefore has minimal protein folding effects. Thus may provide the maximal Pb(II) affinities for these
three coordination motifs as evaluated using the metal-ligand pH-independent formation constant, KfML.[91,92]
Or in other words, the free energy of Pb(II)-binding is not used to drive GGG folding,
i.e. ΔGapoGGG-folding = 0.0 kcal/mol. UV-vis absorption and fluorescence emission spectroscopies as well as
potentiometry measurements are employed to characterize the pH dependence of the thermodynamics of
Pb(II)-binding to the GGG peptide variants. The protonation mechanism upon metal binding is determined
from the fluorescence data, while the metal-ligand coordination structures at each protonation step are
provided by the UV-vis data. The metal’s preference to bind cysteine thiolate or histidine imidazole
is determined independently of pH by a comparison of Pb(II)-GGG pH-independent formation constants,
KfML values, to each coordination motif in the GGG variants. Furthermore, a comparison of the Pb(II)
affinities of each coordination motif between the GGG peptide and natural ZFPs reveals the folding events
and the cost for ZFPs folding, ΔGapoZFP-folding in the latter.

3.3 Experimental Procedures
Materials. Lead nitrate, zinc nitrate, nitric acid (HNO3), ethylenediaminetetraacetic acid (EDTA),
2-(N-morpholino)ethanesulfonic acid (MES), 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES),
2-Bis(2-hydroxyethyl)amino-2-(hydroxymethyl)-1,3-propanediol

(BisTris), and

3-(Cyclohexylamino)-1-

propanesulfonic acid (CAPS), all were obtained from the Sigma-Aldrich Chemical Company.

Protein Synthesis and Purification. The stock solutions of the three GGG peptides used for the
Pb(II) studies are the same peptide stock solutions prepared and used for the Co(II) studies, as described
earlier in Chapter Two of this thesis. Using the same peptide stock solutions allowed for a more accurate
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comparison of the Pb(II) and Co(II) binding thermodynamics to the GGG variants by eliminating
experimental errors related to peptide synthesis or purity.

Ultraviolet-Visible Spectroscopy. Varian Cary 100 / 300 spectrophotometers were used to record
Ultraviolet-visible (UV-vis) spectra (at 200-450 nm wavelengths) of samples in a 1.0 cm pathlength screw
cap rectangular quartz cell under strict anaerobic conditions. These recorded absorbance spectra for
Pb(II)-GGG complexes were corrected by subtracting the spectrum of the free unbound apo-GGG peptide
or the spectrum of the Zn(II)-GGG complexes, for direct Pb(II) titrations or competitive titrations with Zn(II),
respectively.

Fluorescence Spectroscopy. Cary Eclipse fluorimeter was used to record the emission spectra
for peptide samples resulting from excitation at wavelength of 280 nm (of the C-terminal tryptophan),
with excitation and emission slit widths of 5 nm. These samples were prepared under strict anaerobic
conditions and maintained in a 1.0 cm path length screw cap quartz cells.

Kinetics of Metal-Ion Binding / Exchange. The equilibration times for the metal-ion binding to
apo-GGG and metal-ion substitution in the holo-GGG competition titration reactions, as well as the
exchange of the metal-ion between peptide and competitor EDTA, were determined via the change in
UV-vis and fluorescence spectra over time. The peptide samples were prepared in a 1.0 cm path length
screw cap quartz cells under strict anaerobic conditions. 1.0 eq of aqueous Pb(NO3)2 was added and the
measurements of absorption and fluorescence spectra were taken every minute. After 2 minutes the
spectra were identical, leading to the conclusion that the equilibration times less than 2 minutes. To ensure
that indeed the reaction are given enough time to reach equilibrium, all titration measurements in this work
were given 5 minutes to reach equilibrium after addition of the metal-ion solution and prior to recording of
their spectra.
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Pb(II) Binding Titrations. Direct isothermal titrations allowed to determine the coordination of the
Pb(II)-GGG variants, whereas competitive isothermal titrations allowed to determine the conditional
metal-ligand dissociation constant, Kd values, of Pb(II)-GGG complexes. All additions of Pb(NO3)2 were
done in an anaerobic glovebox to ensure no oxygen leakage into the sample.

Direct Pb(II) Titration: Titrations were carried out into 1.0 mL samples of peptide solutions in buffer
(100 mM HEPES) pH 7.5. Microliter aliquots of aqueous 10.0 mM Pb(NO3)2 in 0.1 M HNO3 were added and
samples were allowed to equilibrate for 5 minutes before the measurements of their individual absorption
and fluorescence (λex = 280 nm) spectra. The increase in the S→Pb(II) ligand to metal-ion charge-transfer
(LMCT) transition absorbance and the decrease in Trp fluorescence emission at λ maxem of 355 nm were
monitored to establish the characteristics of each Pb(II)-GGG coordination.

Pb(II)/Zn(II) Competition Titration: As the Pb(II)-GGG bound structures are unknown, it was
important to start the titration experiments with known structures – tetrahedral Zn(II)-GGG complexes,
and slowly titrate Pb(II) for competition and displacement of the Zn(II)-ion in the metal-GGG complexes.
This experimental design allowed for an accurate determination of Kd values for Pb(II)-GGG complexation.
These titrations were carried out using 1.0 mL samples of peptide solutions in a buffer (100 mM MES /
BisTris / HEPES / CAPS, pH range 5.5 - 10.0) with a presence of 2.0 - 3.0 equivalence of the competitor
10.0 mM Zn(NO3)2 in 0.1 M HNO3. Microliter aliquots of Pb(NO3)2 were titrated into the samples under
strictly anaerobic conditions. UV-vis and fluorescence spectra were recorded after 5 minutes from each
titration. Eqns. 3.1-3.5 are the competition equilibrium-binding model which was used to fit plots of the
spectral data against [Pb(II)]/[peptide] to determine the competition constant, Kcomp values. Full derivation
of this model is shown in the Appendix.

[Zn(II)-GGG] + Pb(II) ⇌ [Pb(II)-GGG] + Zn(II)

𝐾comp =

[Pb(II)−𝐆𝐆𝐆][Zn(II)]
[Zn(II)−𝐆𝐆𝐆][Pb(II)]
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=

(Eqn. 3.1)

Zn(II)−𝐆𝐆𝐆

𝐾d

Pb(II)−𝐆𝐆𝐆
𝐾d

(Eqn. 3.2)

−b±√(b)2 +4(1−𝐾comp )([M2 T ][LT ]𝐾comp )

Abs = Abs0 + εBound × (

2(1−𝐾comp )

−b±√(b)2 +4(1−𝐾comp )([M2 T ][LT ]𝐾comp )

F = F0 + (Flim − F0 ) × (

2(1−𝐾comp )[LT ]

b = ([M2 T ] + [LT ])𝐾comp + [M1 T ] − [M2 T ]

)

(Eqn. 3.3)

)

(Eqn. 3.4)

(Eqn. 3.5)

Where Abs and F are the measured absorbance and fluorescence emission, respectively; Abs 0 and F0 are
the absorbance and fluorescence measured for the GGG prior to the addition of the metal-ion, respectively;
𝜀𝐵𝑜𝑢𝑛𝑑 is the molar-extinction coefficient of the holo-GGG while Flim is the limiting fluorescence of this
Pb(II)-GGG complex; M1T and M2T are the total concentration of the Zn(II) and Pb(II) added, respectively;
LT is the total concentration of the GGG peptide in the solution; Kcomp is the conditional competition binding
constant.
Division of the conditional metal-ligand dissociation constants for Zn(II) to the GGG variants,
KdZn(II)-GGG values, by each of the measured Kcomp value, gives the conditional metal-ligand dissociation
constants for Pb(II) to the GGG peptides, KdPb(II)-GGG (rearrangement of eqn. 3.2).

EDTA Competition Titration: To confirm the validity of the conditional metal-ligand dissociation
constants for Pb(II)-GGG complexes, as were determined by Pb(II)/Zn(II) competition titration, competition
titrations with EDTA were performed. These titrations were carried out using 1.0 mL samples of peptide
solutions in a buffer (100 mM HEPES pH 8.2) with a presence of competitor EDTA, and microliter aliquots
of Pb(NO3)2 were titrated under strictly anaerobic conditions. UV-vis and fluorescence spectra were
recorded after 5 minutes from each titration. Eqns. 3.6-3.11 are the competition equilibrium-binding model
which was used to fit plots of the spectral data against [Pb(II)]/[peptide] to determine the Kcomp values.
Full derivation of these eqns. is shown in the Appendix.
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EDTA + Pb(II) ⇌ [Pb(II) − EDTA]

(Eqn. 3.6)

𝐆𝐆𝐆 + Pb(II) ⇌ [Pb(II) − 𝐆𝐆𝐆]

(Eqn. 3.7)

𝐾comp =

Pb(II)−𝐆𝐆𝐆

[Pb(II)−EDTA][𝐆𝐆𝐆]

=
[EDTA][Pb(II)−𝐆𝐆𝐆]

𝐾d

(Eqn. 3.8)

Pb(II)−EDTA

𝐾d

−b±√(b)2 +4(1−𝐾comp )([MT ][LT ]𝐾comp )

Abs = Abs0 + εBound × (

2(1−𝐾comp )

−b±√(𝑏)2 +4(1−𝐾comp )([MT ][LT ]𝐾comp )

F = F0 + (Flim − F0 ) × (

2(1−𝐾comp )[LT ]

b = (−[MT ] − [LT ])𝐾comp − [MT ] − [BT ]

)

)

(Eqn. 3.9)

(Eqn. 3.10)

(Eqn. 3.11)

Where Abs and F are the measured absorbance and fluorescence emission, respectively; Abs 0 and F0 are
the absorbance and fluorescence measured for the GGG prior to the addition of the metal-ion, respectively;
𝜀𝐵𝑜𝑢𝑛𝑑 is the molar-extinction coefficient of the holo-GGG while Flim is the limiting fluorescence of this
Pb(II)-GGG complex; MT is the total concentration of the Pb(II) added; LT is the total concentration of the
GGG peptide in the solution; BT is the total concentration of the competitor EDTA present in the solution;
Kcomp is the conditional competition binding constant.
Each measured Kcomp value, when coupled with metal-competitor conditional equilibrium dissociation
constant, KdPb(II)-EDTA value, gives the conditional metal-ligand dissociation constants for Pb(II) to the GGG
peptides, KdPb(II)-GGG (rearrangement of eqn. 3.8). The KdPb(II)-EDTA value can be determined over a broad
pH range using the Pb(II)-EDTA formation constant (i.e. KfPb(II)-EDTA = 7.59 ×1017 M-1)[120] and the mole
fraction (αY6− ) of fully deprotonated EDTA complexes at the experimental pH values, as shown in
eqns. 3.12 and 3.13 and derived in the Appendix.

𝐾dPb(II)−EDTA =

1
𝐾f Pb(II)−EDTA ×αY6−
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(Eqn. 3.12)

αY6− =

K1 K2 K3 K4 K5 K6
[H+ ]6 +[H+ ]5 K1 +[H+ ]4 K1 K2 +[H+ ]3 ]K1 K2 K3 +[H+ ]2 K1 K2 K3 K4 +[H+ ]K1 K2 K3 K4 K5 +K1 K2 K3 K4 K5 K6

(Eqn. 3.13)

Where K(1-6) are the EDTA stepwise acid dissociation constants value of K1=1.00, K2=3.16×10-2,
K3=1.00×10-2, K4=2.04×10-3, K5=3.39×10-7, K6=4.27×10-11.[120]

Potentiometric pH Titration. Potentiometric pH titrations of the holo-GGG complexes allowed for
the determination of the metal-ligand effective acid dissociation constants, pKaeff values. Each Pb(II)-GGG
complex in unbuffered water at pH ~10.0 was placed in a 1.0 cm path length cuvette with a magnetic stir
bar and fitted with a pH electrode (as previously shown in Chapter Two, Figure 2.4). Throughout the titration,
strictly anaerobic conditions were maintained using a constant flow of hydrated nitrogen gas. Addition of
microliter aliquots of 0.1 M HNO3 was followed by measurement of the UV-vis absorbance and fluorescence
emission spectra. After each addition of acid, the solution was stirred and allowed to equilibrate for
5 minutes prior to recording the change in the pH of the solution and measurement of the solution’s spectra.
The pH dependence of the UV-vis and fluorescence spectra for each Pb(II)-GGG complex were fit to the
simplest chemically reasonable protonation model, as shown in eqns. 3.14-3.17 (and derived similarly to
the Co(II)-GGG models as shown in the Appendix), which yielded the pKaeff values of the ligands bound to
the metal-ion. The non-linear least square fitting of the data, using eqns. 3.14 and 3.15, indicated that
Pb(II)-GGG-Cys4 complex undergoes a cooperative three-protonation transition involving three Cys
residues (pKa1,2,3eff) and a separate one-proton transition of the forth Cys residue (pKa4eff).
Eqns. 3.16 and 3.17 for Pb(II)-GGG-Cys3His1 complex showed a cooperative two-proton transition involving
two Cys residues (pKa2,3eff) and a separate one-proton transition of the third Cys residue (pKa4eff).
And in the case of Pb(II)-GGG-Cys2His2 complex, the best fit for the measured data showed to utilize the
complexation model as described by eqns. 3.14 and 3.15, exhibiting a cooperative three-protonation
transition involving a Cys and two His residues (pKa1,2,3eff) and a separate one-proton transition of a forth
Cys residue (pKa4eff).
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For the Pb(II)-GGG-Cys4 and Pb(II)-GGG-Cys2His2 complexes:
(Eqn. 3.14)

Abs = Abs0 +

εMLH
(−3pH+3p𝐾𝑎1,2,3 𝑒𝑓𝑓 )
(pH−p𝐾𝑎4 𝑒𝑓𝑓 )
10
+10
+1

+

εMLH4
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 +3pH)
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +4pH)
10
+10
+1

(Eqn. 3.15)

F = F0 +

∆FMLH
10

(−3pH+3p𝐾𝑎1,2,3

𝑒𝑓𝑓 )

+10

(pH−p𝐾𝑎4

𝑒𝑓𝑓 )

∆FMLH4

+
+1

10

(−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 +3pH)

(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +4pH)
+1

+10

For the Pb(II)-GGG-Cys3His1 complex:
(Eqn. 3.16)

Abs = Abs0 +

εMLH
(−2pH+2p𝐾𝑎2,3 𝑒𝑓𝑓 )
(pH−p𝐾𝑎4 𝑒𝑓𝑓 )
10
+10
+1

+

εMLH3
(−2p𝐾𝑎2,3 𝑒𝑓𝑓 +2pH)
(−2p𝐾𝑎2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +3pH)
10
+10
+1

(Eqn. 3.17)

F = F0 +

∆FMLH
(−2pH+2p𝐾𝑎2,3 𝑒𝑓𝑓 )
(pH−p𝐾𝑎4 𝑒𝑓𝑓 )
10
+10
+1

∆FMLH3

+
10

(−2p𝐾𝑎2,3

𝑒𝑓𝑓 +2pH)

+10

(−2p𝐾𝑎2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +3pH)
+1

Where Abs and F are the measured absorbance and fluorescence intensities, respectively; Abs 0 and F0
are the initial absorbance of the Pb(II)-GGG complexes; εMLH , εMLH3 , and εMLH4 are the molar-extinction
coefficient of the MLH, MLH2, MLH3, and MLH4 species, respectively; ΔFMLH, ΔFMLH3, and ΔFMLH4 are the
change in fluorescence emission due to the formation of the various protonation species of the metal
complexes; and pKaeff terms are the effective acid dissociation constants of these metal-ligand complexes.

pH Dependence of Conditional Dissociation Constants. As described in Section 1.5 of this
thesis, the conditional dissociation constants, Kd values, of Pb(II)-GGG complexes are expected to be
pH dependent. Therefore, they were measured at various pH value solutions and determined as described
above. The resulting Kd values were plotted as -log Kd vs. pH and fitted to the general equilibrium model
shown in eqn. 3.18 and derived in the Appendix.

76

− 𝑙𝑜𝑔 𝐾𝑑 = 𝑙𝑜𝑔 [𝐾𝑓 𝑀𝐿 ×

𝛼𝐿
]
𝛼𝑀𝐿

(Eqn. 3.18)

Where Kd is the observed conditional dissociation constant at any given pH value; KfML is the
pH-independent formation constant for the Pb(II)-GGG complexes; αL and αML are the molar fractions of
the fully deprotonated apo- and holo-GGG in the solution, respectively.
The dissociation of the Pb(II)-GGG complexes is governed by the intrinsic pKa values of the binding ligands
in the apo-GGG peptides, and the pKaeff values of these ligands in the holo-GGG complexes, as shown in
Scheme 1.1 (Section 1.5) and given by eqns. 3.19-3.20.
For the Pb(II)-GGG-Cys4 and Pb(II)-GGG-Cys2His2 complexes:
(Eqn. 3.19)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−pH+p𝐾𝑎4 ) + 10(−4pH+3p𝐾𝑎1,2,3 +p𝐾𝑎4 )
)
(−pH+p𝐾
)
(−2pH+p𝐾
𝑎4 + 10
𝑎4 +p𝐾𝑎3 ) + 10(−3pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 ) + 10(−4pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 +p𝐾𝑎1 )
1 + 10

For the Pb(II)-GGG-Cys3His1 complex:
(Eqn. 3.20)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

𝑒𝑓𝑓

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−pH+p𝐾𝑎4 ) + 10(−3pH+p𝐾𝑎4 +2p𝐾𝑎2,3 ) + 10(−4pH+p𝐾𝑎4 +2p𝐾𝑎2,3 +p𝐾𝑎1 )
)
1 + 10(−pH+p𝐾𝑎4) + 10(−2pH+p𝐾𝑎4+p𝐾𝑎3) + 10(−3pH+p𝐾𝑎4+p𝐾𝑎3 +p𝐾𝑎2 ) + 10(−4pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2+p𝐾𝑎1)

The plateau of these fits at the basic region gives the pH-independent formation constants for fully
deprotonated Pb(II)-GGG complexes, KfML values, whereas the plateau of the acid region yields the
pH-independent formation constants for fully protonated Pb(II)-GGG complexes, KfMLH4 values.
The KfML values reveal the free energy contribution from metal-ion binding applied toward protein
stabilization, as shown in eqn. 3.21:
ΔGPb(II)-GGG-Obs = - RT ln(KfML)

(Eqn. 3.21)

Experimental Error. Based on multiple titration trials, the experimental error for individual Kd
values was estimated to be less than factor of 10, or 1.3 kcal/mol. The error of the KfML values determined
using the pH, pHeff and Kd values was estimated to be less than factor of 10, or 1.3 kcal/mol.
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3.4 Results
Experimental Design. Many proteins in Nature require the incorporation of a structural metal-ion
cofactor to thermodynamically drive their folding, and ZFPs are one of the most studied groups of such
proteins.[3,4,6-9] Complexation of the Zn(II)-ion with the unfolded apo-ZFPs leads to a spontaneous folding
into biologically active three-dimensional confirmation. On the other hand, incorporation of xenobiotic
metals into these proteins showed to disrupt their biological activity, resulting in serious health problems
and even death.[147,148] In fact, the hypothesis for lead’s toxicity is attributed to such behavior - the ability
of Pb(II) to substitute Zn(II) in complexation with cysteine-rich binding sites, altering the holo-folded
structure and obstructing the function of these proteins.[106-108,179-181] The literature data that drove this
hypothesis compared the highly pH dependent affinity constants of ZFPs for Zn(II) and Pb(II), without
incorporating the different metal-induced protein folding events that these proteins undergo upon the
binding of each metal-ion.
Figure 3.5 shows a free energy diagram of coupled metal-induced protein folding events upon
Zn(II) vs. Pb(II)-binding to ZFPs. The ΔGapofolding is the free energy that is required to fold the apo-unfolded
ZFPs into the apo-folded ZFPs (i.e. the same folded structure as observed in the holo-folded ZFPs just
minus the bound metal-ion). The ΔGML-Obs is the observed free energy upon metal-ligand binding that drives
the apo-unfolded structure to transit into the holo-folded structure. Its value can be simply determined from
the experimentally measured dissociation constants, Kd values, based on their relationship, similarly shown
in eqn. 3.21. However, the actual free energy contribution by metal-ligand binding, ΔGML value, is larger
than the ΔGML-Obs value by the cost of protein folding, ΔGapofolding value (i.e. ΔGML = ΔGML-Obs + ΔGapofolding).
Therefore, for accurate comparison of the preference a protein has to bind Zn(II) over Pb(II) or vice versa,
it is necessary to compare their actual ΔGML values, and not the observed ΔGML-Obs values.
In Figure 3.5, the energy level for the apo-unfolded state is equivalent for both Zn(II) and Pb(II)
complexations with ZFPs, as the comparison is done for the same protein. The holo-folded states, on the
other hand, are not equivalent. This was determined by the example of Pb(II)-GATA complexation, where
binding Pb(II) resulted in a dysfunctional hemidirected three-coordination geometry for Pb(II)-GATA
complex, compared to the tetrahedral four-coordination for Zn(II)-GATA.[181] The position of the energy level
for the holo-folded Pb(II)-ZFPs as compared to the energy level for the holo-folded Zn(II)-ZFPs can be
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determined by the measured Kd values for each metal complex. For example, in the case of the GATA
protein with a Cys4 binding site, the data reported indicates a slightly weaker affinity for the Pb(II)-ion
compared to the Zn(II)-ion, i.e. KdPb(II)-GATA-1 = 1.6 × 10-10 M and KdZn(II)-GATA-1= 5.0 × 10-11 M,[181] therefore the
energy level for holo-folded Pb(II)-GATA complex will be slightly higher than the energy level for the
holo-folded Zn(II)-GATA complex, as shown in Figure 3.5. On the other hand, in an example of
CP-1(CCCC), the energy level for holo-folded Pb(II)-CP-1 complex would be lower than the energy level
for the holo-folded Zn(II)-CP-1 complex due to the tighter affinity for the Pb(II)-ion (not shown),
i.e. KdPb(II)-CP-1(CCCC) = 3.8 × 10-14 M and KdZn(II)-CP-1(CCCC) = 1.1 × 10-12 M.[180] The coupled thermodynamics of
the metal-ion binding and the protein folding, with no direct method to measure and determine the value of
ΔGapofolding, leaves a question to the relative position of the energy levels for the apo-folded structures, and
hence a question to the value of the actual ΔGML for the Pb(II)-ZFPs complexation.

Figure 3.5: Free energy diagram for Zn(II)-ZFPs vs. Pb(II)-ZFPs complexation. The energy level for the
apo-unfolded ZFPs is equivalent as the comparison is done for the same protein. The energy levels for the
holo-folded structures are different due to the different coordination of the ZFPs with each metal-ion. The
relative position of the energy levels for the apo-folded structures is undetermined with no direct method to
measure it. Therefore the actual free energy contribution by metal-ligand binding, ΔGML value of Pb(II) to
ZFPs, and hence the preferred metal-ion, is unknown (as shown in dashed arrows).
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The experimental design for the Pb(II)-GGG complexation study is based on the desire to separate
the thermodynamics of metal-ion affinity and protein folding in ZFPs and to obtain the pH-independent
formation constant for Pb(II)-GGG complexation. Three GGG variants, with Cys4, Cys3His1, or Cys2His2
coordination motifs, were utilized to determine the intrinsic affinities of Pb(II) to each of the three ZFPs
coordination motifs from minimal equilibria models for Pb(II)-GGG complexations. Each proton competition
equilibrium was modeled based on measured pH dependent conditional dissociation constants,
the Kd values, for the Pb(II)-binding to the GGG variants, as well as the intrinsic and effective acid
dissociation constants, the pKa and pKaeff values for the apo- and holo-GGG, respectively.
These intrinsic affinities will be used to investigate the preference of Pb(II)-ion for binding cysteine
thiolate versus histidine imidazole. Previously, GGG has been used to show that Zn(II) prefers cysteinate
to histidine imidazole coordination. And in Chapter Two of this thesis, GGG was used to show that Co(II)
has no preference binding Cys over His ligands. A further comparison of the Pb(II) affinities of each
coordination motif between the GGG peptide and natural ZFPs is expeted to elucidate the cost of protein
folding in natural ZFPs, ΔGapoZFP-folding, is minimal (less than +4.5 kcal/mol) for all three coordination motifs
(Cys4, Cys3His1, and Cys2His2), based on the previously reported results for Zn(II) [92], and as reported in
Chapter Two for Co(II). This is because the methodology used to separate these thermodyanically coupled
values is expected not to rely on the identity of the metal-ion cofactor.

Pb(II) Binding Titrations. The Pb(II)-bound spectra of the three coordination motifs for GGG are
shown in Figure 3.6. Incorporation of Pb(II) into each of the three GGG variants showed distinctive UV-vis
spectra, which are sensitive to both the metal-ion coordination geometry and the coordination motif.
Figure 3.6A shows that addition of Pb(NO3)2 into buffered (100 mM HEPES pH 7.5) solutions of GGG-Cys4,
GGG-Cys3His1, and GGG-Cys2His2 result in characteristic S→Pb(II) LMCT transitions, which are observed
by increased intensity of absorption bands in the near-UV spectrum at 236 nm and 330 nm for both
Pb(II)-GGG-Cys4 and Pb(II)-GGG-Cys3His1, and at 236 nm and 305 nm for Pb(II)-GGG-Cys2His2.
The Pb(II)-buffer interactions absorb very weakly in the 250-450 nm region and as so do not contribute to
the holo-GGG spectrums in this range.
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The 355 nm Trp fluorescence emissions maximum (λmaxem) for both apo- and holo-GGG in all three
peptide variants (Figure 3.6B) indicates that Trp is exposed to the solvent [123] and doesn’t shift with
Pb(II) incorporation. This observation is consistent with Trp position at the C-terminal of the designed
GGG peptides and the lack of hydrophobic burial in their scaffold. Addition of Pb(NO3)2 into apo-peptide
solutions at pH 7.5, results in decreased Trp fluorescence emission intensity of the holo-GGG complexes,
which is expected as Pb(II)-ion is a strong fluorescence quencher.
Figure 3.6 affirms that both absorbance and fluorescence spectroscopy measurements can be
used to determine the conditional metal-ligand dissociation constants, Kd values, of Pb(II)-GGG complexes.
When combined together these spectroscopies give a more complete picture of the binding kinetics and
thermodynamics of the complexation process.

Figure 3.6: UV-Vis absorbance and fluorescence emission spectra for Pb(II)-GGG complexes (solid lines)
in 100mM HEPES pH 7.5. (A) Upon metal ion binding, an increase in the absorbance is observed for
Pb(II)-thiolate charge transfer bands at 292-306 nm region. Pb(II)-buffer interaction is shown as triangles
∆, green line. (B) A decrease in Trp fluorescence emission intensity at 355 nm results from the incorporation
of Pb(II) into the GGG variants. Apo-GGG is shown as dashed purple line.

Analysis of the Conditional Dissociation Constant pH Dependence via Competition Titration
with Zn(II)-ion. Figure 3.7 shows competition titration curves at pH 7.5 (100 mM HEPES), where 10.0 mM
Pb(NO3)2 solution was titrated into buffered peptide solutions containing 2.0 - 10.0 equivalents of Zn(II)-ion.
The Pb(II)-ion is competing to displace the Zn(II)-ion from the Zn(II)-GGG complexation. At pH 7.5,
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the Zn(II)-GGG variants possess dissociation constants, KdZn(II)-GGG values, of 1.1 × 10-13 M, 5.2 × 10-13 M,
and 3.1 × 10-11 M for Zn(II)-GGG-Cys4, Zn(II)-GGG-Cys3His1, and Zn(II)-GGG-Cys2His2, respectively.[92]
The competition equilibrium binding isotherms fit to competition constant value of 3.3 for Pb(II)-GGG-Cys4
(Figure 3.7A,B), Kcomp value of 5.5 for Pb(II)-GGG-Cys3His1 (Figure 3.7C,D), and Kcomp value of 2.2 for
Pb(II)-GGG-Cys2His2 (Figure 3.7E,F). These competition constants were fitted into eqn. 3.2 to determine
the dissociation constants, KdPb(II)-GGG values, for Pb(II)-GGG-series and resulted in values of 34.9 fM for
Pb(II)-GGG-Cys4, Kd value of 21.1 fM for Pb(II)-GGG-Cys3His1, and dissociation constant value of 13.9 pM
for Pb(II)-GGG-Cys2His2.

Figure 3.7: Determination of the Kd values for Pb(II)-GGG complexes via competition titration with Zn(II)-ion
at pH 7.5 (100 mM HEPES). Buffered solutions of the GGG peptides in the presence of competitor Zn(II)
were titrated with 10.0 mM Pb(NO3)2 solution. (A,B) Titration of Pb(NO3)2 into 33 μM GGG-Cys4 solution,
with 2.1 eq Zn(II) presence, fit a competition constant value of 3.3 between Pb(II) and Zn(II). Since the Kd
of Zn(II)-GGG-Cys4 is 110 fM at pH 7.5, the resulting Pb(II)-GGG-Cys4 dissociation constant is 34.9 fM.
(C,D) A solution of 28 μM GGG-Cys3His1 and 10.8 eq Zn(II) was titrated with Pb(NO3)2 to fit Kcomp value 5.4.
Since the Kd of Zn(II)-GGG-Cys3His1 is 520 fM at pH 7.5, the resulting Pb(II)-GGG-Cys3His1 Kd value is
21.1 fM. (E,F) Into 29 μM GGG-Cys2His2 and 3.1 eq Zn(II), 10.0 mM Pb(NO3)2 were titrated to fit Kcomp value
2.2. Since the Kd of Zn(II)-GGG-Cys2His2 is 31 pM at pH 7.5, the resulting Pb(II)-GGG-Cys2His2 dissociation
constant value is 13.9 pM.
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Analysis of the Conditional Dissociation Constant pH Dependence via Competition Titration
with Chelator EDTA. Figure 3.8 shows competition titration curves at pH 8.2 (100 mM HEPES), where
10.0 mM Pb(NO3)2 solution was titrated into buffered peptide solutions containing 2.0 eq EDTA,
a competitive chelator. EDTA is competing with the peptide for metal-ion binding with a dissociation
constant, KdPb(II)-EDTA value, of 2.17 × 10-16 M (for pH 8.2) - calculated as described in eqn. 3.12, with
KfPb(II)-EDTA value of 7.59 × 1017 M-1 and αY6− is 6.07 × 10-3.[120] The competition equilibrium binding isotherms
fit to competition constant value of 2.2 for Pb(II)-GGG-Cys4 (Figure 3.8A,B), Kcomp value of 3.4 for
Pb(II)-GGG-Cys3His1 (Figure 3.8C,D), and Kcomp value of 8.6 for Pb(II)-GGG-Cys2His2 (Figure 3.8E,F).
These competition constants were fitted into eqn. 3.8 to determine the dissociation constants,
KdPb(II)-GGG values, for Pb(II)-GGG-series and resulted in values of 481 aM for Pb(II)-GGG-Cys4, Kd value
of 0.74 fM for Pb(II)-GGG-Cys3His1, and dissociation constant value of 2.0 fM for Pb(II)-GGG-Cys2His2.
The main objective for using competition titration with EDTA was to verify the Kd values for
Pb(II)-GGG complexations as were determined by Pb(II)/Zn(II) competition titration. A comparison of the
KdPb(II)-GGG constants from both types of titrations showed that in the case of Pb(II)-GGG-Cys4, the KdPb(II)-GGG
value at pH 8.2 is 481 aM or 539 aM based on competition titration with EDTA or with Pb(II)/Zn(II),
respectively. Or, in the case of Pb(II)-GGG-Cys3His1, the KdPb(II)-GGG value at pH 8.2 is 0.74 fM or 7.3 fM
based on competition studies with EDTA or with Pb(II)/Zn(II), respectively. Both competition titration
methods resulted in similar KdPb(II)-GGG constants for the Pb(II)-GGG variants, within experimental error
(i.e. a factor of 10). Therefore, both methods can be applied for determining the conditional dissociation
constants for Pb(II)-GGG complexations.
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Figure 3.8: Determination of the Kd values for Pb(II)-GGG complexes via competition titration with EDTA
at pH 8.2 (100 mM HEPES). Buffered solutions of the GGG peptides in the presence of 2.0 eq competitor
EDTA were titrated with 10.0 mM Pb(NO3)2 solution. (A,B) Titration of Pb(NO3)2 into 33 μM GGG-Cys4
solution and EDTA, fit a competition constant value of 2.2 between GGG-Cys4 and EDTA. Since the Kd of
Pb(II)-EDTA is 217 aM at pH 8.2, the resulting Pb(II)-GGG-Cys4 dissociation constant is 481 aM. (C,D) A
solution of 28 μM GGG-Cys3His1 + EDTA was titrated with Pb(NO3)2 to fit Kcomp value 3.4, resulting in
Pb(II)-GGG-Cys3His1 Kd value of 0.74 fM. (E,F) Into 29 μM GGG-Cys2His2 and EDTA, Pb(NO3)2 were
titrated to fit Kcomp value 8.6, resulting in Pb(II)-GGG-Cys2His2 dissociation constant value of 2.0 fM.
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Potentiometric pH Titration. The Pb(II)-GGG effective acid dissociation constants, pKaeff values,
were measured via potentiometric pH titrations in the range of pH 10.0 to pH 3.0 followed by both UV-vis
and fluorescence spectroscopies. As the pH of the solution is lowered by addition of microliter aliquots of
0.1 M HNO3, an increase in tryptophan fluorescence emission intensity at 355 nm is observed. This is a
result of thiolate and imidazole ligand protonation and dissociation from the bound Pb(II). When Pb(II) is
bound to the peptide, at higher pH values, it has higher quenching effect on Trp fluorescence, but as the
pH is lowered and the peptide is protonated and loses its bounded structure, the Trp position become
farther from Pb(II) and feels less the quenching effect. Lowering the pH of the solution on the other hand
leads to a decrease in the absorbance spectra at S→Pb(II) LMCT as a result of Pb(II)-ligand bond
dissociation. Interestingly, when the pH of the solution lowered to pH 6.5, all three absorbance spectra
showed an increase in absorbance, prior to the expected decrease. This behavior is not observed in the
fluorescence emission spectra. A possible explanation is the formation of Pb(OH) 2 bonds. Pb(II) is known
to bind sulfur, nitrogen, and oxygen donors and have the ability to create complexes with coordination
numbers ranging from 2 to 12. As the Pb(OH)2 has a pKa of 6.48[186], it is possible that the new resulting
structure, Pb(II)(GGG)(OH)2, leads to an increase in absorbance. As the pH of the solution is lowered, the
peptide dissociates from the metal-ion resulting in the expected absorbance decrease. The absorbance
spectra for Pb(II)-GGG-Cys4 (Figure 3.9A-right) shows a midpoint for the increase absorbance slope at pH
5.5, therefore the proposed explanation does not support the observed behavior in this complex.
At the moment, it is unclear to the reason for the increase in the absorbance.
Figure 3.9A-left, shows that the fluorescence emission for the pH change in 200 μM
Pb(II)-GGG-Cys4 solution is best fitted to an equilibrium model involving two separate protonation events,
a cooperative three-proton event with a pKa1,2,3eff value of 4.1 and a one-proton event with pKa4eff value
of 5.8. Figure 3.9A-right, shows the UV-vis absorbance at S→Pb(II) LMCT bands for pH change in 200 μM
Pb(II)-GGG-Cys4 solution, and best fitted to an equilibrium model with a cooperative three-proton event
pKa1,2,3eff value of 4.2 and a one-proton event with a pKa4eff value of 5.8.
Figure 3.9B shows the pH change in 70 μM Pb(II)-GGG-Cys3His1 solution. Both spectral probes
(Trp fluorescence emission and the UV-vis for both S→Pb(II) LMCT transition) fit to a model involving
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a cooperative two-proton event with pKa2,3eff value of 4.6 and a one-proton event with a pKa4eff value of 4.9.
The protonation of the histidine imidazole, i.e. pKa1eff is not observed spectroscopically.
In Figure 3.9C the pH change, upon addition of acid into 130 μM Pb(II)-GGG-Cys2His2 solution,
provided a cooperative three-proton event with a metal-ligand effective acid dissociation constant,
pKa1,2,3eff value of 4.2 and a one-proton event with a pKa4eff value of 5.1.

Figure 3.9: Potentiometric pH titration of Pb(II)-GGG complexes. The effective acid dissociation constants
for Pb(II)-GGG complexes were determined from Trp fluorescence at 355 nm and absorbance spectra at
S→Pb(II) LMCT bands. (A) Pb(II)-GGG-Cys4; Fluorescence: pKa1,2,3eff = 4.1, pKa4eff = 5.8; UV-vis at 330 nm:
pKa1,2,3eff = 4.2, pKa4eff = 5.8 (B) Pb(II)-GGG-Cys3His1; Fluorescence: pKa2,3eff = 4.6, pKa4eff = 4.8; UV-vis at
330 nm: pKa2,3eff = 4.6, pKa4eff = 4.9 (C) Pb(II)-GGG-Cys2His2; Fluorescence: pKa1,2,3eff = 4.2, pKa4eff = 5.1;
UV-vis at 305 nm: pKa1,2,3eff = 4.3, pKa4eff = 5.2.
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pH Dependence of Conditional Dissociation Constants. The conditional dissociation constants
for the Pb(II)-GGG complexes are highly pH dependent due to the competition between metal-ion and
proton binding. The binding affinity at any given pH is conditioned by the speciation of the apo- and
holo-peptide. Apo-peptide speciation is defined by the intrinsic acid dissociation constants, pKa values,
determined from previous work[92]. Holo-peptide speciation is defined by the effective acid dissociation
constants, pKaeff values, determined from the Pb(II)-GGG potentiometric pH titration, as described above.
This pH dependence and speciation of Pb(II)-GGG complexes can be modeled by minimal equilibria sets
as shown is Scheme 3.1. The measured Kd values over a broad pH range are fitted to these equilibria
models and presented in Figure 3.10. From both Scheme 3.1 and Figure 3.10, the Pb(II)-GGG complexation
reaction and the conditional Kd values can be described by a combination of equilibria steps, which depend
on the pH conditions of the solution.

Scheme 3.1: Minimal equilibria used to model the pH dependence of Pb(II)-GGG complexation.
(A) Pb(II)-GGG-Cys4. (B) Pb(II)-GGG-Cys3His1. (C) Pb(II)-GGG-Cys2His2.
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Figure 3.10: pH dependence of conditional dissociation constants, Kd values. (A) Pb(II)-GGG-Cys4,
(B) Pb(II)-GGG-Cys3His1, (C) Pb(II)-GGG-Cys2His2. The formation constants, KfML values, for Pb(II)-GGG
with Cys4, Cys3His1, and Cys2His2 binding motifs are 7.3 × 1016, 3.7 × 1015, and 7.3 × 1013 M-1, respectively.
Resulting in free energy contribution of -23.0, -21.2, and -18.1 kcal/mol to the stabilization of
Pb(II)-GGG-Cys4, Pb(II)-GGG-Cys3His1, and Pb(II)-GGG-Cys2His2, respectively.

As with the Co(II)-GGG-Cys4 complexation, the conditional Kd value measured at any pH value for
Pb(II)-GGG-Cys4 (Scheme 3.1A and Figure 3.10A) can be described by any one or mixture of the four
equilibria steps:
𝐩𝐇 > p𝐾𝑎1−4 𝐶𝑦𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠
Pb(II) + [𝐆𝐆𝐆 − (Cys − )4 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )4 ]

(Eqn. 3.22)

p𝐾𝑎1−4 𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)4 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )4 ] + 4H +

(Eqn. 3.23)

p𝐾𝑎1−4 𝐶𝑦𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)4 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )3 − (CysH)] + 3H +

(Eqn. 3.24)

p𝐾𝑎1−4 𝐶𝑦𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇
Pb(II) + [𝐆𝐆𝐆 − (CysH)4 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (CysH)4 ]

(Eqn. 3.25)

At high pH values (eqn. 3.22), above the intrinsic pKa of the free Cys ligands (i.e. p𝐾𝑎1−4 𝐶𝑦𝑠 ), the fit levels
out at the value of the pH-independent formation constant, KfML value, corresponds to the dissociation of
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the fully deprotonated Pb(II)-GGG-Cys4 complex into free Pb(II)-ion and deprotonated GGG-Cys4.
The fit to the data in eqn. 3.19, gives KfML value of 7.3 × 1016 M-1 for this complex. This value corresponds
to -23.0 kcal/mol free energy contribution to the protein’s stabilization by Pb(II)-binding based on the relation
ΔGPb(II)-GGG-Obs = - RT ln(KfML), as was previously shown in eqn. 3.21. As the pH is lowered below the intrinsic
pKa values of the Cys ligands (eqn. 3.23) the conditional dissociation constants, Kd values, become pH
dependent due to proton competition, with a [H+]4 dependence. When the pH values approach the effective
pKa4eff-Cys and pKa1,2,3eff-Cys values of the Pb(II)-GGG-Cys4 complex (eqn. 3.24), the measured solutions will
contain a mixture of protonated cysteine thiol complexes with all four Cys ligands protonated
(i.e. Pb(II)-GGG-(CysH)4 or Pb(II)-tetrathiol) and only one Cys ligand protonated (i.e. Pb(II)-GGG-(CysH) or
Pb(II)-trithiolate monothiol). At these conditions the Kd values are pH dependent as well, however the
dependency is weaker than [H+]4 as fewer protons are released upon Pb(II)-binding. At low pH values
(eqn. 3.25), below both the intrinsic pKa values of the Cys ligands and the pKaeff of the Pb(II)-GGG complex,
the fit levels out again and corresponds to the value of the pH-independent formation constant, KfMLH4, for
fully protonated Pb(II)-GGG-Cys4 complex. Fitting the data to eqn. 3.19 gives a KfMLH4 value of 4.4 × 10-2 M-1
for the dissociation of the Pb(II)-GGG-(CysH)4 complex into free Pb(II)-ion and fully protonated
GGG-(CysH)4, indicating a limited affinity for Pb(II) at these pH conditions.
In the case of Pb(II)-GGG-Cys3His1 (Scheme 3.1B and Figure 3.10B), the binding reaction can be
described by the following six equilibria steps, and the Kd value measured at any pH value is given by any
one or mixture of these equilibria:
𝐩𝐇 > p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (Cys − )3 − (His)] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )3 − (His)]

(Eqn. 3.26)

p𝐾𝑎2−4 𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)3 − (His)] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )3 − (His)] + 3H +

(Eqn. 3.27)

p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > 𝐩𝐇 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)3 − (HisH + )] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )3 − (His)] + 4H +

(Eqn. 3.28)

p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)3 − (HisH + )] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (CysH) − (Cys − )2 − (His)] + 3H +

89

(Eqn. 3.29)

p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)3 − (HisH + )] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (CysH)3 − (His)] + 1H +

(Eqn. 3.30)

p𝐾𝑎2−4 𝐶𝑦𝑠 > p𝐾𝑎1 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎2,3 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1 𝑒𝑓𝑓−𝐻𝑖𝑠 > 𝐩𝐇
Pb(II) + [𝐆𝐆𝐆 − (CysH)3 − (HisH + )] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (CysH)3 − (HisH + )]

(Eqn. 3.31)

At high pH values (eqn. 3.26), above the intrinsic pKa of the free Cys and His ligands (i.e. p𝐾𝑎2−4 𝐶𝑦𝑠 and
p𝐾𝑎1 𝐻𝑖𝑠 ), the fit levels out and corresponds to the KfML value for the dissociation of the fully deprotonated
Pb(II)-GGG-Cys3His1 complex into free Pb(II)-ion and deprotonated GGG- Cys3His1 peptide. The fit to the
data, as shown in eqn. 3.20, gives KfML value of 3.7 × 1015 M-1 for this complex, which corresponds
to -21.2 kcal/mol free energy contribution to the stabilization of GGG by the binding of Pb(II)-ion, based on
eqn. 3.21. As the pH is lowered below the intrinsic pKa values of the unbound Cys ligands (eqn. 3.27),
proton competition leads the Kd values to express [H+]3 dependence as a result of the release of three
protons from the cysteine thiol ligands in the complexation of Pb(II) and GGG-(CysH)3-(His). Further
lowering the pH of the solutions, below the intrinsic pKa value of the unbound His ligand (eqn. 3.28), leads
to a release of four protons by the binding of Pb(II) to GGG-(CysH)3-(HisH+). Therefore, the Kd values under
these conditions exhibit [H+]4 dependence. When the pH values drop below the effective pKa4eff-Cys value of
the Pb(II)-bound thiolate (eqn. 3.29), the metal complexation produces protonated thiol deprotonated
dithiolate imidazole complex (i.e. Pb(II)-GGG-(CysH)-(Cys-)2-(His) complex). At these conditions
the Kd values are pH dependent as well, with dependency of [H+]3. Lowering the pH values below the
effective pKa2,3eff-Cys value of the Pb(II)-bound thiolates (eqn. 3.30), the metal complexation produces
protonated trithiol deprotonated imidazole complex (i.e. Pb(II)-GGG-(CysH)3-(His) complex). At these
conditions the Kd values are pH dependent as well, however the dependency is only [H+]1. At low pH values
(eqn. 3.31), below the effective pKa1eff-His value of the Pb(II)-bound imidazolium, both the reactants and the
products are tetraprotonated, thus the reaction is expected to be pH-independent. However, experimentally
the formation of the Pb(II)-GGG-(CysH)3-(HisH+) species is not observed, leading to the prediction of its
formation below pH 4.0. Fitting the data to eqn. 3.20 results in the leveling of the fit at low pH values, which
corresponds to a KfMLH4 value of 2.8 × 10-2 M-1 for fully protonated Pb(II)-GGG-Cys3His1 complex.
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In the case of Pb(II)-GGG-Cys2His2 (Scheme 3.1C and Figure 3.10C), the binding reaction can be
described by the following five equilibria steps, and the Kd value measured at any pH value is given by any
one or mixture of these equilibria:
𝐩𝐇 > p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠+2𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (Cys − )2 − (His)2 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )2 − (His)2 ]

(Eqn. 3.32)

p𝐾𝑎3−4 𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠+2𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)2 − (His)2 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )2 − (His)2 ] + 2H +

(Eqn. 3.33)

p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > 𝐩𝐇 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠+2𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (Cys − )2 − (His)2 ] + 4H +

(Eqn. 3.34)

p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > 𝐩𝐇 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠+2𝐻𝑖𝑠
Pb(II) + [𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (CysH) − (Cys − ) − (His)2 ] + 3H +

(Eqn. 3.35)

p𝐾𝑎3−4 𝐶𝑦𝑠 > p𝐾𝑎1−2 𝐻𝑖𝑠 > p𝐾𝑎4 𝑒𝑓𝑓−𝐶𝑦𝑠 > p𝐾𝑎1,2,3 𝑒𝑓𝑓−𝐶𝑦𝑠+2𝐻𝑖𝑠 > 𝐩𝐇
Pb(II) + [𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ] ⇌ [Pb(II) − 𝐆𝐆𝐆 − (CysH)2 − (HisH + )2 ]

(Eqn. 3.36)

At high pH values (eqn. 3.32), above the intrinsic pKa of the free Cys and His ligands (i.e. p𝐾𝑎3−4 𝐶𝑦𝑠 and
p𝐾𝑎1−2 𝐻𝑖𝑠 ), the fit levels out and corresponds to the KfML value for the dissociation of the fully deprotonated
Pb(II)-GGG-Cys2His2 complex. The fit to the data, as shown in eqn. 3.19, gives KfML value of 7.3 × 1013 M-1
for this complex, which corresponds to -18.1 kcal/mol free energy contribution to the stabilization of
Pb(II)-GGG-Cys2His2 complex, based on eqn. 3.21. As the pH is lowered below the intrinsic pKa values of
the Cys ligands in the apo-peptide (eqn. 3.33), proton competition leads to the Kd values to express [H+]2
dependence as a result of the release of two protons from the cysteine thiol ligands to produce
Pb(II)-GGG-(Cys-)2-(His)2. Further lowering the pH of the solutions, below the intrinsic pKa value of the His
ligands in the apo-peptide (eqn. 3.34), leads to a release of four protons due to the complexation of free
Pb(II)-ion and dithiol diimidazolium GGG peptide. Therefore, the Kd values under these conditions exhibit
[H+]4 dependence. When the pH values drop below the effective pKa4eff-Cys value of the Pb(II)-bound thiolate
(eqn. 3.35), the metal complexation produces protonated monothiol deprotonated thiolate diimidazole
complex (i.e. Pb(II)-GGG-(CysH)-(Cys-)-(His)2 complex). At these conditions the Kd values are
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pH dependent as well, with the dependency of [H+]3. At low pH values (eqn. 3.36), below the effective
pKa1,2,3eff-Cys+2His value of the Pb(II)-bound thiolate diimidazolium both the reactants and the products are
tetraprotonated, thus the reaction is expected to be pH-independent.
The evaluation of proton competition in Pb(II)-GGG complexes as modeled by the minimal
equilibria in Scheme 3.1 is based on a combination of results from several experimental determinations,
thus it is critical to check and validate these models. Thermodynamic comparison of the free energy
𝑒𝑓𝑓

difference between the conditional binding constants (i.e. ∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎 ) to the free energy
difference between the formation constants of fully protonated bound complex, MLH 42+, and fully
𝑀𝐿2−

deprotonated bound complex, ML2-, (i.e. ∆∆𝐺 = ∆𝐺 𝐾𝑓
models. By

definition, the two

− ∆𝐺

must be equivalent.

𝑀𝐿𝐻4 2+

𝐾𝑓

) will allow for the validation of these

Calculations

of

the

ΔΔG

values

for

the Pb(II)-GGG complexes are given in the Appendix (eqns. A.106-A.112). Notably, each of the three
Pb(II)-GGG complexes have similar thermodynamic differences, within experimental error of 0.4 kcal/mol,
validating the proposed complete minimal equilibria models described in Scheme 3.1.

3.5 Discussion
In this study, the thermodynamic contribution of Pb(II)-ion binding to the three ZFPs coordination
motifs - Cys4, Cys3Hi1, and Cys2His2, in a designed minimalistic unstructured GGG peptide has been
evaluated as a function of pH. Equilibrium measurements were utilized to elucidate the solution speciation
of each Pb(II)-GGG complex over a broad pH range (i.e. between pH 3.0 – 10.0) and to determine the
intrinsic affinities of Pb(II) to these three ZFPs motifs. The data indicates pH-independent formation
constants, KfML values, of 7.3 × 1016 M-1, 3.7 × 1015 M-1, and 7.3 × 1013 M-1, which correspond to free energy
contribution of -23.0 kcal/mol, -21.2 kcal/mol, and -18.1 kcal/mol by the metal-ion binding to the protein
stabilization, for Pb(II)-GGG-Cys4, Pb(II)-GGG-Cys3His1, and Pb(II)-GGG-Cys2His2, respectively.
These results indicate that at high pH values (i.e. above pH 10.0) the Pb(II)-ion has preference binding
cysteine thiolate over histidine imidazole with a 4.9 kcal/mol range. As the pH is lowered below the intrinsic
cysteine pKa values, the dissociation constants, KdML values, become pH dependent due to proton
competition. Figure 3.11 shows that all three Pb(II)-GGG complexes possess similar Kd values of 78 pM at
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pH 6.8, within experimental error (i.e. a factor of 10 or 1.3 kcal/mol). The slope of the -logKd vs. pH plots,
for each complex variant, represent the protonation pattern of each complex and is unique to the
coordination motif based on its intrinsic pKa and pKaeff values. In the case of Pb(II)-GGG-Cys4, a one-proton
protonation event is observed followed by a cooperative three-proton event. For Pb(II)-GGG-Cys3His1,
a one-proton protonation event is followed by a cooperative two-proton event (protonation of the three Cys
ligands) and followed by another presumed one-proton event (protonation of His ligand). And in the case
of Pb(II)-GGG-Cys2His2, a one-proton protonation event of a Cys ligand is followed by a cooperative
three-proton event for protonation of Cys and both His ligands.

Figure 3.11: Comparison of the Kd values as a function of pH for the three Pb(II)-GGG complexes. All three
complexes, GGG-Cys4 (full circles ●, black line), GGG-Cys3His1 (empty circles 〇, red line), and
GGG-Cys2His2 (diamonds ◆, blue line), show to possess the same conditional dissociation constant, Kd
value, of 78 pM at pH 6.8, within experimental error (i.e. a factor of 10 or 1.3 kcal/mol).

The lack of energetic penalty for protein folding in the GGG scaffold allows for evaluation of the
energetic cost for natural ZFPs folding by a comparison of the Kd values for Pb(II)-GGG complexes at pH
6.7 and pH 7.0 with literature constants for natural ZFPs that undergo metal-induced protein folding events,
as shown in eqn. 3.39. These thermodynamic values are reported in Table 3.1.
ΔGapoZFP-folding = ΔGML-Pb(II)-ZFP-obs - ΔGML-Pb(II)-GGG-obs
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(Eqn. 3.37)

Table 3.1: The cost of protein folding upon Pb(II)-ion binding in zinc finger proteins.

Protein

pH

Protein
Kd

Protein
ΔGML-Obs
(kcal/mol)

GGG
Kd

GGG

Protein

ΔGML-Obs

ΔGapoZFP-folding

(kcal/mol)

(kcal/mol)

Ref

Pb(II)-Cys4 Sites
Chicken GATA-1 (CF)

7.0

156 pM

-13.91

6 pM

-15.30

+ 1.39

181

CP-1 (CCCC)

7.0

39 fM

-19.02

6 pM

-15.30

- 3.72

179

Pb(II)-Cys3His1 Sites
HIV-CCHC

6.7

300 pM

-13.51

177 pM

-13.33

- 0.21

179

CP-1 (CCHC)

6.7

80 pM

-14.32

177 pM

-13.33

- 1.02

179

CP-1 (CCCH)

6.7

12.6 pM

-15.46

177 pM

-13.33

- 2.16

180

-13.16

- 1.45

179

Pb(II)-Cys2His2 Sites
CP-1 (CCHH)

7.0

50 pM

-14.61

221 pM

In the case of the Cys4 site of Chicken GATA-1, where the Pb(II) data comparison shows that
ΔGapoZFP-folding value is positive, metal-ion binding contributes free energy to the protein folding process.
In other words, the protein folding process is being thermodynamically driven by the metal-ion binding.
This data indicates that the free energy cost of protein folding is minimal, less than +1.4 kcal/mol. This value
is significantly lower contribution than previously estimated in the literature (i.e. +16 kcal/mol)[88-90].
In the case of the Cys3His1 site of HIV-CCHC, the value of ΔGapoZFP-folding is close to zero kcal/mol.
This finding indicates that the energetic cost for folding this natural zinc finger is equivalent to the cost of
folding the GGG peptide. This value is presumed to be zero kcal/mol because GGG lacks secondary
structure in both apo- and holo-states and the Zn(II)-GGG-Cys3His1 data are identical to Zn(II)-TFIIB which
is prefolded prior to Zn(II) binding. These data support the conclusion that the free energy cost of protein
folding in most ZFPs is minimal, less than +4.5 kcal/mol.
One particular case stands out – the three binding motifs in CP-1[179,180] with tighter Pb(II)-binding
affinities than Pb(II)-GGG complexes, resulting in negative protein folding cost, ΔGapoZFP-folding values
of -3.72 kcal/mol, -2.16 kcal/mol, -1.02 kcal/mol, and -1.45 kcal/mol for CP-1(CCCC), CP-1(CCCH),
CP-1(CCHC), and CP-1(CCHH), respectively. The zing finger Consensus Peptide 1 (CP-1) is a 26 amino
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acid peptide designed by Krizek et al.[95,96] based on the consensus sequence from 131 ZFPs.
Therefore, one may state that CP-1 represents an optimized peptide sequence for folding. The observed
behavior can be also explained by the shift in the pKa and pKaeff values for CP-1 variants, as compared to
the GGG variants. As discussed earlier in Chapter Two of this thesis and shown in Figure 2.6A, small
changes in the pKa and pKaeff values result in substantial changes in Kd values. Table 3.2 shows the intrinsic
pKa values for both CP-1 and GGG peptides. It is evident that all three binding motifs in CP-1 show an
acidic shift in their intrinsic acid dissociation constants. This can be explained by the presence of cationic
amino acid side chains from arginine (Arg) and four lysine (Lys) residues. Although pKaeff values for CP-1
has yet to be reported, they are likely to be lower (more acidic) than those reported for the GGG variants.
Furthermore, the tighter affinity for CP-1(CCCC), as compared to the other binding motifs, can be explained
by the Arg-Cys electrostatic interactions that add to the stabilization of the folded peptide structure.
The amino acid sequence of the CP-1 variants is as follows:
ProTyrLysCysProGluCysGlyLysSerPheSerGlnLysSerAspLeuValLysXGlnArgThrXThrGly
Arg is positioned towards the C-terminal of the peptide, between the two X amino acid residues that can be
either His or Cys. The positive side chain of Arg can interact with the negative thiolate in Cys residue
through electrostatic interactions and stabilize the folded structure, leading CP-1(CCCC) to be a more
stable structure and hence with a more negative ΔGapoZFP-folding value.

Table 3.2: Intrinsic pKa values for GGG and CP-1 variants.
Cys4
Residue

GGG

[92]

Cys3His1
CP-1 [98]

GGG

[92]

Cys2His2

CP-1 [98]

GGG

[92]

CP-1 [98]

His

-

-

-

-

6.5

6.3

His

-

-

6.5

6.4

6.9

6.3

Cys

7.8

7.6

-

-

-

-

Cys

8.1

8.1

8.1

7.6

-

-

Cys

8.7

8.7

8.6

8.5

8.8

7.7

Cys

9.0

9.1

9.0

8.7

9.1

8.7
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As the main objective of this thesis is to understand the role of a specific metal-ion cofactor on the
metal-protein thermodynamics, a comparison of the observed behavior for Pb(II) to the previously reported
behavior for Zn(II) is important. The Pb(II)-ion shows to have preference for binding cysteine thiolates
compared to histidine imidazole, with pH-independent formation constants, KfML values, of 7.3 × 1016 M-1,
3.7 × 1015 M-1, and 7.3 × 1013 M-1, for Pb(II)-GGG-Cys4, Pb(II)-GGG-Cys3His1, and Pb(II)-GGG-Cys2His2,
respectively, indicating a loss of approximately 2.0 to 3.0 kcal/mol for each Cys to His substitution. The
Zn(II)-ion was reported to also prefer binding cysteine thiolate over histidine imidazole. The KfML values
reported for Zn(II)-GGG complexes are 5.6 × 1016 M-1, 1.5 × 1015 M-1, and 2.5 × 1013 M-1 for
Zn(II)-GGG-Cys4, Zn(II)-GGG-Cys3His1, and Zn(II)-GGG-Cys2His2, respectively, indicating a loss of
approximately 2.0 kcal/mol as well for each Cys to His substitution.[92] The formation constants of the
Pb(II)-GGG complexes are 1.3 to 3.0 fold tighter than the Zn(II)-GGG formation constants, demonstrating
that independently of pH, Pb(II) can thermodynamically compete with Zn(II) for all three deprotonated zinc
binding motifs.
The evaluation of the free energy cost for apo-ZFPs folding based on data in Table 3.1 indicates
that in natural ZFPs less than +1.4 kcal/mol are required to fold the protein. This evaluation is comparable
with previously reported data in the Zn(II)-GGG complexes study where ΔGapoZFP-folding for most ZFPs is less
than +4.2 kcal/mol[92], as well as with the reported ΔGapoZFP-folding value less than +4.5 kcal/mol, based on
Co(II)-GGG complexation study in Chapter Two of this thesis.
Figure 3.12 shows the free energy diagram for Zn(II)-GATA vs. Pb(II)-GATA complexation. The
observed thermodynamic values of -14.6 kcal/mol and -13.9 kcal/mol for ΔGZn(II)-GATA-obs and ΔGPb(II)-GATA-obs,
respectively, were calculated from the published conditional dissociation constants, Kd values, by Godwin
and colleagues.[96,181] The energetic cost for natural GATA protein folding, ΔGapofolding, upon Zn(II) vs. Pb(II)
binding was evaluated by comparison of the literature metal(II)-GATA binding affinities to the
metal(II)-GGG constants. The Pb(II)-GGG value of 1.4 kcal/mol was determined in this research and
presented earlier in Table 3.1, while the Zn(II)-GGG value of 0.5 kcal/mol was obtained from previously
published Zn(II) studies by Gibney and coworkers [92]. The energy levels for the apo-Unfolded structure of
GATA are the same in both free energy diagrams, whereas the apo-Folded energy levels for Zn(II)-GATA
and Pb(II)-GATA are distinct due to the different thermodynamic contribution of each metal-ion to the folding
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of the protein. Hence it can be concluded that the two folded structures are dissimilar, and Pb(II) binding to
GATA results in a different folded structure compared to Zn(II)-GATA complex. This observation confirms
Godwin and colleagues proposed hypothesis that Pb(II) binding changes protein’s folding[181]. The actual
free energy contribution by metal-ligand binding, ΔGML value, is the sum of the observed experimentally
ΔGML-Obs value and the determined ΔGapofolding value (i.e. ΔGML = ΔGML-Obs + ΔGapofolding). Therefore, the
thermodynamic contribution of Zn(II) and Pb(II) binding to GATA is equivalent (15.1 kcal/mol and
15.3 kcal/mol for Zn(II)-GATA and Pb(II)-GATA, respectively).

Figure 3.12: Free energy diagram for Zn(II)-GATA vs. Pb(II)-GATA complexation. The thermodynamic
contribution of Zn(II) and Pb(II) binding to GATA is equivalent.
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3.6 Conclusions
In this chapter, the thermodynamic contribution of Pb(II)-binding to each of the three naturally
occurring ZFPs binding motifs in a designed unstructured simple peptide, GGG, was elucidated. The lack
of energetic penalty for protein folding in the GGG scaffold allowed for evaluation of the the intrinsic affinity
of each site for Pb(II). These pH-independent Pb(II)-GGG formation constants demonstrated that cysteine
thiolate is a better ligand for Pb(II)-ion as compared to histidine imidazole, and each substitution of Cys by
His ligand lowered the contribution of Pb(II)-binding towards protein stabilization by ~ 2.0 kcal/mol.
At pH 6.8 the three binding motif variants showed to possess similar conditional dissociation constants.
Furthermore, these data allowed for an anlysis of the energetic cost for natural ZFPs folding when Pb(II)
binds for proteins that undergo metal-induced protein folding events showed that the cost for apo-ZFPs
folding in natural ZFPs appears to be minimal (less than +1.4 kcal/mol) compared to the contribution of
Pb(II) binding (-14 kcal/mol). This evaluation is comparable with the minimal energetic cost of folding, less
than +4.5 kcal/mol, as was shown in Chapter Two of this thesis (Co(II)-GGG complexation studies), and
less than +4.2 kcal/mol, as was previously reported in the Zn(II)-GGG complexes study[92]. Therefore, we
confirm that the proposed GGG model is an effective asset in the study of the energetic cost for ZFPs
folding regardless of the metal-ion cofactor.
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CHAPTER FOUR – Summary
The work in this thesis seeks to understand the principal that governs the thermodynamics for
metalloprotein structure and function. The research presented herein studied the metal-induced protein
folding phenomena in metalloproteins and the role a specific metal-ion cofactor has on these
thermodynamics. For this purpose, an unstructured minimally designed peptide, GGG, with incorporated
Cys4-xHisx (x=0,1,2) was utilized as it lacks energetic penalty for protein folding, thus possessing
the maximal affinity for metal-ions. Equilibrium measurements provided values for conditional dissociation
constants over a broad pH range as well as values for pH-independent metal(II)-peptide formation
constants (Table 4.1) for Co(II)- and Pb(II)-GGG complexes. The data demonstrated that Co(II)-ion has
no preference binding cysteine thiolate over histidine imidazole, while Pb(II)-ion has a preference binding
cysteine thiolate and each substitution of Cys by His lowered the contribution of Pb(II)-binding towards
protein stabilization by approximately 2.0 kcal/mol - similarly to the previously reported data for Zn(II) [92].
However, at pH 6.8, both Cys and His showed to be equivalent ligands for Pb(II) – a result of proton
competition at these conditions. An evaluation of the energetic cost for natural ZFPs folding that undergo
metal-induced protein folding events showed that the cost for apo-ZFPs folding in natural ZFPs is minimal,
less than 4.5 kcal/mol, as compared to the thermodynamic contribution by metal-ion binding (Table 4.1).
The GGG model is shown to be an effective asset in the study of the energetic cost for ZFPs folding
regardless of the metal-ion cofactor.

Table 4.1: The pH-independent formation constants and the thermodynamic contribution of Zn(II), Co(II),
and Pb(II) binding to the GGG variants.

Peptide
GGG-Cys4
GGG-Cys3His1
GGG-Cys2His2

KfML-Zn(II)

KfML-Co(II)

KfML-Pb(II)

ΔGML-Zn(II)

ΔGML-Co(II)

ΔGML-Pb(II)

(M-1) [92]

(M-1)

(M-1)

(kcal/mol) [92]

(kcal/mol)

(kcal/mol)

5.6 × 1016

3.4 × 1011

7.3 × 1016

- 22.8

- 15.7

- 23.0

1015

1011

1015

- 20.3

- 15.5

- 21.2

13

- 18.3

- 15.0

- 18.1

1.5 ×

2.5 × 10

13

2.2 ×

1.0 × 10

11

3.7 ×

7.3 × 10
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APPENDIX
I. Derivation of 1:1 Equilibrium Binding Model

M + L ⇌ ML

𝐾𝑑 =

[M][L]

(Eqn. A.1)

[ML]

Mass Balances:
LT = L + ML

(Eqn. A.2)

MT = M + ML

(Eqn. A.3)

Substitution of the mass balances (eqns. A.2 and A.3) for the free metal-ion, M, and the apo-peptide, L,
terms into the equilibrium constant, Kd, expression (eqn. A.1), and rearrangement in terms of
holo-peptide complexation, [ML], yields a quadratic equation (eqn. A.4):

𝐾𝑑 =

[M][L]
([MT ] − [ML])([LT ] − [ML]) [MT ][LT ] − [MT ][ML] − [ML][LT ] + [ML]2
=
=
[ML]
[ML]
[ML]

𝐾𝑑 [ML] = [MT ][LT ] − [MT ][ML] − [ML][LT ] + [ML]2
0 = [ML]2 − 𝐾𝑑 [ML] − [MT ][ML] − [ML][LT ] + [MT ][LT ]
0 = [ML]2 + (−( 𝐾𝑑 + [MT ] + [LT ]))[ML] + [MT ][LT ]

a × [ML]2 + b × [ML] + c = 0
Where:

(Eqn. A.4)

a=1
b = −( 𝐾𝑑 + [MT ] + [LT ])
c = [MT ][LT ]

Thus, the physically meaningful root for the concentration of [ML] is:
[ML] =

[ML] =

−b ± √b 2 − 4ac
2a
(𝐾𝑑 +[MT ]+[LT ])±√( −(Kd −[MT ]−[LT ])2 −4[MT ][LT ]
2

100

(Eqn. A.5)

The Absorbance Signal:
The absorbance signal, Abs, is the sum of the absorbance of holo-peptide, ML, and the free metal-ion,
M, and can be express as following:
Abs = Abs0 + (εBound × b × [ML]) + (εFree × b × [M])

(Eqn. A.6)

Where b is the pathlength of the cuvette (1.0 cm); 𝜀𝐵𝑜𝑢𝑛𝑑 is the molar-extinction coefficient of the bound
complex, ML; and 𝜀𝐹𝑟𝑒𝑒 is the molar-extinction coefficient of the free metal-ion, i.e. zero. Therefore, the
absorbance signal can be simplified and expressed by eqn. A.7:

Abs = Abs0 + (εBound × [ML])

(Eqn. A.7)

If we to substitute the term [ML] by its expression in eqn. A.5, it will give us the following equilibrium fit:
2

Abs = Abs0 + εBound × (

(𝐾𝑑 +[MT]+[LT])±√(−𝐾𝑑 −[MT]−[LT ]) −4[MT][LT ]
)
2

(Eqn. A.8)

The Fluorescence Signal:
The fluorescence signal, F, is related to the equilibrium concentration of the holo-peptide complex, ML,
by the following expression:
F = F0 + ∆F × αML

(Eqn. A.9)

Where F0 is the fluorescence of the apo-peptide (initial fluorescence); ΔF is the change in fluorescence
due to the M(II)-peptide complex, ML, formation; and αML is the mole fraction of ML formed. Thus, the
fluorescence signal can be expressed as in eqn. A.10:
F = F0 + (Flim − F0 ) ×

[ML]
[LT ]

(Eqn. A.10)

Where the substitution of [ML] term with its expression in eqn. A.5, gives the equilibrium fit:
F = F0 + (Flim − F0 ) × (

𝐾𝑑 +[MT ]+[LT ]±√(−𝐾𝑑 −[MT ]−[LT ])2 −4[MT ][LT ]
)
2[LT ]
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(Eqn. A.11)

II. Derivation of Equilibrium Competition Binding Model with a Chelator

M + L ⇌ ML

𝐾𝑑 𝑀𝐿 =

M + B ⇌ MB

𝐾𝑑 𝑀𝐵 =

[M][L]

(Eqn. A.12)

[ML]
[M][B]

(Eqn. A.13)

[MB]

Where L is the apo-peptide; M is the free metal-ion; ML is the M(II)-peptide complex; B is the free
competitor (chelating agent such as EGTA or EDTA); and MB is the M(II)-competitor complex.
Competition Binding Reaction:
ML + B ⇌ L + MB

𝐾𝑐𝑜𝑚𝑝 =

[L][MB]

𝐾 𝑀𝐿

= 𝐾 𝑑𝑀𝐵
[ML][B]

(Eqn. A.14)

𝑑

The value for Kcomp can be determined from the titration experiments.
The value for KdMB can be calculated from the formation constants for metal-EGTA or metal-EDTA
complexes.[120]

II. a. Determination of K c o m p
Mass Balances:
LT = L + ML

(Eqn. A.15)

BT = B + MB

(Eqn. A.16)

MT = ML + MB

(Eqn. A.17)

Substitution of the competition binding constant, Kcomp, (eqn. A.14) with the mass balance terms
(eqns. A.15-A.17), and rearrangement in terms of [L] (as the decrease in the fluorescence
emission intensity is due to the amount of the free peptide present in the solution), gives the
quadratic equation:
a[L]2 + b[L] + c = 0

(Eqn. A.18)

Where: a = 1 − 𝐾𝑐𝑜𝑚𝑝
b = (−[MT ] − [LT ])𝐾𝑐𝑜𝑚𝑝 − [MT ] − [BT ]
c = −[MT ][LT ]𝐾𝑐𝑜𝑚𝑝

102

Thus, the meaningful root for the concentration of [L] is:
(Eqn. A.19)
[L] =

−((−[MT ]−[LT ])𝐾comp −[MT ]−[BT ])±√((−[MT ]−[LT ])𝐾comp −[MT ]−[BT ])2 −4(1−𝐾comp )(−[MT ][LT ]𝐾comp )
2(1− 𝐾comp )

The Absorbance Signal:
(Eqn. A.20)
2

Abs = Abs0 + εBound × (

(([MT ]+[LT ])𝐾comp +[MT ]+[BT ])±√((−[MT ]−[LT])𝐾comp −[MT ]−[BT ])

+4(1−𝐾comp )([MT ][LT ]𝐾comp)

2(1− 𝐾comp)

)

Where Abs is the measured absorbance; Abs0 is the initial absorbance of the apo-peptide; 𝜀𝐵𝑜𝑢𝑛𝑑
is the molar-extinction coefficient of the bound complex, ML; MT is the total concentration of the
metal-ion added; LT is the total concentration of the peptide in the solution; B T is the total
concentration of the competitor, EGTA, preset in the solution; Kcomp is the conditional competition
binding constant.

The Fluorescence Signal:
F = F0 − ∆F × αL

(Eqn. A.21)

Where F0 is the fluorescence of the apo-peptide (aka, the initial fluorescence); ΔF is the change
in fluorescence due to the ML complexation; and αL is the mole fraction of the free peptide, [L].
F = F0 − (Flim − F0 ) ×

[L]
[LT ]

Substitution of the [L] term with its expression from eqn. A.19, to give the following fit:
(Eqn. A.22)
2

F = F0 − (Flim − F0 ) × (

(([MT]+[LT ])𝐾comp+[MT ]+[BT ])±√((−[MT ]−[LT ])𝐾comp−[MT ]−[BT ])

2(1− 𝐾comp )[LT]

+4(1−𝐾comp )([MT ][LT ]𝐾comp )

)

Where F is the measured fluorescence emission; F 0 is the fluorescence measured for the
apo-peptide; Flim is the limiting fluorescence of ML complex; MT is the total concentration of the
metal-ion added; LT is the total concentration of the peptide in the solution; BT is the total
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concentration of the competitor, EGTA, preset in the solution; Kcomp is the conditional competition
binding constant.

II. b. Determination of K d M B
The conditional equilibrium dissociation constant of M(II)-competitor is express by eqn. A.23:
𝐾𝑑 𝑀𝐵 =

1

(Eqn. A.23)

𝐾𝑓 𝑀𝐵 ×𝛼𝑌4−

Where KdMB is the conditional equilibrium dissociation constant of M(II)-competitor complex, MB;
KfMB is the formation constant of the metal-ion with the chelator, EGTA or EDTA; αY4- is the mole
fraction of the fully deprotonated chelator, B.
EGTA and EDTA are monoprotic systems with several acid-dissociation steps. In the case of
EGTA, a tetraprotic system, there are four protonation steps as follow:
H4 Y ⇌ H3 Y − + H +

𝐾1 =

H3 Y − ⇌ H2 Y 2− + H +

𝐾2 =

H2 Y 2− ⇌ HY 3− + H +

𝐾3 =

HY 3− ⇌ Y 4− + H +

𝐾4 =

[H3 Y− ][H+ ]

(Eqn. A.24)

[H4 Y ]
[H2 Y2− ][H+ ]
[H3 Y− ]
[HY3− ][H+ ]

(Eqn. A.25)

(Eqn. A.26)

[H2 Y2− ]
[Y4− ][H+ ]

(Eqn. A.27)

[HY3− ]

The mole fraction of fully deprotonated B defined as:
αY4− =

[Y4− ]

(Eqn. A.28)

[B]

Where [B] is the total concentration of all free chelator species:
[B] = [H4 Y] + [H3 Y − ] + [H2 Y 2− ] + [HY 3− ] + [Y 4− ]

(Eqn. A.29)

Expression of the concentration for each specie (eqns. A.24-A.27) in terms of [Y4-], [H+], and K(1-4):
[H4 Y] =
[H3 Y − ] =

[H3 Y− ][H+ ]
𝐾1

=

[H2 Y2− ][H+ ]
𝐾2

[H2 Y2− ][H+ ]2

=

𝐾1 𝐾2
[HY3− ][H+ ]2
𝐾2 𝐾3

=
=

[HY3− ][H+ ]3
𝐾1 𝐾2 𝐾3
[Y4− ][H+ ]3
𝐾2 𝐾3 𝐾4
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=

[Y4− ][H+ ]4
𝐾1 𝐾2 𝐾3 𝐾4

(Eqn. A.30)
(Eqn. A.31)

[H2 Y 2− ] =
[HY 3− ] =

[HY3− ][H+ ]
𝐾3

=

[Y4− ][H+ ]2

(Eqn. A.32)

𝐾3 𝐾4

[Y4− ][H+ ]

(Eqn. A.33)

𝐾4

Substitution of the [B] in eqn. A.29 with the expressed concentrations in eqns. A.30-A.33:
[B] =

[B] =

4−
+ 4
[Y ][H ]

𝐾1 𝐾2 𝐾3 𝐾

+

4

4−
+ 3
[Y ][H ]

𝐾 2 𝐾3 𝐾

+

4

4−
+ 2
[Y ][H ]

𝐾3 𝐾4

+

4−
+
[Y ][H ]

𝐾4

+ [Y 4− ]

[Y 4− ][H + ]4 + [Y 4− ][H + ]3 𝐾1 + [Y 4− ][H + ]2 𝐾1 𝐾2 + [Y 4− ][H + ]𝐾1 𝐾2 𝐾3 + [Y 4− ]𝐾1 𝐾2 𝐾3 𝐾4
𝐾1 𝐾2 𝐾3 𝐾4

Substitution of the [B] term into the mole fraction (eqn. A.28) for EGTA, gives the following mole
fraction expression:
αY4− =

𝐾1 𝐾2 𝐾3 𝐾4
[H+ ]4 +[H+ ]3 𝐾1 +[H+ ]2 𝐾1 𝐾2 +[H+ ]𝐾1 𝐾2 𝐾3 +𝐾1 𝐾2 𝐾3 𝐾4

(Eqn. A.34)

In the case of EDTA (a hexaprotic system) there will be two additional protonation steps leading
to a mole fraction expression:
(Eqn. A.35)
αY6− =

𝐾1 𝐾2 𝐾3 𝐾4 𝐾5 𝐾 6
6

5

4

3

2

[H+ ] + [H+ ] 𝐾1 + [H+ ] 𝐾1 𝐾2 + [H+ ] 𝐾1 𝐾2 𝐾3 + [H+ ] 𝐾1 𝐾2 𝐾3 𝐾4 + [H+ ]𝐾1 𝐾2 𝐾3 𝐾4 𝐾5 + 𝐾1 𝐾2 𝐾3 𝐾4 𝐾5 𝐾6

The formation constant, KfMB, is the equilibrium constant for metal-chelator complex formation:
M n+ + Y 4− ⇌ MY n−4

𝐾𝑓 =

[MYn−4 ]
[Mn+ ][Y4− ]

(Eqn. A.36)

The value of the formation constant id given in the literature[120]: KfCo(II)-EGTA = 2.24×1012 M-1 and
KfPb(II)-EDTA = 7.59×1017 M-1.
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III. Derivation of Equilibrium Competition Binding Model with Two Meatal -Ions

M1 + L ⇌ M1 L

𝐾𝑑 𝑀1𝐿 =

M2 + L ⇌ M2 L

𝐾𝑑 𝑀2 𝐿 =

[M1 ][L]

(Eqn. A.37)

[M1 L]
[M2 ][L]

(Eqn. A.38)

[M2 L]

Where L is the apo-peptide; M1 is the free Zn(II)-ion; M1L is the Zn(II)-peptide complex; M2 is the free
Pb(II)-ion; M2L is the Pb(II)-peptide complex.
Competition Binding Reaction:
M1 L + M2 ⇌ M2 L + M1

Rearranging eqn. A.39:

𝐾𝑐𝑜𝑚𝑝 =

[M2 L][M1 ][L]
[M1 L][M2 ][L]

=

[M2 L][M1 ]
[M1 L][M2

=
]

𝑀 𝐿
𝐾d 1
𝑀 𝐿
𝐾d 2

(Eqn. A.39)

𝐾𝑑 𝑀2 𝐿 = 𝐾𝑐𝑜𝑚𝑝 × 𝐾𝑑 𝑀1𝐿

The value for Kcomp is given by the titration experiments.
The value for KdM1L, the conditional dissociation constant values for Zn(II)-GGG complexes, were
previously published by our group[91,92].

III. a. Determination of K c o m p
Mass Balances:
LT = M1 L + M2 L

(Eqn. A.40)

M1 T = M1 + M1 L

(Eqn. A.41)

M2 T = M2 + M2 L

(Eqn. A.42)

Substitution of the competition binding constant, Kcomp, (eqn. A.39) with the mass balance terms
(eqns. A.40-A.42), and rearrangement in terms of [M2L], gives the quadratic equation:

a[M2 L]2 + b[M2 L] + c = 0
Where:

(Eqn. A.43)

a = 1 − 𝐾𝑐𝑜𝑚𝑝
b = ([M2 T ] + [LT ])𝐾𝑐𝑜𝑚𝑝 + [M1 T ] − [M2 T ]
𝑐 = −[LT ][M2 T ]𝐾𝑐𝑜𝑚𝑝
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Thus, the physically meaningful root for the concentration of [M2L] is:
(Eqn. A.44)
2

[M2 L] =

−(([M2 T ]+[LT ])𝐾𝑐𝑜𝑚𝑝 +[M1 T ]−[M2 T ])±√(([M2 T ]+[LT ])𝐾𝑐𝑜𝑚𝑝 +[M1 T ]−[M2 T ]) −4(1− 𝐾comp )(−[LT ][M2 T ]𝐾comp )
2(1− 𝐾comp )

The Absorbance Signal:
(Eqn. A.45)
2

(−([M2 T ]+[LT ])𝐾𝑐𝑜𝑚𝑝 −[M1 T ]+[M2 T ])±√(([M2 T ]+[LT ])𝐾𝑐𝑜𝑚𝑝 +[M1 T ]−[M2 T ]) +4(1− 𝐾comp )[LT ][M2 T ]𝐾comp

Abs = Abs0 + εBound × (

2(1− 𝐾comp )

)

The Fluorescence Signal:
(Eqn. A.46)
2

(−([M2 T ]+[LT ])𝐾𝑐𝑜𝑚𝑝 −[M1 T ]+[M2 T ])±√(([M2 T ]+[LT ])𝐾𝑐𝑜𝑚𝑝 +[M1 T ]−[M2 T ]) +4(1− 𝐾comp )[LT ][M2 T ]𝐾comp

F = F0 − (Flim − F0 ) × (

2(1− 𝐾comp )[LT ]

)

Where Abs and F are the measured absorbance and fluorescence emission, respectively; Abs 0
and F0 are the absorbance and fluorescence measured for the apo-peptide, respectively; 𝜀𝐵𝑜𝑢𝑛𝑑
is the molar-extinction coefficient of the holo-peptide while Flim is the limiting fluorescence of this
ML complex; M1T and M2T are the total concentration of the Zn(II) and Pb(II) added, respectively;
LT is the total concentration of the peptide in the solution; Kcomp is the conditional competition
binding constant.
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IV. Derivation of Equilibrium Protonation Model from Potentiometric pH Titration
The UV-vis and fluorescence emission spectra allowed for detection of protonation models for the
Co(II)-GGG complexes, as described below. The analogous models for the Pb(II)-GGG complexes
were derived similarly, but are not shown.

A. For Co(II)-GGG-Cys 4 complex:
Protonation Reactions:
3

(𝐾𝑎1,2,3 𝑒𝑓𝑓 ) =

MLH4 ⇌ MLH + 3H +

𝐾𝑎4 𝑒𝑓𝑓 =

MLH ⇌ ML + H +

[MLH][H+ ]3

(Eqn. A.47)

[MLH4 ]

[ML][H+ ]

(Eqn. A.48)

[MLH]

Mass Balance:
MLT = MLH4 + MLH + ML

(Eqn. A.49)

The mole fraction, α, of each protonation specie of the metal-ligand complex, i.e. ML, MLH, and
MLH4, can be given by substitution of the equilibrium constants expressions (eqns. A.47 and A.48)
into the mass balance for the total concentration of the various protonation states of the metal-ligand
species (eqn. A.49).
MLH4 =

[MLH][H + ]3
(𝐾𝑎1,2,3 𝑒𝑓𝑓 )

3

[MLH4 ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )
MLH =
[H + ]3

3

3

3

[MLH]𝐾𝑎4 𝑒𝑓𝑓
[MLH4 ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓 [MLH4 ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓
{plug
[MLH]
ML =
=
in
term}
=
=
[H + ]4
[H + ]
[H + ][H + ]3

Expression of MLT in terms of MLH:
MLT =

[MLH][H + ]3
(𝐾𝑎1,2,3 𝑒𝑓𝑓 )

[MLH] +
3+

[MLH]𝐾𝑎4 𝑒𝑓𝑓
[H + ]
3

=

3

[MLH][H + ]3 [H + ] + [MLH][H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) + [MLH]𝐾𝑎4 𝑒𝑓𝑓 [H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )
3

[H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )
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3

=

3

[MLH] ([H + ]4 + [H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) + 𝐾𝑎2 𝑒𝑓𝑓 [H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) )
[H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )

3

3

αMLH

[MLH]
[H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )
=
= [MLH] ×
𝑒𝑓𝑓 3
[MLT ]
[MLH] ([H + ]4 + [H + ](𝐾
) +𝐾
𝑎1,2,3

=

=

=

=

[H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )
3

10−4pH + 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 −pH

3

+ 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 +3p𝐾
𝑒𝑓𝑓
𝑎1,2,3

αMLH =

[MLH]
[MLT ]

=

= {replace [H + ] = 10−pH }

𝑒𝑓𝑓 −p𝐾 𝑒𝑓𝑓
𝑎4

+ 10−3p𝐾𝑎1,2,3

10−pH−3p𝐾𝑎1,2,3
𝑒𝑓𝑓
10−pH−3p𝐾𝑎1,2,3

3

[H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) )

𝑒𝑓𝑓

10−pH−3p𝐾𝑎1,2,3
10−pH−3pH−3p𝐾𝑎1,2,3

𝑒𝑓𝑓

3

[H + ]4 + [H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) + 𝐾𝑎4 𝑒𝑓𝑓 [H + ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )
10−pH−3p𝐾𝑎1,2,3

𝑎4

𝑒𝑓𝑓

𝑒𝑓𝑓 −pH

+ 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 −p𝐾 𝑒𝑓𝑓 −pH+pH
𝑎4

𝑒𝑓𝑓

𝑒𝑓𝑓
(10−3pH+3p𝐾𝑎1,2,3

+

𝑒𝑓𝑓
10pH−p𝐾𝑎4

= {cancel 10−pH−3p𝐾𝑎1,2,3

+ 1)

𝑒𝑓𝑓

1

}

(Eqn. A.50)

𝑒𝑓𝑓
𝑒𝑓𝑓
10−3pH+3p𝐾𝑎1,2,3
+10pH−p𝐾𝑎4
+1

Expression of MLT in terms of MLH4:
3

MLT = MLH4 +

αMLH4 =

[MLH4 ](𝐾𝑎1,2,3 𝑒𝑓𝑓 )
[H+ ]3

[MLH4 ]
= [MLH4 ] ×
[MLT ]

+

=

[H+ ]4

3

3

[MLH4 ]([H + ]4 + (𝐾𝑎1,2,3 𝑒𝑓𝑓 ) [H + ] + (𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓 )
[H + ]4

[H + ]4 + (𝐾𝑎1,2,3

=

=

3

[MLH4 ]([H+ ] +(𝐾𝑎1,2,3 𝑒𝑓𝑓 ) [H+ ]+(𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓 )

[H + ]4

=

=

[H+ ]4

3

4

3

[MLH4 ](𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓

𝑒𝑓𝑓 3

) [H + ] + (𝐾𝑎1,2,3

𝑒𝑓𝑓

3

= {replace [H + ] = 10−pH }

) 𝐾𝑎4

𝑒𝑓𝑓

10−4pH
10−4pH + 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 −pH

+ 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 −p𝐾 𝑒𝑓𝑓
𝑎4

10−4pH
10−4pH + 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 −4pH+3pH

+ 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 −p𝐾 𝑒𝑓𝑓 −4pH+4pH
𝑎4

10−4pH
10−4pH (1 + 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 +3pH
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+ 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓 −p𝐾 𝑒𝑓𝑓 +4pH
𝑎4

)

= {cancel 10−4pH }

αMLH4 =

[MLH4 ]
[MLT ]

=

1
𝑒𝑓𝑓 +3pH
𝑒𝑓𝑓 −p𝐾 𝑒𝑓𝑓 +4pH
𝑎4
1+10−3p𝐾𝑎1,2,3
+10−3p𝐾𝑎1,2,3

(Eqn. A.51)

The Absorbance Signal:
The absorbance signal is the sum of the absorbance of all holo-peptide protonated species, ML,
MLH, and MLH4, and can be express as following:
Abs = Abs0 + (εMLH × b × [MLH]) + (εMLH4 × b × [MLH4 ])

(Eqn. A.52)

Where Abs is the measured absorbance; Abs0 is the initial absorbance of the holo-peptide, ML; b is
the pathlength of the cuvette (1.0 cm); εMLH and εMLH4 are the molar-extinction coefficient of the
MLH and MLH4 species, respectively; [MLH] and [MLH4] are the mole fraction of these species.
Substitution of the mole fractions by their expression (eqns. A.50 and A.51) gives:
(Eqn. A.53)

Abs = Abs0 +

εMLH
(−3pH+3p𝐾𝑎1,2,3 𝑒𝑓𝑓 )

10

(pH−p𝐾𝑎4 𝑒𝑓𝑓 )

+10

+
+1

εMLH4
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 +3pH)

10

(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +4pH)

+10

+1

Where pKa1,2,3eff and pKa4eff are the effective acid dissociation constants of the metal-ligand complex.

The Fluorescence Signal:
The fluorescence signal is related to the equilibrium protonation by the following expression:
F = F0 + ∆FMLH × αMLH + ∆FMLH4 × αMLH4

(Eqn. A.54)

Where F0 is the initial fluorescence of the holo-peptide, ML; ΔFMLH and ΔFMLH4 are the change in
fluorescence due to the formation of MLH and MLH4 species, respectively; αMLH and αMLH4 are the
mole fraction of these species. Thus, the fluorescence signal can be expressed as in eqn. A.55:
(Eqn. A.55)

F = F0 +

∆FMLH
(−3pH+3p𝐾𝑎1,2,3 𝑒𝑓𝑓 )
(pH−p𝐾𝑎4 𝑒𝑓𝑓 )
10
+10
+1

+

∆FMLH4
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 +3pH)
(−3p𝐾𝑎1,2,3 𝑒𝑓𝑓 −p𝐾𝑎4 𝑒𝑓𝑓 +4pH)
10
+10
+1

Where pKa1,2,3eff and pKa4eff are the effective acid dissociation constants of the metal-ligand complex.
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B. For the Co(II)-GGG-Cys 3 His 1 complex:
Protonation Reactions:
MLH3 ⇌ ML + 3H +

3

(𝐾𝑎2,3,4 𝑒𝑓𝑓 ) =

[ML][H+ ]3

(Eqn. A.56)

[MLH3 ]

Mass Balance:
MLT = MLH3 + ML

(Eqn. A.57)

Substitution of the equilibrium constant expression (eqn. A.56) into the mass balance for the total
concentration of the various species of the metal-ligand (eqn. A.57) and rearrangement of the terms
gives the mole fraction, α, of the protonation specie MLH3:

αMLH3 =

[MLH3 ]
[MLT ]

=

1
𝑒𝑓𝑓 +3pH
1+10−3p𝐾𝑎2,3,4

(Eqn. A.58)

The Absorbance Signal:
The absorbance signal is the sum of the absorbance of all holo-peptide protonated species, i.e. ML
and MLH3, and can be express as following:
Abs = Abs0 +

10

εMLH3
(3pH−3p𝐾𝑎2,3,4 𝑒𝑓𝑓 )

(Eqn. A.59)
+1

Where Abs is the measured absorbance; Abs0 is the initial absorbance of the holo-peptide, ML;
εMLH3 is the molar-extinction coefficient of the MLH3 specie; pKa2,3,4eff is the effective acid dissociation
constants of the metal-ligand complex.

The Fluorescence Signal:
The fluorescence signal is related to the equilibrium protonation by the following expression:
F = F0 +

∆FMLH3
(3pH−3p𝐾𝑎2,3,4 𝑒𝑓𝑓 )
10
+1

(Eqn. A.60)

Where F0 is the initial fluorescence of the holo-peptide, ML; ΔFMLH3 is the change in fluorescence
due to the formation of the MLH3 specie; and pKa2,3,4eff is the effective acid dissociation constants of
the metal-ligand complex.
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C. For the Co(II)-GGG-Cys 2 His 2 complex:
Protonation Reactions:
2

(𝐾𝑎3,4 𝑒𝑓𝑓 ) =

MLH2 ⇌ ML + 2H +

[ML][H+ ]2
[MLH2 ]

(Eqn. A.61)

Mass Balance:
MLT = MLH2 + ML

(Eqn. A.62)

Substitution of the equilibrium constant expression (eqn. A.61) into the mass balance for the total
concentration of the various species of the metal-ligand (eqn. A.62) and rearrangement of the terms
gives the mole fraction, α, of the protonation specie MLH2:

αMLH2 =

[MLH2 ]
[MLT ]

=

1

(Eqn. A.63)

𝑒𝑓𝑓 +2pH
1+10−2p𝐾𝑎3,4

The Absorbance Signal:
The absorbance signal, Abs, is the sum of the absorbance of all holo-peptide protonated species,
i.e. ML and MLH2, and can be express as following:
Abs = Abs0 +

εMLH2
(2pH−2p𝐾𝑎3,4 𝑒𝑓𝑓 )
10
+1

(Eqn. A.64)

The Fluorescence Signal:
The fluorescence signal, F, is related to the equilibrium protonation by the following expression:
F = F0 +

∆F

MLH2
(2pH−3p𝐾𝑎3,4 𝑒𝑓𝑓 )
10
+1

(Eqn. A.65)

Where Abs0 and F0 are the initial UV-vis absorbance and fluorescence of the holo-peptide, ML,
respectively; εMLH2 is the molar-extinction coefficient of the MLH2 specie; ΔFMLH2 is the change in
fluorescence due to the formation of the MLH2 specie; and pKa3,4eff is the effective acid dissociation
constants of the metal-ligand complex.
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V. Derivation of pH Dependence of the Conditional Dissociation Constants
The minimal equilibria models for pH dependence of the metal binding to the Co(II)-GGG peptides were
derived from the general model, as described in Scheme 1.1 (Section 1.5), and are shown below. The
analogous models for the Pb(II)-GGG complexes were derived similarly, but are not shown.

A. For the Co(II)-GGG-Cys 4 complex:

Scheme A.1: Minimal equilibrium model used to fit the pH dependence of the conditional
dissociation constants at various pH values for Co(II)-GGG-Cys4 complex.
Protonation Reactions:
𝐾𝑎1 𝐿𝐻4 =

[LH3 ][H+ ]
[LH4 ]
3

(𝐾𝑎1,2,3 𝑒𝑓𝑓 ) =
𝐾𝑓 𝑀𝐿 =

[ML]
[M][L]

; 𝐾𝑎1 𝐿𝐻3 =

[MLH][H+ ]3
[MLH4 ]

; 𝐾𝑓 𝑀𝐿𝐻 =

[LH3 ][H+ ]
[LH4 ]

; 𝐾𝑎4 𝑒𝑓𝑓 =
[MLH]
[M][LH]

; 𝐾𝑎1 𝐿𝐻4 =

[LH3 ][H+ ]
[LH4 ]

[ML][H+ ]

[LH3 ][H+ ]
[LH4 ]

(Eqn. A.66)

(Eqn. A.67)

[MLH]

; 𝐾𝑓 𝑀𝐿𝐻4 =

; 𝐾𝑎1 𝐿𝐻4 =

[MLH4 ]
[M][LH4 ]

(Eqn. A.68)

Mass Balance:
LT = LH4 + LH3 + LH2 + LH + L

(Eqn. A.69)

MLT = MLH4 + MLH + ML

(Eqn. A.70)

The mole fraction of the apo-GGG, αL, in the solution can be given by substitution of the equilibrium
constants expressions (eqn. A.66) into the mass balance for the total concentration of the various
protonation states of the apo-ligand (eqn. A.69), as follow:
[LH] =

[L][H + ]
𝐿𝐻
𝐾𝑎4
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[LH2 ] =

[LH3 ] =

[LH4 ] =

LT =

[LH][H + ]
𝐿𝐻

𝐾𝑎3 2

= {plug in [LH]} =

[LH2 ][H + ]
𝐿𝐻

[LH3 ][H + ]

= {plug in [LH3 ]} =

𝐿𝐻

𝐾𝑎1 4
[L][H + ]4
𝐿𝐻

𝐿𝐻

𝐿𝐻
𝐾𝑎3 2 𝐾𝑎4

= {plug in [LH2 ]} =

𝐾𝑎2 3

𝐿𝐻

[L][H + ]2

+
𝐿𝐻

𝐿𝐻

𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4

[L][H + ]3
𝐿𝐻

𝐿𝐻

[L][H + ]3
𝐿𝐻

[L][H + ]4
𝐿𝐻

𝐿𝐻

𝐿𝐻

𝐿𝐻

𝐿𝐻
𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4

+
𝐿𝐻

𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4
𝐿𝐻

𝐿𝐻

𝐿𝐻
𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4

[L][H + ]2

+
𝐿𝐻

𝐿𝐻

[L][H + ]
𝐿𝐻
𝐾𝑎4

𝐾𝑎3 2 𝐾𝑎4

+ [L]

𝐿𝐻

𝐿𝐻
= {common denominator 𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4
}

=

𝐿𝐻4
𝐿𝐻4 𝐿𝐻3
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
[L][H + ]4 + 𝐾𝑎1
[L][H + ]3 + 𝐾𝑎1
𝐾𝑎2 [L][H + ]2 + 𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 [L][H + ] + 𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4
[L]
𝐿𝐻

𝐿𝐻

𝐿𝐻

𝐿𝐻
𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4

αL =

[L]
[L]
=
[LT ] [L][H + ]4 + 𝐾 𝐿𝐻4 [L][H+ ]3 + 𝐾 𝐿𝐻4 𝐾 𝐿𝐻3 [L][H + ]2 + 𝐾 𝐿𝐻4 𝐾 𝐿𝐻3 𝐾 𝐿𝐻2 [L][H + ] + 𝐾 𝐿𝐻4 𝐾 𝐿𝐻3 𝐾 𝐿𝐻2 𝐾 𝐿𝐻 [L]
𝑎4
𝑎1
𝑎1
𝑎2
𝑎1
𝑎2
𝑎3
𝑎1
𝑎2
𝑎3
𝐿𝐻

𝐿𝐻

𝐿𝐻

𝐿𝐻
𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4
𝐿𝐻

=

𝐿𝐻

𝐿𝐻

𝐿𝐻
𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4
𝐿𝐻4
𝐿𝐻4 𝐿𝐻3
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
𝐿𝐻
[H+ ]4 + 𝐾𝑎1
[H + ]3 + 𝐾𝑎1
𝐾𝑎2 [H + ]2 + 𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 [H+ ] + 𝐾𝑎1 4 𝐾𝑎2 3 𝐾𝑎3 2 𝐾𝑎4

= {replace [H+ ] = 10−pH }
=

10−p𝐾𝑎1
10−4pH + 10−3pH−p𝐾𝑎1

= {cancel 10−p𝐾𝑎1

𝐿𝐻4

+ 10−2pH−p𝐾𝑎1

𝐿𝐻4

−p𝐾𝑎2 𝐿𝐻3

𝐿𝐻4
−p𝐾𝑎2 𝐿𝐻3 −p𝐾𝑎3 𝐿𝐻2 −p𝐾𝑎4 𝐿𝐻

𝐿𝐻4
−p𝐾𝑎2 𝐿𝐻3 −p𝐾𝑎3 𝐿𝐻2 −p𝐾𝑎4 𝐿𝐻

+ 10−pH−p𝐾𝑎3

𝐿𝐻2
−p𝐾𝑎2 𝐿𝐻3 −p𝐾𝑎1 𝐿𝐻4

+ 10−p𝐾𝑎1

𝐿𝐻

−p𝐾𝑎3 𝐿𝐻2 −p𝐾𝑎2 𝐿𝐻3 −p𝐾𝑎1 𝐿𝐻4

}

(Eqn. A.71)
αL =

1
10−4pH+p𝐾𝑎1

𝐿𝐻4 +p𝐾 𝐿𝐻3 +p𝐾 𝐿𝐻2 +p𝐾 𝐿𝐻
𝑎4
𝑎2
𝑎3

+10−3pH+p𝐾𝑎2

𝐿𝐻3 +p𝐾 𝐿𝐻2 +p𝐾 𝐿𝐻
𝑎4
𝑎3

+10−2pH+p𝐾𝑎3

𝐿𝐻2 +p𝐾 𝐿𝐻
𝑎4

+10−pH+p𝐾𝑎4

𝐿𝐻

+1

The mole fraction of the holo-GGG, αML, in the solution can be given by substitution of the equilibrium
constants expressions (eqn. A.67) into the mass balance for the total concentration of the various
protonation states of the holo-ligand complexes (eqn. A.70), as follow:
MLH =

MLH4 =

[ML][H + ]
𝐾𝑎4 𝑒𝑓𝑓
[MLH][H + ]3
3

( 𝐾𝑎1,2,3 𝑒𝑓𝑓 )

= {plug in [MLH]} =

[ML][H + ]3 [H + ]
3

( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓
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=

[ML][H + ]4
3

( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓

MLT =

[ML][H + ]4
( 𝐾𝑎1,2,3

𝑒𝑓𝑓 3

) 𝐾𝑎4

𝑒𝑓𝑓

+

[ML][H + ]
𝐾𝑎4

𝑒𝑓𝑓

3

+ [ML] = {common denominator ( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓 }
3

=

αML =

3

[ML][H + ]4 + ( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) [ML][H + ] + ( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓 [ML]
3

( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓

[ML]
[ML]
=
3
3
𝑒𝑓𝑓
[MLT ] [ML][H + ]4 + ( 𝐾
) [ML][H + ] + ( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓 [ML]
𝑎1,2,3
3

( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓
3

=

=

αML =

( 𝐾𝑎1,2,3 𝑒𝑓𝑓 ) 𝐾𝑎4 𝑒𝑓𝑓
[H+ ]4

+ ( 𝐾𝑎1,2,3

𝑒𝑓𝑓 3

)

[H + ]

10−3p𝐾𝑎1,2,3
10−4pH +10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓

+ ( 𝐾𝑎1,2,3

𝑒𝑓𝑓

−pH

𝑒𝑓𝑓 3

) 𝐾𝑎4

𝑒𝑓𝑓

= {replace [H+ ] = 10−pH }

−p𝐾𝑎4 𝑒𝑓𝑓

+ 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓

−p𝐾𝑎4 𝑒𝑓𝑓

= {cancel 10−3p𝐾𝑎1,2,3

𝑒𝑓𝑓

−p𝐾𝑎4 𝑒𝑓𝑓 }

1

(Eqn. A.72)

𝑒𝑓𝑓 +p𝐾 𝑒𝑓𝑓
𝑒𝑓𝑓 −pH
𝑎4
10−4pH+3p𝐾𝑎1,2,3
+10p𝐾𝑎4
+1

The pH dependence of the conditional dissociation constant (Kd) can be related to the
pH-independent equilibrium constant (KfML) as follow:

𝐾𝑑 =

[M][LT ]
[MLT ]

[L]
αL
[ML]
αML

[M]

=

=

[M][L]αML

(Eqn. A.73)

[ML]αL

= {substitution of concentrations with equilibrium term in eqn. A. 68} = (𝐾𝑓 𝑀𝐿 )−1 ×

αML
αL

The fit for the plot -log Kd vs. pH, therefore, will be:
− log 𝐾𝑑 = −log [(𝐾𝑓 𝑀𝐿 )−1 ×

αML
αML −1
αL
] = log [(𝐾𝑓 𝑀𝐿 )−1 ×
] = log [𝐾𝑓 𝑀𝐿 ×
] = log [𝐾𝑓 𝑀𝐿 ×
αL
αL
αML
1

10−4pH+p𝐾𝑎1

𝐿𝐻4 +p𝐾 𝐿𝐻3 +p𝐾 𝐿𝐻2 +p𝐾 𝐿𝐻
𝑎2
𝑎3
𝑎4

+ 10−3pH+p𝐾𝑎2

𝐿𝐻3 +p𝐾 𝐿𝐻2 +p𝐾 𝐿𝐻
𝑎3
𝑎4

+ 10−2pH+p𝐾𝑎3

𝐿𝐻2 +p𝐾 𝐿𝐻
𝑎4

1
10−4pH+3p𝐾𝑎1,2,3

𝑒𝑓𝑓 +p𝐾 𝑒𝑓𝑓
𝑎4

+ 10p𝐾𝑎4

𝑒𝑓𝑓 −pH

+ 10−pH+p𝐾𝑎4

𝐿𝐻

+ 1]

+1

(Eqn. A.74)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−pH+p𝐾𝑎4 ) + 10(−4pH+p𝐾𝑎4 +3p𝐾𝑎1,2,3 )
)
(−pH+p𝐾
)
(−2pH+p𝐾
𝑎4
𝑎4 +p𝐾𝑎3 ) + 10(−3pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 ) + 10(−4pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 +p𝐾𝑎1 )
1 + 10
+ 10
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B. For the Co(II)-GGG-Cys 3 His 1 complex:

Scheme A.2: Minimal equilibrium model used to fit the pH dependence of the conditional
dissociation constants at various pH values for Co(II)-GGG-Cys3His1 complex.

Protonation Reactions:
𝐾𝑎1 𝐿𝐻4 =
𝐾𝑎1 𝑒𝑓𝑓 =
𝐾𝑓 𝑀𝐿 =

[LH3 ][H+ ]
[LH4 ]

; 𝐾𝑎1 𝐿𝐻3 =

[MLH3 ][H+ ]
[MLH4 ]
[ML]

[M][L]

[LH3 ][H+ ]
[LH4 ]
3

; (𝐾𝑎2,3,4 𝑒𝑓𝑓 ) =

; 𝐾𝑓 𝑀𝐿𝐻3 =

[MLH3 ]
[M][LH3 ]

; 𝐾𝑎1 𝐿𝐻4 =

[LH3 ][H+ ]
[LH4 ]

; 𝐾𝑎1 𝐿𝐻4 =

[LH3 ][H+ ]
[LH4 ]

[ML][H+ ]3

(Eqn. A.76)

[MLH3 ]

; 𝐾𝑓 𝑀𝐿𝐻4 =

(Eqn. A.75)

[MLH4 ]

(Eqn. A.77)

[M][LH4 ]

Mass Balance:
LT = LH4 + LH3 + LH2 + LH + L

(Eqn. A.78)

MLT = MLH4 + MLH3 + ML

(Eqn. A.79)

The mole fraction of the apo-GGG, αL, in the solution is the same as derived in eqn. 72.
Substitution of the equilibrium constants expressions (eqn. A.76) into the mass balance for the total
concentration of the various protonation states of the holo-ligand complexes (eqn. A.79), gives the
mole fraction of the holo-GGG, αML, in the solution:
αML =

1

(Eqn. A.80)

𝑒𝑓𝑓 +3p𝐾
𝑒𝑓𝑓
𝑒𝑓𝑓 −3pH
𝑎2,3,4
10−4pH+p𝐾𝑎1
+103p𝐾𝑎2,34
+1

Substitution of the mole fractions of the apo- and holo-GGG (eqns. A.72 and A.80) into the relation
between the pH dependent Kd and the pH-independent KfML (eqn. A.73), gives the following plot fit:
(Eqn. A.81)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−3pH+3p𝐾𝑎2,3,4 ) + 10(−4pH+p𝐾𝑎1 +3p𝐾𝑎2,3,4 )
)
(−pH+p𝐾
)
𝑎4
1 + 10
+ 10(−2pH+p𝐾𝑎4+p𝐾𝑎3) + 10(−3pH+p𝐾𝑎4+p𝐾𝑎3+p𝐾𝑎2) + 10(−4pH+p𝐾𝑎4+p𝐾𝑎3+p𝐾𝑎2+p𝐾𝑎1)
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C. For the Co(II)-GGG-Cys 2 His 2 complex:

Scheme A.3: Minimal equilibrium model used to fit the pH dependence of the conditional
dissociation constants at various pH values for Co(II)-GGG-Cys2His2 complex.

Protonation Reactions:
𝐾𝑎1 𝐿𝐻4 =

[LH3 ][H+ ]
[LH4 ]
2

(𝐾𝑎1,2 𝑒𝑓𝑓 ) =
𝐾𝑓 𝑀𝐿 =

; 𝐾𝑎1 𝐿𝐻3 =

[MLH2 ][H+ ]2

[ML]
[M][L]

[MLH4 ]

; 𝐾𝑓 𝑀𝐿𝐻2 =

[LH3 ][H+ ]
[LH4 ]
2

; 𝐾𝑎1 𝐿𝐻4 =

; (𝐾𝑎3,4 𝑒𝑓𝑓 ) =
[MLH2 ]
[M][LH2 ]

[LH3 ][H+ ]
[LH4 ]

; 𝐾𝑎1 𝐿𝐻4 =

[LH3 ][H+ ]
[LH4 ]

[ML][H+ ]2

(Eqn. A.83)

[MLH2 ]

; 𝐾𝑓 𝑀𝐿𝐻4 =

(Eqn. A.82)

[MLH4 ]

(Eqn. A.84)

[M][LH4 ]

Mass Balance:
LT = LH4 + LH3 + LH2 + LH + L

(Eqn. A.85)

MLT = MLH4 + MLH2 + ML

(Eqn. A.86)

The mole fraction of the apo-GGG, αL, in the solution is the same as derived in eqn. 72.
Substitution of the equilibrium constants expressions (eqn. A.83) into the mass balance for the total
concentration of the various protonation states of the holo-ligand complexes (eqn. A.86), gives the
mole fraction of the holo-GGG, αML, in the solution:
αML =

1

(Eqn. A.87)

𝑒𝑓𝑓 +2p𝐾
𝑒𝑓𝑓
𝑒𝑓𝑓 −2pH
𝑎3,4
10−4pH+2p𝐾𝑎1,2
+102p𝐾𝑎34
+1

Substitution of the mole fractions of the apo- and holo-GGG (eqns. A.72 and A.87) into the relation
between the pH dependent Kd and the pH-independent KfML (eqn. A.73), gives the following plot fit:
(Eqn. A.88)
𝑒𝑓𝑓

−log𝐾𝑑 = log (𝐾𝑓 𝑀𝐿 ×

𝑒𝑓𝑓

𝑒𝑓𝑓

1 + 10(−2pH+2p𝐾𝑎3,4 ) + 10(−4pH+2p𝐾𝑎1,2 +2p𝐾𝑎3,4 )
)
(−pH+p𝐾
)
𝑎4 + 10(−2pH+p𝐾𝑎4 +p𝐾𝑎3 ) + 10(−3pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 ) + 10(−4pH+p𝐾𝑎4 +p𝐾𝑎3 +p𝐾𝑎2 +p𝐾𝑎1 )
1 + 10
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VI. Validation of the Complete Co(II)-GGG Minimal Equilibria Models
The minimal equilibria models for pH dependence of the metal binding to the GGG peptides were
validated by a comparison of the free energy difference, ΔΔG, between the intrinsic and the effective
acid dissociation constants, pKa and pKaeff values, for each of the three Co(II)-GGG-complexes, to the
ΔΔG between the fully protonated bound complex, MLH42+, and fully deprotonated bound complex,
ML2-, formation constants.
A. For the Co(II)-GGG-Cys 4 complex:
𝑀𝐿

∆∆𝐺 = ∆𝐺 𝐾𝑓 − ∆𝐺

𝑀𝐿𝐻4

𝐾𝑓

?

𝑒𝑓𝑓

⇔ ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎

(Eqn. A.89)

The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pKaeff values:
𝑒𝑓𝑓

∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎
−2.303 × 1.9872036
−2.303 × 1.9872036

𝑒𝑓𝑓

𝑒𝑓𝑓

= −𝑅𝑇 ln (10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((9.0 + 8.7 + 8.1 + 7.8) − (3 × 6.3 + 6.7)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (33.6 − 25.6) = −10.9

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.90)

The free energy difference between the formation constants of fully protonated bound complex,
MLH42+, and fully deprotonated bound complex, ML2-:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (8.0) = −10.9

𝑐𝑎𝑙
× 298 𝐾 × (11.4 − 3.4) =
𝐾 𝑚𝑜𝑙

𝑘𝑐𝑎𝑙

(Eqn. A.91)

𝑚𝑜𝑙

B. For the Co(II)-GGG-Cys 3 His 1 complex:
The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pKaeff values:
𝑒𝑓𝑓

∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎
−2.303 × 1.9872036
−2.303 × 1.9872036

𝑒𝑓𝑓

𝑒𝑓𝑓

= −𝑅𝑇 ln (10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((9.0 + 8.6 + 8.1 + 6.5) − (4.8 + 3 × 6.5)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (32.2 − 24.3) = −10.8
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𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.92)

The free energy difference between the formation constants of fully protonated bound complex,
MLH42+, and fully deprotonated bound complex, ML2-:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (7.9) = −10.8

𝑐𝑎𝑙
× 298 𝐾 × (11.3 − 3.4) =
𝐾 𝑚𝑜𝑙

𝑘𝑐𝑎𝑙

(Eqn. A.93)

𝑚𝑜𝑙

C. For the Co(II)-GGG-Cys 2 His 2 complex:
The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pKaeff values:
𝑒𝑓𝑓

∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎
−2.303 × 1.9872036
−2.303 × 1.9872036

𝑒𝑓𝑓

𝑒𝑓𝑓

= −𝑅𝑇 ln (10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((9.1 + 8.8 + 6.9 + 6.5) − (2 × 5.0 + 2 × 6.9)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (31.3 − 23.8) = −10.2

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.94)

The free energy difference between the formation constants of fully protonated bound complex,
MLH42+, and fully deprotonated bound complex, ML2-:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (7.5) = −10.2
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𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

𝑐𝑎𝑙
× 298 𝐾 × (11.0 − 3.5) =
𝐾 𝑚𝑜𝑙
(Eqn. A.95)

VII. Reevaluation of the Equilibria Models for Zn(II) -CP1 Complexations
Due to the raised questions to the validity of the obtained pK’a4 values for Zn(II)-CP1 complexes by
Sénèque and Latour[98] when using the SPECFIT/32 program[142], the potentiometric titration data was
reanalyzed using the KaleidaGraph program[143]. The pH dependence of the CD spectra (Figure A.1),
measuring the appearance of S→Zn(II) LMCT bands during potentiometry measurements for each
Zn(II)-CP1 complex, were fit to the simplest chemically reasonable protonation model, as shown in
eqns. A.96-A.98 (based on the formally derived models for the GGG peptides in eqns. A.47-A.64).
These potentiometric models yielded the effective acid dissociation constants, i.e. the pK’a values*, of
the ligands bound to the metal-ion.
For the Zn(II)-CP1(CCCC) complex:
(Eqn. A.96)

CD = CD0 +

∆CDMLH
′
(−3pH+3p𝐾′ 𝑎1,2,3 )
10
+10(pH−p𝐾 𝑎4 ) +1

+

10

(−3p𝐾′ 𝑎1,2,3 +3pH)

∆CDMLH4

′
′
+10(−3p𝐾 𝑎1,2,3 −p𝐾 𝑎4 +4pH) +1

For the Zn(II)-CP1(CCHC) complex:
(Eqn. A.97)

CD = CD0 +

10

∆CDMLH2
(−2pH+2p𝐾′ 𝑎2,3 )
(pH−p𝐾′ 𝑎4 )
+10

+1

+

10

(−2p𝐾′ 𝑎2,3 +2pH)

∆CDMLH3

′
′
+10(−2p𝐾 𝑎2,3 −p𝐾 𝑎4 +3pH) +1

For the Zn(II)-CP1(CCHH) complex:
CD = CD0 +

∆CDMLH2
(2pH−2p𝐾′ 𝑎3,4 )
10
+1

(Eqn. A.98)

Where CD is the measured CD intensity; CD0 is the initial CD signal of the Zn(II)-CP1 complexes;
ΔCDMLH, ΔCDMLH2, ΔCDMLH3, and ΔCDMLH4 are the change in CD signal due to the formation of the
various protonation species of the metal complexes; and pK’a terms are the effective acid dissociation
constants of these metal-ligand complexes.

*

In this section the effective acid dissociation constants will be referred to as pK’a values (instead of pKaeff values) in
order to be consistent with the way they were originally reported and addressed by Sénèque and Latour[98].
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The non-linear least square fitting of the data (Figure A.1) using eqn. A.96 indicated that
Zn(II)-CP1(CCCC) complex undergoes a cooperative three protonation transition involving three Cys
residues (pK’a1,2,3) value of 4.8 and a separate one proton transition of the forth Cys residue (pK’a4)
value of 5.8, eqn. A.97 for Zn(II)-CP1(CCHC) complex showed a cooperative three proton transition
involving two Cys residues (pK’a2,3) value of 3.9 and a separate one proton event of the third Cys
residue (pK’a4) value of 5.3, and eqn. A.98 for Zn(II)-CP1(CCHH) complex exhibited a cooperative two
proton transition involving two Cys residues (pK’a3,4) value of 3.9.

Figure A.1: Potentiometric pH titration of Zn(II)-CP1 complexes. Data adopted from the reported Figure
6 by Sénèque and Latour[98] based on CD spectra at S→Zn(II) LMCT band, and reanalyzed using the
KaleidaGraph program. (A) Zn(II)-CP1(CCCC); pK’a1,2,3 = 4.8 (averaged from the two fits), pK’a4 = 5.8
(B) Zn(II)-CP1(CCHC); pK’a2,3 = 3.9, pK’a4 = 5.3 (C) Zn(II)-CP1(CCHH); pK’a3,4 = 3.9.

The minimal equilibria models for pH dependence of the Zn(II) binding to the CP1 peptides were
validated by a comparison of the free energy difference, ΔΔG, between the intrinsic and the effective
acid dissociation constants, pKa and pK’a values, for each of the three Zn(II)-CP1 complexes, to the
ΔΔG between the fully protonated bound complex, MLH4, and fully deprotonated bound complex, ML,
formation constants.
𝑀𝐿

∆∆𝐺 = ∆𝐺 𝐾𝑓 − ∆𝐺

𝑀𝐿𝐻4

𝐾𝑓
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?

⇔ ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾

′

𝑎

(Eqn. A.99)

A. For the Zn(II)-CP1(CCCC) complex:
The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pK’a values:
∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾
−2.303 × 1.9872036
−2.303 × 1.9872036

′

𝑎

′

= −𝑅𝑇 ln(10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾 𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾 ′ 𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((9.2 + 8.7 + 8.1 + 7.4) − (3 × 4.8 + 5.8)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (33.4 − 20.2) = −17.5

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.100)

The free energy difference between the formation constants of fully protonated bound complex,
MLH4, and fully deprotonated bound complex, ML:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (13.1) = −17.3

𝑐𝑎𝑙
× 298 𝐾 × (17.8 − 4.7) =
𝐾 𝑚𝑜𝑙

𝑘𝑐𝑎𝑙

(Eqn. A.101)

𝑚𝑜𝑙

B. For the Zn(II)-CP1(CCHC) complex:
The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pK’a values:
∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾
−2.303 × 1.9872036
−2.303 × 1.9872036

′

𝑎

′

= −𝑅𝑇 ln(10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾 𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾 ′ 𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((8.9 + 8.3 + 7.5 + 6.3) − (3 × 3.9 + 5.3)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (31.0 − 17.0) = −19.1

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.102)

The free energy difference between the formation constants of fully protonated bound complex,
MLH4, and fully deprotonated bound complex, ML:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (13.8) = −18.8
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𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

𝑐𝑎𝑙
× 298 𝐾 × (18.8 − 5.0) =
𝐾 𝑚𝑜𝑙
(Eqn. A.103)

C. For the Zn(II)-CP1(CCHH) complex:
The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pK’a values:
∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾
−2.303 × 1.9872036
−2.303 × 1.9872036

′

𝑎

′

= −𝑅𝑇 ln(10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾 𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾 ′ 𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((8.7 + 7.7 + 6.6 + 6.0) − (2 × 3.5 + 2 × 3.9)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (29.0 − 14.8) = −19.4

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.104)

The free energy difference between the formation constants of fully protonated bound complex,
MLH4, and fully deprotonated bound complex, ML:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (14.2) = −19.4
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𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

𝑐𝑎𝑙
× 298 𝐾 × (17.6 − 3.4) =
𝐾 𝑚𝑜𝑙
(Eqn. A.105)

VIII.

Validation of the Complete Pb(II) -GGG Minimal Equilibria Models

The minimal equilibria models for pH dependence of the metal binding to the GGG peptides were
validated by a comparison of the free energy difference, ΔΔG, between the intrinsic and the effective
acid dissociation constants, pKa and pKaeff values, for each of the three Pb(II)-GGG-complexes, to the
ΔΔG between the fully protonated bound complex, MLH42+, and fully deprotonated bound complex,
ML2-, formation constants.
A. For the Pb(II)-GGG-Cys 4 complex:
𝑀𝐿

∆∆𝐺 = ∆𝐺 𝐾𝑓 − ∆𝐺

𝑀𝐿𝐻4

𝐾𝑓

?

𝑒𝑓𝑓

⇔ ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎

(Eqn. A.106)

The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pKaeff values:
𝑒𝑓𝑓

∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎
−2.303 × 1.9872036
−2.303 × 1.9872036

𝑒𝑓𝑓

𝑒𝑓𝑓

= −𝑅𝑇 ln (10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((9.0 + 8.7 + 8.1 + 7.8) − (3 × 4.1 + 5.8)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (15.5) = −21.1

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.107)

The free energy difference between the formation constants of fully protonated bound complex,
MLH42+, and fully deprotonated bound complex, ML2-:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (15.5) = −21.1

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

𝑐𝑎𝑙
× 298 𝐾 × (16.9 − 1.4) =
𝐾 𝑚𝑜𝑙
(Eqn. A.108)

B. For the Pb(II)-GGG-Cys 3 His 1 complex:
The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pKaeff values:
𝑒𝑓𝑓

∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎
−2.303 × 1.9872036
−2.303 × 1.9872036

𝑒𝑓𝑓

𝑒𝑓𝑓

= −𝑅𝑇 ln (10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((9.0 + 8.6 + 8.1 + 6.5) − (4.0 + 2 × 4.6 + 4.9)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (14.1) = −19.2
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𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.109)

The free energy difference between the formation constants of fully protonated bound complex,
MLH42+, and fully deprotonated bound complex, ML2-:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (14.0) = −19.1

𝑐𝑎𝑙
× 298 𝐾 × (15.6 − 1.6) =
𝐾 𝑚𝑜𝑙

𝑘𝑐𝑎𝑙

(Eqn. A.110)

𝑚𝑜𝑙

C. For the Pb(II)-GGG-Cys 2 His 2 complex:
The free energy difference between the intrinsic and the effective acid dissociation constants, pKa
and pKaeff values:
𝑒𝑓𝑓

∆∆𝐺 = ∆𝐺 Σ𝑝𝐾𝑎 − ∆𝐺 Σ𝑝𝐾𝑎
−2.303 × 1.9872036
−2.303 × 1.9872036

𝑒𝑓𝑓

𝑒𝑓𝑓

= −𝑅𝑇 ln (10Σ𝑝𝐾𝑎 − 10Σ𝑝𝐾𝑎 ) = −2.303𝑅𝑇(log Σ𝑝𝐾𝑎 − log Σ𝑝𝐾𝑎 )

𝑐𝑎𝑙
× 298 𝐾 × ((9.1 + 8.8 + 6.9 + 6.5) − (3 × 4.2 + 5.1)) =
𝐾 𝑚𝑜𝑙
𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

× 298 𝐾 × (log13.6) = −18.5

𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

(Eqn. A.111)

The free energy difference between the formation constants of fully protonated bound complex,
MLH42+, and fully deprotonated bound complex, ML2-:
𝑀𝐿𝐻4

∆∆𝐺 = −2.303𝑅𝑇(log 𝐾𝑓𝑀𝐿 − log 𝐾𝑓
−2.303 × 1.9872036

𝑐𝑎𝑙
𝐾 𝑚𝑜𝑙

) = −2.303 × 1.9872036

× 298 𝐾 × (13.3) = −18.1
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𝑘𝑐𝑎𝑙
𝑚𝑜𝑙

𝑐𝑎𝑙
× 298 𝐾 × (13.9 − 0.6) =
𝐾 𝑚𝑜𝑙
(Eqn. A.112)
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